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ABSTRACT 
 Alcohol consumption is a leading cause of substance-related morbidity and mortality 
globally. In Canada, there are established Guidelines for Low-Risk Drinking, which are 
designed to reduce the risk of disease, injury, or death by outlining recommended maximum 
volumes of, and frequency for, alcohol consumption (Butt, Beirness, Gliksman, Paradis, & 
Stockwell, 2011). Exceeding the recommended limits places individuals at risk of developing 
alcohol use disorder (AUD), and subsequently increases the likelihood of alcohol-related 
adverse health outcomes. In rural, remote, and northern British Columbia (BC), there are 
significant rates of AUD and alcohol-related morbidity and mortality. In these geographic 
areas, the responsibility for recognition and treatment of patients with AUD usually resides 
with the primary care provider. Primary care management of patients with AUD in BC is 
supported by evidence-based treatment guidelines; however, these guidelines suggest that 
certain patients may benefit from referral to specialist AUD services, which may be a barrier 
to treatment in this geographic context. In rural, remote, and northern BC, primary care 
providers often experience significant barriers to referral of patients outside of the home 
community, suggesting that the guidelines may be discordant with the realities of AUD 
treatment in these areas. In order to improve AUD treatment, participation and success 
within patients’ home communities, an integrative review was conducted to assess the 
optimum primary care treatment modalities within rural, remote, and northern settings. The 
findings from this integrative review suggest that there are some modifications to current 
primary care practice, which could benefit patients with AUD in rural, remote, and northern 
BC. In order to enhance treatment options for future patients with AUD, recommendations 
for primary care practice, nurse practitioner education, and further research are proposed. 
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INTRODUCTION 
 Alcohol use disorder (AUD) is ubiquitous throughout many parts of the world. In 
2012, alcohol consumption accounted for 3.3 million deaths globally and 5.9 percent of all 
deaths worldwide (World Health Organization, 2014). In comparison, during 2014 there 
were an estimated 207,400 drug-related deaths globally (excluding alcohol) (United Nations 
Office on Drugs and Crime, 2016). These numbers demonstrate that the mortality risk posed 
by alcohol is significantly greater than all other drugs combined. In addition, there is also a 
significant risk of morbidity associated with excessive alcohol consumption; it has been 
linked to over 200 injury and disease processes (World Health Organization, 2015). 
Furthermore, because of the risk of violence and injuries related to intoxication, such as those 
associated with impaired driving, the health risks associated with alcohol use often extend 
beyond the individual consumer.  
 Canadians are not exempt from the deleterious effects of excessive alcohol 
consumption. During 2013, 18.9% of Canadians chronically exceeded the recommended safe 
amount of alcohol consumption as stated in the Guidelines for Low-Risk Drinking (Butt et 
al., 2011; Statistics Canada, 2014). Consequently, nearly one in five Canadians are directly at 
risk of adverse health effects related to alcohol consumption.  
  The impetus for this integrative review stemmed from my personal experiences 
working as an emergency department registered nurse (RN). During my career as a RN, I 
worked in emergency departments in the Lower Mainland of British Columbia (BC), and as 
far north as Whitehorse, Yukon. Regardless of the emergency department’s location, I 
observed a seemingly endless stream of patients who were either acutely intoxicated with 
alcohol, or who met the Diagnostic and Statistical Manual of Metal Disorders-V (DSM-V) 
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criteria for AUD (American Psychiatric Association, 2013). During my time working in 
northern emergency departments, I perceived that alcohol-related health and social 
dysfunction was disproportionally more prevalent then I had noted in my urban Lower 
Mainland experience. These acute care experiences lead me to consider how patients with 
AUD are managed in the primary care setting and whether there are any challenges 
specifically related to AUD treatment in the north. The resultant research question for this 
integrative review is: in rural, remote, and northern primary care settings, what is the 
optimum treatment for adults with AUD? The research question considers primary care 
settings in general, irrespective of whether the provider is a physician or a nurse practitioner. 
However, this particular integrative review does address the question from a nurse 
practitioner’s perspective because the review is a key component of my University of 
Northern British Columbia Masters of Science Nursing-Family Nurse Practitioner (MScN-
FNP) degree.  
 To narrow the focus of the research question, a geographical target area was chosen. 
Northern BC was selected because it exemplifies all of the requisite components of the 
research question and is the location where my nurse practitioner education was provided. 
This region is a large, northern geographical area that is sparsely populated and that has a 
significant prevalence of AUD (British Columbia Ministry of Health, 2013; University of 
Victoria, 2017a). Since primary care providers are the mainstay of rural health care service 
provision in BC, such providers are responsible for the majority of AUD screening, 
diagnosis, and treatment implementation (Slaunwhite & Macdonald, 2015). Furthermore, 
alcohol-specific services, such as inpatient detoxification units, residential treatment 
programs, and addictions medicine specialists, are only available in a select few locations in 
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Northern BC (Canada Drug Rehab Addiction Services Directory, 2017; McEachern et al., 
2016; Northern Health Authority, n.d.; Slaunwhite & Macdonald, 2015). This combination of 
attributes makes Northern BC an ideal location to examine rural, remote, and northern 
primary care treatment of AUD. 
 To begin the integrative review process, I conducted a preliminary literature search to 
gather relevant articles. This literature search produced a number of articles that addressed 
key aspects of the research question, but none that addressed it completely. As a result, 
literature from a variety of sources, both domestic and international, was synthesized to help 
answer the research question as fully as possible.  
 This literature review is comprised of four chapters, which will systematically 
address my research question. Chapter One, Background, provides a foundational 
understanding of AUD, AUD in BC, the current status quo of primary care treatment of 
AUD within Northern BC, and the Health Belief Model (HBM). Chapter Two, Methods, 
details the preliminary literature search, the focused search with the application of inclusion 
and exclusion criteria, and the methodological plan that provided for a comprehensive 
analysis of the selected literature. A visual representation of the disposition of all articles 
produced by the literature search is included within this chapter. In Chapter Three, Findings, 
common themes within the selected articles are identified through the use of a literature 
review matrix (see Appendix). The literature review matrix provided a standardized format 
through which the selected articles were evaluated for study attributes, strengths and 
weaknesses. In Chapter Four, Discussion, the common themes identified within the literature 
review matrix have been synthesized and applied in the context of rural, remote and northern 
primary care. The HBM is utilized in this chapter to support the discussion and to 
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substantiate any suggested changes to the current primary care model of AUD treatment. 
Since the role of nurse practitioners in rural, remote, and northern BC is currently expanding, 
ideas to enhance nurse practitioner education in the area of AUD are discussed. Lastly, gaps 
within the current body of evidence are highlighted with the intent of providing stronger 
evidence for the various AUD treatment modalities within a rural, remote, and northern 
primary care setting. Chapter Five, Conclusion, revisits the impetus for this integrative 
review, briefly summarizes the key findings, and closes by highlighting the importance of the 
nurse practitioner role within the context of rural, remote, and northern AUD treatment.  
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CHAPTER ONE: BACKGROUND 
 Alcohol enjoys a unique social status in Canadian culture that other psychoactive 
drugs do not. Toasts with alcohol are made at weddings, wakes, and other special occasions, 
and social gatherings are often centered on “having a drink” with friends and family. The 
social status of alcohol is fostered by its nearly ubiquitous availability in all regions in 
Canada (National Alcohol Strategy Working Group, 2007). Subsequently, alcohol is the most 
utilized psychoactive drug in Canada and is consumed by 80% of the population; this is four-
times the number of people who use tobacco (Public Health Agency of Canada, 2016). 
However, not all Canadians who drink alcohol do so in sufficient quantities or with sufficient 
frequently to increase their risk of health problems. 
Drinking alcohol in large quantities or for a long duration of time is associated with 
significant health risks (Alderazi & Brett, 2007; Molina, Gardner, Souza-Smith, & Whitaker, 
2014; Public Health Agency of Canada, 2016; Schuckit, 2009). These health risks can be the 
result of either acute intoxication, which instigates risk taking behaviour, or chronic 
consumption, which can lead to diseases in nearly every bodily system (Molina et al., 2014). 
In addition to the significant health risk associated with problematic alcohol consumption, 
there are also social and financial ramifications that affect the lives of many Canadians. 
It is estimated that in British Columbia (BC), there are 350,000 individuals who 
consume problematic amounts of alcohol consistent with AUD (British Columbia Ministry 
of Health, 2013). These individuals suffer more ill health and consume disproportionally 
more health care resources that those who abstain from, or consume small amounts of 
alcohol (Public Health Agency of Canada, 2016). A recent longitudinal study in BC reported 
that over a 10-year period, approximately 200,000 problematic drinkers were responsible for 
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nearly 700,000 health care visits. The majority of these visits (65%) took place in the 
primary care setting, with the remainder occurring in emergency departments or in hospitals 
(Slaunwhite & Macdonald, 2016). Clearly, assessing and treating AUD and its associated the 
health implications is an import component of primary care practice. Appropriate recognition 
and treatment has the potential to make a positive difference in the lives of individuals, 
families, and communities. 
This chapter will provide background information and context for the research 
question: in rural, remote, and northern primary care settings, what is the optimum treatment 
for adults with AUD? A description of AUD, its diagnostic criteria, its negative health 
effects, and its financial costs to Canadians will be provided. A review of pertinent Canadian 
statistics for prevalence of AUD will be presented, with a particular emphasis on northern 
British Columbia (BC). Northern BC was selected as a focus for this integrative review 
because the population can be classified as rural, remote, and northern, and there is sufficient 
research available to examine this population in depth. Further, a discussion regarding 
AUD’s etiology and its associated pathophysiological mechanisms will be presented in 
detail. An examination of the current Canadian and BC Guidelines will follow, with 
particular emphasis on variations between the guidelines. 
The final section of the background will discuss the Health Belief Model (HBM). The 
HBM is a behavioural change model that has been used since the 1950s (Champion & 
Skinner, 2008). The HBM helps to predict how likely an individual is to address a potential 
health problem. This integrative review is focused on improving AUD treatment for 
individuals who live in rural, remote, or northern communities, and as such, the HBM will be 
used to help guide treatment recommendations in hopes of successful remission of AUD. 
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Alcohol Use Disorder and Diagnostic Criteria 
AUD is a pattern of drinking behaviours that impair an individual’s ability to achieve 
goals and place the individual’s health at risk both in the short- and long-term. Health 
impacts are extensive but include: psychosis, risk for unintentional trauma, suicide, 
hypertension, pancreatitis, liver cirrhosis, and multiple types of cancer (Public Health 
Agency of Canada, 2016). AUD is a Diagnostic and Statistical Manual of Mental Disorders-
5 (DSM-5) diagnosis with rigid diagnostic criteria (American Psychiatric Association, 2013). 
It is a novel term that replaced the terms alcohol abuse and alcohol dependence found in the 
DSM-4 (American Psychiatric Association, 1998). AUD encompasses all of the previous 
diagnostic criteria for both alcohol abuse and alcohol dependence, with an additional 
criterion for cravings. However, it should be noted that some of the literature included in this 
review may still utilize the antiquated terminology because it was published prior to the 
release of the DSM-5.  
AUD is defined as, “a problematic pattern of alcohol use leading to clinically 
significant impairment or distress, as manifested by at least two of the following [diagnostic 
criteria], occurring within a 12-month period” (American Psychological Association, 2013, 
p. 490). Please refer to Table 1 for the list of diagnostic criteria for AUD. A key component 
of the AUD diagnostic criteria is the presence of withdrawal symptoms, such as tremors and 
anxiety, when drinking is reduced or stopped. Table 2 provides the diagnostic criteria for 
alcohol withdrawal. The presence of withdrawal symptoms is an important component for 
the diagnosis of AUD because they not only indicate more severe disease, but also pose a 
risk to the individual’s safety. The severity of AUD is graded in relation to the number of 
criteria present from Table 1. Mild AUD requires two or three criteria, moderate AUD 
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requires four or five criteria, and severe AUD requires six or more criteria (American 
Psychiatric Association, 2013). 
Table 1 DSM-5 Diagnostic Criteria for AUD 
1. Alcohol is often taken in larger amounts or over a longer period than was intended. 
2. There is a persistent desire or unsuccessful efforts to cut down or control alcohol use. 
3. A great deal of time is spent in activities necessary to obtain alcohol, use alcohol, or 
recover from its effects. 
4. Craving, or a strong desire or urge to use alcohol. 
5. Recurrent alcohol use resulting in a failure to fulfil major role obligations at work, 
school, or home. 
6. Continued alcohol use despite having persistent or recurrent social or interpersonal 
problems caused or exacerbated by the effects of alcohol. 
7. Important social, occupational, or recreational activities are given up or reduced 
because of alcohol use. 
8. Recurrent alcohol use in situations in which it is physically hazardous. 
9. Alcohol use is continued despite knowledge of having a persistent or recurrent physical 
or psychological problem that is likely to have been caused or exacerbated by alcohol. 
10. Tolerance, as defined by either of the following: 
• A need for markedly increased amounts of alcohol to achieve intoxication or 
desired effect. 
• A markedly diminished effect with continued use of the same amount of 
alcohol. 
11. Withdrawal, as manifested by either of the following: 
• The characteristic withdrawal syndrome for alcohol (refer to Criteria A and B 
the criteria set for alcohol withdrawal [see Table 2]. 
• Alcohol (or a closely related substance, such as a benzodiazepine) is taken to 
relieve or avoid withdrawal symptoms. 
(American Psychiatric Association, 2013, pp. 490–491) 
 
Table 2 DSM-5 Diagnostic Criteria for Alcohol Withdrawal 
A. Cessation of (or reduction in) alcohol use that has been heavy and prolonged. 
 
B. Two (or more) of the following, developing within several hours to a few days after the 
cessation (or reduction in) alcohol use described in Criterion A: 
• Autonomic hypersensitivity (e.g. sweating or pulse rate greater than 100bpm). 
• Increased hand tremor. 
• Insomnia. 
• Nausea or vomiting. 
• Transient visual, tactile, or auditory hallucinations or illusions. 
• Psychomotor agitation. 
• Anxiety. 
• Generalized tonic-colonic seizures. 
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C. The signs or symptoms of Criterion B cause clinically significant distress or 
impairment in social, occupational, or other important areas of functioning. 
D. The signs and symptoms are not attributed to another medical condition and are not 
better explained by another mental disorder, including intoxication or withdrawal from 
another substance. 
(American Psychiatric Association, 2013, pp. 499–500) 
Health Effects 
 Alcohol use has potential health implications in the setting of both short- and long-
term consumption. In the short-term, health impacts are positively correlated with the degree 
of impairment, and are dose-dependent on a single occasion. Whereas, for long-term 
consumption patterns, health impacts are associated with end organ damage over time and 
the development of dependence (Butt et al., 2011) Long-term alcohol exposure is positively 
correlated with the volume and duration of alcohol consumption (Butt et al., 2011; World 
Health Organization, 2014). To best facilitate early recognition and treatment, it is 
imperative that primary care providers remain vigilant for both the short- and long-term 
adverse effects of alcohol consumption because patients may present with either in the 
clinical setting. Specific details associated with short- and long-term consumption will be 
discussed more below.  
Short-Term Health Effects 
Short-term health effects are primarily linked to cognitive and psychomotor 
impairment, precipitating harm to the individual drinker as well as others. Homeostatic 
suppression due to the sedating effects of alcohol poses a risk for hypoventilation, aspiration, 
hypothermia, and death (Public Health Agency of Canada, 2016). Lay-people often refer to 
this state as “alcohol poisoning,” which, if left untreated, can result in permanent brain 
damage or even death. Violent acts against self and others, including up to 30% of all 
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suicides in Canada, are also associated with alcohol intoxication (Public Health Agency of 
Canada, 2016; World Health Organization, 2014).  
 However, driving while intoxicated by alcohol is likely the most publicly recognized 
short-term health risk. In BC, 35% of motor vehicle incident-related fatalities are attributed 
to impairment, primarily with alcohol (British Columbia Coroners Service, 2015). Other 
vehicle passengers, pedestrians, bicyclists, and other road users are also at significant risk of 
fatal harm from impaired drivers. Although mortality rates have improved since the 1980s, 
impaired driving continues to be a significant health risk today (Public Health Agency of 
Canada, 2016). Non-fatal injuries also represent a substantial concern in BC. In 2007 there 
were 2990 impaired driving related injuries in BC, representing a significant amount of 
morbidity, human suffering, health care resource consumption, and lost wages (BC Injury 
Research and Prevention Unit, 2017).  
Long-Term Health Effects 
Long-term health effects tend to be more difficult to directly attribute to the 
consumption of alcohol, and instead, researchers must rely on epidemiology for correlation. 
Epidemiological studies have helped to causally link a number of health conditions to long-
term alcohol consumption. These conditions include neurological, psychiatric, 
gastrointestinal, cardiovascular, and neoplastic diseases, which have high rates of morbidity 
and mortality (Public Health Agency of Canada, 2016). Many of the alcohol-associated 
conditions are quite severe, demonstrating the importance of proactive treatment in the 
primary care setting. 
Neurological and psychiatric conditions, including epilepsy, withdrawal seizures, 
anxiety, and depression, are all causally linked to long-term alcohol use (World Health 
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Organization, 2014). A change in an individual’s neurological and psychiatric capacity alters 
their ability to function in society, maintain employment, and to meet personal or family 
obligations. This alteration means that alcohol consumption affects not only the drinker, but 
also the greater community and support systems around them.  
Gastrointestinal disorders, most prominently liver cirrhosis, pancreatitis, and gastric 
ulcers are also causally linked to long-term alcohol use (Canadian Centre on Substance 
Abuse, 2014; Public Health Agency of Canada, 2016; World Health Organization, 2014). 
Morbidity and mortality are significant, especially for liver disease that has progressed to the 
point of decompensated cirrhosis (Martin, DiMartini, Feng, Brown, & Fallon, 2014). 
Hospitalization is usually required, and without liver transplantation, life expectancies are 
short (Martin et al., 2014).  
Cardiovascular diseases, such as stroke, myocardial infarction, and hypertension are 
also linked to long-term alcohol exposure (Public Health Agency of Canada, 2016; World 
Health Organization, 2014). These conditions are noted in patients who chronically exceed 
the Guidelines for Low-Risk Drinking (Table 3), and they represent significant sources of 
morbidity and mortality. However, there is some controversy regarding the cardiovascular 
effects of alcohol consumption. Some research suggests that low-dose alcohol can actually 
be cardioprotective and help to reduce the incidence of myocardial infarction, and stroke 
(Roerecke & Rehm, 2012). Cardioprotection is found in some, but not all epidemiological 
studies, and there is insufficient evidence to justify advocacy for prescriptive drinking 
(Roerecke & Rehm, 2012). 
Other significant health effects that show positive associations with long-term alcohol 
use include cancers of the mouth, throat, liver, breast, and digestive tract, as well as diabetes 
12 
 
and infectious diseases (Canadian Centre on Substance Abuse, 2014; Public Health Agency 
of Canada, 2016; World Health Organization, 2014). Patients suffering from any one of the 
health effects listed above tend to have a lower quality of life and will likely require greater 
amounts of health care services, with a large portion requiring specialist care. Overall, the 
social and systemic burdens of long-term drinking behaviours are severe. Addressing these 
health effects and their root causes needs to be a top priority for the public and for primary 
care providers alike.  
Fetal Alcohol Spectrum Disorder 
Pregnant women are a population of particular concern because of alcohol’s 
deleterious effects on unborn fetuses. Maternal consumption of alcohol places the fetus at 
high-risk for a spectrum of physical, emotional, behavioural, and neurological derangements, 
referred to as Fetal Alcohol Spectrum Disorder (FASD) (Cook et al., 2016; Public Health 
Agency of Canada, 2010). Although there is no known absolute volume of maternal alcohol 
consumption that precludes teratogenic effects in the fetus, larger volumes and greater 
frequency have been found to increase the risk to the fetus (Canadian Centre on Substance 
Abuse, 2014; May & Gossage, 2011; Public Health Agency of Canada, 2016; World Health 
Organization, 2014).  
Depending on the severity of FASD, children may have lifelong disabilities and may 
require more societal and familial resources throughout their lives (Public Health Agency of 
Canada, 2010). In the general Canadian population, approximately 14% of fetuses are 
exposed to alcohol, with some populations reaching exposure rates of 60% (Popova, Lange, 
Burd, & Rehm, 2015). Maternal alcohol ingestion does not necessarily result in FASD, as 
demonstrated by the Canadian FASD prevalence of approximately 1%, although certain 
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rural, remote, and northern communities FASD has been reported up to 20% (Popova et al., 
2015). There is a significant challenge in breaking the cycle for the next generation (Popova 
et al., 2015). The prevalence of FASD, especially in some of these communities, places a 
significant burden on families, communities, and the health care system. FASD prevalence is 
a key indicator that expectant mothers need to be a top priority when considering treatment 
for alcohol consumption. 
Financial Costs  
In Canada, alcohol is legally sold through provincial and territorial controlled 
distribution systems (Thomas, 2012). This means that the money raised through taxation and 
costs incurred, through health care and other indirect expenses, moves in and out of the same 
governmental coffers. The last detailed breakdown of the financial burden of alcohol in 
Canada was for the year 2003 (Rehm et al., 2006). At that time, the nation-wide total cost 
attributed to alcohol consumption was 14.6 billion dollars (Rehm et al., 2006). Although 
direct health care costs were the largest single expenditure at 3.3 billion dollars, law 
enforcement costs were a close second at 3.1 billion dollars (Thomas, 2012). By far, the 
largest cost associated with AUD in Canada is lost productivity at work, accounting for 7.1 
billion dollars (Thomas, 2012). Causes of lost productivity include: long-term disability, 
short-term disability, and premature death (Thomas, 2012). Additional costs associated with 
alcohol included traffic accident damage, fire damage, administrative costs, prevention and 
research, and losses associated with workplace damage (Public Health Agency of Canada, 
2016). Alcohol sales do generate tax revenue in Canada; however, the revenue generated is 
not enough to offset the associated costs (Public Health Agency of Canada, 2016; Thomas, 
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2012). The significant costs associated with alcohol consumption could be partially mitigated 
with appropriate treatment of AUD, thereby saving Canadians billions of dollars. 
Financial analysis provides objective evidence for the short- and long-term harms 
associated with alcohol use. However, the analysis is limited in its scope, and may be grossly 
underestimated, because it does not take into account the downstream costs of lost 
productivity for individuals, families, and communities.  
Alcohol in Canada 
Except for caffeine, alcohol is the most commonly used psychoactive substance in 
Canada (Public Health Agency of Canada, 2016). The Canada Centre on Substance Abuse 
(2014) reports that 70% of people aged 15 to 24, and 80% of people aged 25 and older used 
alcohol in the past year. These statistics are not directly indicative of AUD, but they clearly 
demonstrate the ubiquitousness of alcohol use in the Canadian culture. 
The prevalence of alcohol consumption in Canada may be partially attributed to its 
ease of access. All jurisdictions in Canada maintain governmental control over the sale of 
wholesale alcohol, which means that prices are uniformly set within each province or 
territory (Thomas, 2012). This means that a given bottle of alcohol costs the same in a port 
city as it does in a rural, remote, or northern community. This price-fixing makes alcohol 
seem relatively less expensive when compared to other essential food and drink commodities 
because, unlike those, alcohol prices are unaffected by transport costs (National Alcohol 
Strategy Working Group, 2007; Thomas, 2012). Governmental control over alcohol sales 
was originally instituted in order to limit the physical availability of alcohol, and to ensure 
that social responsibilities were not subordinated by financial pressure; however, in today’s 
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society this price-fixing facilitates relatively easier access for those in rural, remote, and 
northern communities (National Alcohol Strategy Working Group, 2007).  
Alcohol holds a prominent status in the social fabric of Canadian culture, likely 
contributing to Canadians consuming more alcohol than is considered safe or at least without 
deleterious effect (Public Health Agency of Canada, 2016). Alcohol is often consumed in 
celebration or at social gatherings, and there is often an expectation among peers that social 
events will involve drinking alcohol. In Canada, drinking alcohol is viewed as being 
generally acceptable, which promotes consumption and can lead to people feeling as though 
they are obligated to drink (Public Health Agency of Canada, 2016). The social consumption 
of alcohol is not considered a health risk; however, when alcohol is pervasive in Canadian 
culture, it further normalizes drinking and can promote transition into unhealthy and longer-
term drinking behaviours. Ultimately, this results in negative health outcomes and increased 
pressures on the Canadian health care system. 
Who Develops Alcohol Use Disorder?  
Individuals who develop AUD may do so for a multitude of reasons. In Canada, the 
rate of alcohol consumption varies based on sex, age, and geographical location (Statistics 
Canada, 2016b). In 2013, 18.9% of Canadians over the age of 12 were considered heavy 
drinkers because they exceeded the amounts defined in the Guidelines for Low-Risk 
Drinking (Table 3) at least once per month over the preceding year (Statistics Canada, 2014). 
Nearly one in five Canadians in this age category expose themselves to increased health and 
safety risks due to alcohol consumption. Among heavy drinkers, the majority were between 
18 and 54 years of age and there were twice as many males as females (Statistics Canada, 
2014, 2016b). This indicates that AUD in Canada typically affects relatively young and 
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predominantly male individuals. Since young males access health care more infrequently 
than other demographic categories, identification of AUD and their subsequent treatment 
may occur later in the disease process than for other individuals (Navarro, Shakeshaft, 
Doran, & Petrie, 2011).  
The prevalence of heavy drinking in Canada is concerning for both its short- and 
long-term health implications. Moreover, rural, remote, and northern populations display 
elevated rates of heavy drinking and risky drinking behaviours than the general Canadian 
population, placing them at greater risk for poor health outcomes. In Canada, Aboriginal 
peoples comprise a significant percentage of the rural, remote and northern populations and 
appear to suffer disproportionately heavier drinking than their non-aboriginal counterparts 
(Statistics Canada, 2016a). Subsequently, Aboriginal peoples are placed at increased risk for 
negative health outcomes associated with heavy drinking.  
British Columbia 
 The prevalence of heavy drinking is 16.1% in BC, making it one of the few provinces 
below the Canadian median of 18.9% (Statistics Canada, 2016b). In 2014, the median per 
capita consumption in BC was 8.95L of absolute alcohol consumption per year (1 liter of 
alcohol equals 85 standard drinks), which is below the recommended amounts set out in the 
Guidelines for Low-Risk Drinking (Table 3) (Butt et al., 2011; University of Victoria, 
2017a).  
 Within BC, there are regional variations in alcohol consumption that demonstrate 
differences between the mostly urban Lower Mainland and the remainder of the province. 
The lowest per capita consumption of alcohol in BC that year was in the Southern Vancouver 
Coastal Health and Fraser Health Authorities, measuring 8.5L and 6.52L per capita 
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respectively (University of Victoria, 2017a). These two Health Authorities account for more 
than 60% of the total BC population and only a small portion of the geographical area of the 
province (Foster, Keller, McKee, & Ostry, 2011). The rural, remote, and northern 
populations in BC drank the most, with the Northern Vancouver Coastal Health Authority 
drinking the most at 15.6L per capita (University of Victoria, 2017a). This is well above the 
Guidelines for Low-Risk Drinking (Butt et al., 2011). The Interior and Northern Health 
Authorities each respectively drank 12.25L and 11.18L per capita, which is at, and even just 
above, the Low-Risk Drinking threshold (University of Victoria, 2017a).  
When considering alcohol-related harm in BC, the statistics demonstrate that rural, 
remote, and northern populations are at greater risk. Hospitalizations linked to alcohol in the 
Northern and Interior Health Authorities were 732 and 798 per 100,000 people respectively; 
whereas, they were 366 and 393 per 100,000 people in the more urban Fraser Health and 
Vancouver Coastal Health Authorities (University of Victoria, 2017b). Mortality rates linked 
to alcohol were similarly elevated away from the urban areas of the Lower Mainland. In the 
Interior and the Northern Health Authorities, deaths were 43 and 34 per 100,000 people 
respectively while, in the Fraser Health and Vancouver Coastal Health Authorities, rates 
were both 19 per 100,000 people (University of Victoria, 2017b). There is no reported reason 
for the increased incidence of mortality in these regions; however, mortality rates are 
important because they demonstrate the ultimate objective harm associated with drinking, 
and portray the seriousness of AUD-related harm. 
Aboriginal Populations in British Columbia 
 Aboriginal peoples – First Nations, Inuit, and Métis – comprise approximately 5% of 
the total population of BC (Foster et al., 2011). Of the total Aboriginal population, the 
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majority live outside of the Lower Mainland, and approximately one third live in the 
northwestern portion of the province (Foster et al., 2011). 
When surveyed, Aboriginal populations were found to have a greater prevalence of 
heavy drinking than non-Aboriginal Canadians (Statistics Canada, 2015). An estimated 35% 
of off-reserve Aboriginal people exceeded the Guidelines for Low-Risk Drinking at least 
once per month in the 12 month period preceding the survey (Statistics Canada, 2015). This 
number far exceeds the 18.9% total Canadian median, which highlights the prevalence of 
AUD in the rural, remote, and northern communities.  
On-reserve Aboriginals reported weekly heavy drinking rates of 16% (Public Health 
Agency of Canada, 2011). This number appears significant but, unfortunately, there is not an 
equivalent measurement between on- and off- reserve alcohol drinking, limiting the 
possibility of a direct comparison. However, 82.6% of on-reserve Aboriginal respondents 
rated alcohol use as the primary wellness challenge for their communities, followed by 
housing and then employment (Canadian Centre on Substance Abuse, 2017). Considering 
that the vast majority of on-reserve Aboriginal people consider alcohol use to be the primary 
problem in their communities, it is clearly a topic worthy of further consideration. 
Genetics or the Environment 
  Understanding the circumstances that precipitate the development of AUD will help 
researchers cultivate new and more appropriate treatment modalities. Both genetic and 
environmental factors have been linked to the development of AUD, but neither have shown 
definitive, independent causation (Van Der Zwaluw & Engels, 2009). Twin studies have 
demonstrated a 58% heritability rate for developing the AUD phenotype, indicating that 
genetics alone does not explain AUD’s etiology. There is likely an interaction between 
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genetics and environment that provides a more comprehensive etiological understanding 
(Van Der Zwaluw & Engels, 2009). The WHO concurs that there is no single dominant risk 
factor that guarantees an individual will develop AUD, but rather, that an accumulation of 
risk factors increases the likelihood of developing AUD (Schmidt, Mäkelä, Jürgen, & Room, 
2010).  
Among environmental exposures, lower socioeconomic status, exposure to alcohol 
prior to 15 years of age, familial history of AUD, and regulatory control of alcohol are 
leading risk factors for the development of AUD (World Health Organization, 2014). None 
of these risk factors are necessarily pathognomonic for AUD; however, the chance of 
developing AUD increases with each additional environmental risk factors (Schmidt et al., 
2010). Moreover, genetics may also play a role in susceptibility to AUD because there may 
be genetic predispositions that increase the individual’s susceptibility to their environment 
(Van Der Zwaluw & Engels, 2009). For example, lower socioeconomic status is inversely 
correlated with the potential of AUD development, but not all people of low socioeconomic 
status will develop AUD (World Health Organization, 2014). Although both genetics and 
environmental circumstances play significant roles in the development of AUD, in most 
cases it is the combination of risk factors that ultimately determines their susceptibility.  
Pathophysiology of Alcohol Use Disorder 
In order to provide comprehensive care for patients with AUD, it is important for the 
primary care provider to have an understanding of the pertinent pathophysiological processes 
involved. A greater understanding of the pathophysiology will assist the primary care 
provider in selecting an appropriate treatment modality. An additional reason to review the 
pathophysiology of AUD is because patients with AUD are exposed to higher rates of 
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marginalization by some health care providers, and patients may be inappropriately 
dismissed when seeking treatment (Allan, 2010; Slaunwhite & Macdonald, 2015). This 
marginalization can act as a barrier to care and can cause missed opportunities for change.  
Understanding and appreciating the pathophysiology legitimizes AUD for health care 
providers, and fosters empathy for patients seeking care.  
Like many addiction processes, AUD is thought to be the result of complex 
interactions between a person’s genetic predisposition and the environment that is unique to 
that individual’s life (Schuckit, 2009; Wackernah, Minnick, & Clapp, 2014). These 
interactions result in biological adaptations, primarily in the neurological and endocrine 
systems, which reinforce drinking behaviours and can ultimately result in the development of 
AUD. Reinforcement is a term used in addiction literature to describe the formation of 
behaviours in relation to the individual’s previous experiences (Gilpin & Koob, 2008). 
Reinforcement can be either positive or negative; meaning, the behaviour is motivated by a 
pleasing experience or by the avoidance of an adverse experience. The biological 
mechanisms for AUD will be discussed below in terms of positive and negative 
reinforcement. 
Positive Reinforcement  
Positive reinforcement plays a critical role in the development of AUD because it 
creates the desire to seek out the rewarding feelings associated with alcohol ingestion. The 
positive reinforcing features associated with acute alcohol ingestion are feelings of euphoria, 
intoxication, generalized neuronal inhibition, sedation, and muscle relaxation (Gilpin & 
Koob, 2008; Schuckit, 2009; Wackernah et al., 2014). With chronic alcohol exposure, 
alcohol tolerance is developed; therefore, progressively larger doses of alcohol are needed to 
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produce the same functional, metabolic, and positive reinforcing effects (Gilpin & Koob, 
2008). These effects are achieved through a variety of neurotransmitters including dopamine, 
serotonin, endogenous opioids, ϒ-aminobutyric acid (GABA), and glutamate, as well as 
through modulation of the hypothalamus-pituitary-adrenal (HPA) axis.  
 Neurotransmitters and positive reinforcement. In the central nervous system, 
dopamine is considered to be one of the primary neurotransmitters associated with reward. 
Acute exposure to alcohol creates a sense of euphoria by indirectly stimulating dopaminergic 
release from the ventral tegmental area into the nucleus accumbens, which is part of the 
mesolimbic system (Gilpin & Koob, 2008; Schuckit, 2009; Stephens & Wand, 2012). This 
dopaminergic activity is likely mediated through alternate neurotransmitter pathways 
including serotonin, endogenous opioids, GABA, and N-methyl-D-aspartate (NMDA) 
(Gilpin & Koob, 2008).  
Serotonin is associated with positive reinforcement primarily by promoting sedation 
(Marcinkiewcz, 2015). Although serotonin is less strongly associated with reward than 
dopamine, increased concentrations of serotonin are observed in the presence of alcohol, 
indicating some mediation of the reward pathways (Marcinkiewcz, 2015). Acute exposure to 
alcohol also stimulates the central and peripheral release of endogenous opioids, such as 
endorphins, enkephalins, and dynorphins (Gilpin & Koob, 2008; Wackernah et al., 2014). 
These opioids are associated with reward and independently stimulate the release of 
dopamine (Schuckit, 2009). The combination of endogenous opioids and dopamine 
significantly contribute to the euphoric effects of alcohol and are thought to be part of the 
main stimuli for individuals to seek out alcohol (Gilpin & Koob, 2008). 
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Alcohol also acts on GABA receptors, which are considered the primary inhibitory 
neurotransmitters in the central nervous system (Gilpin & Koob, 2008). Alcohol increases 
GABA release from pre-synaptic neurons and increases sensitivity to GABA stimulation in 
post-synaptic neurons (Gilpin & Koob, 2008). GABAminergic activity contributes to 
sedation, muscle relaxation, and intoxication, which are all positive reinforcement traits. 
Conversely, alcohol has an inhibitory effect on glutamate, which is the primary excitatory 
neurotransmitter in the central nervous system (Gilpin & Koob, 2008). Within the glutamate 
system, the NMDA receptor is particularly affected by the acute ingestion of alcohol, and 
when suppressed, contributes to generalized neuronal inhibition and positive reward (Gilpin 
& Koob, 2008; Wackernah et al., 2014).  
 Hypothalamus-pituitary-adrenal axis and positive reinforcement. The HPA axis is 
one of the primary metabolic pathways in the body and it plays a key role in the stress 
response (Rachdaoui & Sarkar, 2013). Hormones communicate between the hypothalamus, 
the pituitary gland, and the adrenal glands in response to stressors. Corticotropin-releasing 
hormone (CRH) is secreted by the hypothalamus, causing the pituitary to secrete 
adrenocorticotropic hormone (ACTH), which triggers the adrenal gland to release 
glucocorticoids – primarily cortisol (Molina et al., 2014; Rachdaoui & Sarkar, 2013). 
Cortisol is chiefly responsible for restoration of homeostasis during a stress response (Molina 
et al., 2014; Rachdaoui & Sarkar, 2013). Cortisol is also required for the function of 
cognitive processes including learning, memory, and decision making (Stephens & Wand, 
2012).  
Alcohol ingestion causes a dose-dependent activation of the HPA axis, which 
correspondingly increases cortisol levels (Rachdaoui & Sarkar, 2013). In addition to 
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modulation of the stress response and facilitation of cognitive processes, it is postulated that 
cortisol stimulates dopaminergic activity and contributes to positive reinforcement (Stephens 
& Wand, 2012).  
Negative Reinforcement 
Negative reinforcement is an important component of the transition from low-risk 
drinking to AUD. As tolerance to alcohol builds, motivation to drink can change from 
seeking out positive reinforcement to avoiding negative reinforcement. Negative 
reinforcement is associated with the avoidance of withdrawal symptoms including tremors, 
sweating, anxiety, and dysphoria (American Psychiatric Association, 2013; Gilpin & Koob, 
2008). With increased tolerance to alcohol, changes are noted in the dopamine, serotonin, 
GABA, and glutamate neurotransmitter systems, as well as the in the HPA axis. These 
systems become reliant on the presence of alcohol for normal homeostatic function and they 
become dysfunctional in the absence of alcohol, precipitating negative symptoms. 
 Neurotransmitters and negative reinforcement. As discussed above, dopamine is the 
neurotransmitter primarily responsible for reward in the central nervous system. Long-term 
indirect stimulation causes the release of dopamine to become dependent on the ingestion of 
alcohol (Gilpin & Koob, 2008). Without the presence of alcohol, a relatively 
hypodopaminergic state is created, causing dysphoria and withdrawal symptoms (Table 2) 
(Gilpin & Koob, 2008). Individuals who experience adverse symptoms are motivated to re-
establish normal dopamine levels through alcohol consumption, leading to relapse and 
further health risks (Stephens & Wand, 2012). The mechanism for dopamine modulation is 
by up-regulation of NMDA receptors and decreased function of GABA receptors, likely 
through down-regulation (Koob, 2011; Wackernah et al., 2014). Since these two 
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neurotransmitters are respectively responsible for neuronal excitation and inhibition, the 
balance is shifted towards a state of hyperexcitability (Wackernah et al., 2014). This is 
acutely manifested as tremors, anxiety, nausea, and dysphoria during alcohol withdrawal 
(Wackernah et al., 2014).  
With chronic exposure to alcohol, serotonin function is also modulated. Overall, 
serotonin is down-regulated in the central nervous system, meaning that serotonergic activity 
becomes reliant on the presence of alcohol for normal functioning (Marcinkiewcz, 2015). 
Decreased sensitivity to serotonin leads to increased alcohol-seeking behaviours and 
promotes relapse (Marcinkiewcz, 2015). However, serotonin function is up-regulated in the 
amygdala, the area of the brain associated with habit formation, and is correlated with 
anxniogenesis during withdrawal (Marcinkiewcz, 2015; Stephens & Wand, 2012). GABA 
dysfunction and glutamate up-regulation are also thought to contribute to both the anxiety 
associated with withdrawal and with the alcohol cravings (Gilpin & Koob, 2008; Wackernah 
et al., 2014).  
 Hypothalamus-pituitary-adrenal axis and negative reinforcement. With long-term 
alcohol use and tolerance, adaptations can be observed in the HPA axis. The HPA axis 
becomes blunted, leading to decreased CRF, ACTH, and cortisol levels (Molina et al., 2014). 
This results in diminished homeostatic responses to both physical and psychological stressors 
(Molina et al., 2014; Rachdaoui & Sarkar, 2013; Stephens & Wand, 2012). The resulting 
relative cortisol deficiency negatively affects the dopamine reward system and impairs the 
stress response, which leads to feelings of dysphoria and cognitive impairment (Stephens & 
Wand, 2012). This negative reinforcement is postulated to be one of the reasons that people 
with AUD often relapse soon after stopping drinking.  
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Current Canadian Guidelines for Alcohol Use Disorder 
 Practice guidelines are designed to support health care providers by providing 
evidence-based recommendations for assessment, diagnosis, and treatment for a variety of 
health conditions. Guidelines condense a large body of evidence into usable 
recommendations for practice.  Guidelines are also useful to inform policy makers as well as 
those members of the public who wish to educate themselves on a particular issue. 
Specific to the assessment and/or treatment of individuals with AUD, there are three 
pertinent guidelines included in this integrative review. They are the Canadian Centre for 
Substance Abuse’s Guidelines for Low-Risk Drinking (Butt et al., 2011), the BC Guidelines 
for Problem Drinking (British Columbia Ministry of Health, 2013), and the Canadian Family 
Physician Guidelines (Canadian Guidelines) (Spithoff & Kahan, 2015b, 2015c).  
In light of the significant health impact associated with drinking alcohol, the 
Canadian Centre on Substance Abuse created the Guidelines for Low-Risk Drinking (Table 
3) (Butt et al., 2011). The intent was to mitigate short- and long-term harms and to reduce the 
prevalence of alcohol tolerance (Butt et al., 2011). This guideline can be used by health care 
practitioners, policy makers, and to inform the creation of subsequent clinical guidelines. The 
Guidelines for Low-Risk drinking are pertinent to both the BC and Canadian Guidelines, and 
aid primary care practitioners in the assessment of patients who drink alcohol.  
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Table 3 Recommended Guidelines for Low-Risk Drinking 
Guideline 1  
Do not drink in these 
situations:  
When operating any kind of vehicle, tools or machinery; 
using medications or other drugs that interact with alcohol; 
engaging in sports or other potentially dangerous physical 
activities; working; making important decisions; if pregnant 
or planning to be pregnant; before breastfeeding; while 
responsible for the care or supervision of others; if suffering 
from serious physical illness, mental illness or alcohol 
dependence.  
Guideline 2  
If you drink, reduce long-
term health risks by staying 
within these average levels:  
Women 
0–2 standard drinks* per day  
No more than 10 standard 
drinks per week  
Men 
0–3 standard drinks* per day  
No more than 15 standard 
drinks per week  
Always have some non-drinking days per week to minimize 
tolerance and habit formation. Do not increase drinking to the 
upper limits as health benefits are greatest at up to one drink 
per day. Do not exceed the daily limits specified in Guideline 
3.  
Guideline 3  
If you drink, reduce short-
term risks by choosing safe 
situations and restricting 
your alcohol intake:  
Risk of injury increases with each additional drink in many 
situations. For both health and safety reasons, it is important 
not to drink more than:  
• Three standard drinks* in one day for a woman  
• Four standard drinks* in one day for a man  
Drinking at these upper levels should only happen 
occasionally and always be consistent with the weekly limits 
specified in Guideline 2. It is especially important on these 
occasions to drink with meals and not on an empty stomach; 
to have no more than two standard drinks in any three-hour 
period; to alternate with caffeine-free, non-alcoholic drinks; 
and to avoid risky situations and activities. Individuals with 
reduced tolerance, whether due to low bodyweight, being 
under the age of 25 or over 65 years old, are advised to never 
exceed Guideline 2 upper levels.  
Guideline 4  
When pregnant or planning 
to be pregnant:  
The safest option during pregnancy or when planning to 
become pregnant is to not drink alcohol at all. Alcohol in 
the mother's bloodstream can harm the developing fetus. 
While the risk from light consumption during pregnancy 
appears very low, there is no threshold of alcohol use in 
pregnancy that has been definitively proven to be safe.  
Guideline 5  
Alcohol and young people:  
Alcohol can harm healthy physical and mental development 
of children and adolescents. Uptake of drinking by youth 
should be delayed at least until the late teens and be 
consistent with local legal drinking age laws. Once a 
decision to start drinking is made, drinking should occur in a 
safe environment, under parental guidance and at low levels 
(i.e., one or two standard drinks* once or twice per week). 
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From legal drinking age to 24 years, it is recommended 
women never exceed two drinks per day and men never 
exceed three drinks in one day.  
Note. * A "standard drink" is equal to a 341 ml (12 oz.) bottle of 5% strength beer, cider or 
cooler; a 142 ml (5 oz.) glass of 12% strength wine; or a 43 ml (1.5 oz.) shot of 40% strength 
spirits (NB: 1 Canadian standard drink = 17.05 ml or 13.45 g of ethanol). 
 
2 Copyright (c) Canadian Centre on Substance Abuse. All rights reserved. Reproduced with 
permission from the Canadian Centre on Substance Abuse.  
 
The BC Guideline (2013) includes recommendations for screening, assessment, 
counseling, office-based alcohol withdrawal, and prescription medication for alcohol 
dependence. This guideline is user-friendly but despite being released in the same year as the 
change was made to the novel term of AUD, it employs the antiquated terms of alcohol 
abuse and alcohol dependence. The most recent Canadian guideline for AUD treatment in the 
primary care setting is a non-systematic review series published in the Journal of the 
Canadian Family Physician (Spithoff & Kahan, 2015b, 2015c). Spithoff and Kahan (2015b, 
2015c) recommend a similar process to the British Columbia Ministry of Health guideline; 
screening and assessment, counseling, prescription of medication, and connection to 
auxiliary or specialized services. Each category of these two guidelines will be reviewed with 
pertinent comparisons and contrasts.  
Screening and Assessment for Alcohol Use Disorder 
 Diagnosing AUD in the primary care setting is a universal challenge experienced by 
primary care providers. There is a finite amount of time available per patient, and providers 
have to balance the patients’ priorities with a multitude of health maintenance demands. The 
Canadian recommendation is for at least yearly screening of all primary care patients 
regardless of demographics, whereas the BC Guideline suggests screening for those 19 years 
of age and older if there is clinical suspicion of at-risk drinking or AUD (Spithoff & Kahan, 
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2015b). Relevant clinical suspicions in this context would include patients who present with 
medical, psychological, and/or psychosocial problems potentially linked to alcohol use 
(British Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015b). The consensus in the 
literature is that consistent annual screening for alcohol problems is more successful than 
targeted screening only (National Institute on Alcohol Abuse, 2005; Navarro et al., 2011; 
Solberg, Maciosek, & Edwards, 2008; Spithoff & Kahan, 2015b). Meta-analysis shows that 
without universal screening, primary care providers’ diagnostic sensitivity for AUD 
detection is 41.7% (Mitchell, Meader, Bird, & Rizzo, 2012). Primary care screening rates are 
reported to be between 2% and 50%, which indicates that more diagnoses of AUD could be 
made by increasing screening rates (Bendtsen et al., 2015; Enoch & Goldman, 2002; Johnson 
& Seale, 2015).  
Primary care screening for unhealthy drinking consists of a step-wise questioning 
process. Initially patients should be screened using a validated single question (Spithoff & 
Kahan, 2015b). The most validated question for screening is: how many times in the past 
year have you had four or more drinks (women), or five or more drinks (men) in a single day 
(Smith, Schmidt, Allensworth-Davies, & Saitz, 2009; Spithoff & Kahan, 2015b)? This single 
question is 82% sensitive and 79% specific for indicating unhealthy drinking (Smith et al., 
2009). If this question is positive, the provider should move on to the 10-question Alcohol 
Use Disorders Identification Test (AUDIT), 3-question AUDIT test, or the cut-down-
annoyed-guilt-eye-opener (CAGE) questionnaire (Spithoff & Kahan, 2015b). The AUDIT-10 
is 92% sensitive and 94% specific, the AUDIT-3 is 86% sensitive and 72% specific, and the 
CAGE is 71% sensitive and 90% specific (Schorling, 2005; Spithoff & Kahan, 2015b). If the 
screening questions are positive, the provider should refer to the DSM-V diagnostic criteria 
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and proceed to more detail questioning. The BC Guideline provides example questions that 
follow the DSM-IV diagnostic criteria and thus would be particularly helpful for primary 
care providers, although there are no questions pertaining to cravings for alcohol as this was 
not added until the DSM-V (American Psychiatric Association, 1998; British Columbia 
Ministry of Health, 2013) 
Screening and assessment tests for AUD are heavily reliant on the patient to report 
the truth of their situation. Patients who are motivated to evade providers’ questions will 
likely be successful and thereby remove themselves from the possibility of effective 
treatment. As a result, the effectiveness of the screening tools relies solely on the individual’s 
honesty with self-reporting.   
Counseling for Alcohol Use Disorder 
 Once a diagnosis of AUD has been made according to the DSM-V diagnostic criteria, 
the patient should be informed of the diagnosis and offered counseling sessions with frequent 
follow-up appointments (American Psychiatric Association, 2013; Spithoff & Kahan, 
2015c). The BC Guideline recommends that primary care providers use the brief intervention 
counseling technique for all patients with alcohol abuse or alcohol dependence (British 
Columbia Ministry of Health, 2013). Brief interventions involve short, goal-directed 
counseling techniques that can be delivered easily in a primary care setting. Among 
counseling techniques that are applicable to the primary care setting, brief interventions 
demonstrate the greatest efficacy and are well supported by the literature (Kaner et al., 2007; 
Navarro et al., 2011; O’Donnell et al., 2014). Although the Canadian Guidelines refer to 
“brief counseling” instead of brief intervention, the technique described is consistent with the 
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brief intervention technique (Barry, 2012; Spithoff & Kahan, 2015c). A more detailed 
discussion on the brief intervention technique will follow.  
 Brief intervention. Brief intervention is a counseling technique that utilizes concepts 
and techniques across a variety of theoretical bases in order to facilitate behavioural changes 
(Barry, 2012). In the setting of alcohol use, the principal theoretical basis for brief 
interventions originates from behavioural self-control literature (Barry, 2012). Behavioural 
self-control theory recognizes the substance user as the foundation for change within the 
counseling process (Barry, 2012), meaning that the patient learns to recognize their drinking 
behaviours through a series of steps, and then develops self-efficacy to overcome those 
behaviours.  
Brief interventions are designed to take between five and 25 minutes to perform, with 
most lasting between five and 15 minutes in the primary care setting (Barry, 2012; Bertholet, 
Daeppen, Wietlisbach, Fleming, & Burnand, 2005). Brief interventions are meant to be 
performed over a number of successive visits, increasing patient engagement and offering 
ongoing opportunities for positive reinforcement. Frequent follow-up with the primary care 
provider is essential with the brief intervention technique and is recommended at least every 
14 days (British Columbia Ministry of Health, 2013). This appointment frequency provides 
time to highlight the patient’s successes and to recognize triggers that may cause continued 
drinking. Frequent follow-up also facilitates the assessment and treatment of comorbid 
diseases, such as depression, that may contribute to the patient’s urge to drink. 
Generally, there are eight sequential steps that comprise a brief intervention for 
alcohol use: 
1. The patient establishes a goal, either a number of drinks per day or abstinence; 
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2. The patient starts to self-monitor the number of drinks and the setting in which the 
consumption occurs; 
3. The patient starts to modify the rate of alcohol consumption; 
4. The patient develops the ability to refuse alcohol when it is offered; 
5. The patient creates a positive reward system for achieving their goals; 
6. The patient determines the circumstances that instigate overdrinking; 
7. The patient learns self-efficacy instead of using alcohol to cope; and 
8. The patient learns methods to prevent relapse. (Barry, 2012)  
In the primary care setting, brief interventions show significant reductions in alcohol 
consumption (Bertholet et al., 2005; O’Donnell et al., 2014). One meta-analysis 
demonstrated a weighted mean average reduction of 38g of ethanol per week (95% CI, -51 to 
-25g/week) – equating to approximately four drinks less per week than the control group 
(Bertholet et al., 2005). This meta-analysis did not find any statistical difference between 
men and women; however, a recent systematic review suggested that the women and youth 
have been understudied in regards to brief intervention for alcohol use (Bertholet et al., 2005; 
Kaner et al., 2007; O’Donnell et al., 2014). Additionally, there is a lack of evidence for 
efficacy of brief intervention in patients with more severe AUD (Saitz, 2010). Both the 
Canadian and BC Guidelines suggest utilizing the brief intervention technique for all 
patients, regardless of sex. Unlike sex, greater severity of AUD is recognized in both of the 
guidelines and is an indication for prescription medications and referral to specialist services.  
There are no statistics available for prevalence of brief intervention usage for AUD in 
BC. However, the general utilization of brief interventions in primary care is thought to be 
between 10% and 50% (Kaner, Lock, McAvoy, Heather, & Gilvarry, 1999; Navarro et al., 
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2011). This indicates that brief interventions may be underutilized in the primary care 
setting, and that there may be a gap in the current treatment of AUD by primary care 
providers. 
Prescribing Medications for Alcohol Use Disorder 
 For patients who have been diagnosed with moderate or severe AUD, both the BC 
and Canadian Guidelines suggest that providers consider instituting pharmacotherapy in 
addition to patient counseling (Spithoff & Kahan, 2015c). Three medications are currently 
approved for the treatment of AUD in Canada – disulfiram, naltrexone, and acamprosate 
(Spithoff & Kahan, 2015c). A description of these medications, their indications, and their 
contraindications will follow. There is no optimal pharmacotherapy treatment duration; 
however, all three medications are suggested for a minimum of six months to one year, and 
for those who respond positively, treatment can be extended to two years (British Columbia 
Ministry of Health, 2013). 
 Despite pharmacotherapy being included in both guidelines for AUD, it appears that 
actual utilization remains quite minimal (Crowley, 2015). A large meta-analysis suggested 
that only 33% of patients with AUD receive any type of treatment, and less than 10% of 
patients receive pharmacological treatment (Jonas et al., 2014).  
 Disulfiram. Disulfiram is the oldest medication approved for the treatment of AUD 
and is relatively well known among both health care providers and patients. It is an aversive 
agent that inhibits the metabolism of alcohol, producing nausea, vomiting, flushing, 
tachycardia, and hypotension (Wackernah et al., 2014). After alcohol is ingested, it is 
metabolized into acetaldehyde by the enzyme alcohol dehydrogenase (ADH); acetaldehyde is 
then oxidized by the hepatic enzyme aldehyde dehydrogenase (ALDH) (Molina et al., 2014). 
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Disulfiram irreversibly inhibits the ALDH enzyme, leading to a accumulation of 
acetaldehyde, which results in the negative physiological affects listed above (Wackernah et 
al., 2014).  
 Despite disulfiram’s relative familiarity, there is minimal evidence demonstrating that 
it significantly reduces drinking (Jonas et al., 2014; Jørgensen, Pedersen, & Tønnesen, 2011). 
In a recent meta-analysis, disulfiram failed to show overall reductions in alcohol 
consumption (Jonas et al., 2014). This is unfortunate because disulfiram is the most widely 
known medication for AUD and its lack of efficacy may deter patients and prescribers from 
initiating pharmacotherapy. However, a systematic review of disulfiram’s efficacy has found 
some evidence that supervised ingestion does reduce alcohol consumption until relapse, 
indicating that there may be a subgroup of individuals who may benefit from this drug 
(Jørgensen et al., 2011). Patients with a spouse, family member, pharmacists, or primary care 
provider that would be willing to supervise ingestion may find more benefit than Jonas et al. 
(2014) reports.  
 Contraindications for disulfiram include usage in patients receiving metronidazole, 
antihypertensives, preparations that contain alcohol – e.g., cough syrup or mouthwash, and in 
patients with severe cardiovascular or cerebrovascular disease (Teter & Sherwood, 2016). To 
ensure patient safety, the primary care provider must provide counseling regarding these 
contraindications and for the need to abstain from all alcohol during treatment (British 
Columbia Ministry of Health, 2013). Since disulfiram is contraindicated with alcohol 
ingestion, patients are required to have already withdrawn from alcohol, which further 
reduces the patient population who may be eligible for its use. 
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 Disulfiram is relatively inexpensive in BC; depending on the dosage, it costs between 
$0.30 and $0.80 per pill (Province of British Columbia, 2017). The provincial 
pharmaceutical plan, BC Fair PharmaCare, does list disulfiram as a regular benefit 
medication in the formulary, indicating that it will be covered without special authority 
according to the patient’s previous year’s taxable income (Province of British Columbia, 
2017). Given the minimal financial burden associated with disulfiram, it may be an option 
for patients who have supervised ingestion available.  
 Acamprosate. Acamprosate is structurally similar to the glutamate and GABA 
neurotransmitters discussed in the pathophysiology section above (Wackernah et al., 2014). 
Acamprosate antagonizes glutamate, which reduces the excess glutaminergic activity 
associated with the up-regulation of glutamate receptors (Wackernah et al., 2014). While 
using acamprosate, the feelings of chronic alcohol withdrawal and the associated urge to 
drink are both diminished (Wackernah et al., 2014).  
 In meta-analysis, acamprosate was only statistically significant in reducing the return 
to any drinking, with a risk difference of -0.09 (95% CI, -0.14 to -0.04) and number needed 
to treat (NNT) of 12 (95% CI, 8 to 26) (Jonas et al., 2014). No significance was found for 
returning to heavy drinking (Jonas et al., 2014). Acamprosate is only approved for use in 
patients who have already withdrawn from alcohol, limiting the eligible patient population 
(British Columbia Ministry of Health, 2013; Jonas et al., 2014). 
 Acamprosate is relatively well tolerated with side effects of anxiety, diarrhea, and 
vomiting being reported more often than with placebo (Jonas et al., 2014). Contraindication 
for acamprosate include hypersensitivity, pregnancy, and severe renal dysfunction, although 
a reduced dose can be used with moderate renal function (British Columbia Ministry of 
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Health, 2013; Spithoff & Kahan, 2015c). Given acamprosate’s relative tolerability and 
limited number of contraindications, it should be considered as a first-line 
pharmacotherapeutic option for patients with AUD. 
 Acamprosate tablets are relatively inexpensive in BC, costing $0.80 per pill, and 
special authority coverage is available under the BC PharmaCare for a three month supply 
(British Columbia Ministry of Health, 2017b; Province of British Columbia, 2017). To 
receive special authority coverage, the patient is required to have been abstinent from alcohol 
for four days or to have contraindications to naltrexone, and they must receive concurrent 
counseling services (British Columbia Ministry of Health, 2017b). One drawback to 
acamprosate is that it requires three times per day dosing, which may be an additional barrier 
for patients who have difficulty with memory of scheduling. 
 Naltrexone. Naltrexone is a competitive opioid antagonist that disrupts the positive 
reward associated with drinking alcohol (Jonas et al., 2014; Wackernah et al., 2014). By 
blocking the alcohol-related stimulation of the endogenous opioid systems, naltrexone 
reduces cravings for alcohol and the euphoria felt after consumption (Wackernah et al., 
2014). In meta-analysis, the risk difference for return to heavy drinking was -0.09 (95% CI, -
0.14 to -0.04) with a NNT of 12 (95% CI, 8 to 26) (Jonas et al., 2014). Return to any 
drinking was less significant with a risk difference of -0.05 (95% CI, -0.10 to -0.002) and a 
NNT of 20 (95% CI, 11 to 500) (Jonas et al., 2014). Naltrexone shows similar efficacy to 
acamprosate and is likewise considered a first-line pharmacotherapeutic agent.  
 Overall side effects to naltrexone are minimal, although it is slightly less well 
tolerated than acamprosate (Jonas et al., 2014). Common side effects include dizziness, 
nausea, vomiting, headache, insomnia, and nervousness, with a number needed to harm 
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(NNH) of 48 to cause trial drop out (Jonas et al., 2014; Teter & Sherwood, 2016). 
Hepatotoxicity has been noted with naltrexone necessitating serum liver transaminase 
measurements at baseline, then periodically throughout treatment (Teter & Sherwood, 2016). 
Naltrexone is subsequently contraindicated with hypersensitivity, liver failure (British 
Columbia Ministry of Health, 2013). Naltrexone is further contraindicated with opioid 
therapy because of the risk of precipitated opioid withdrawal (British Columbia Ministry of 
Health, 2013). For those who have used opioids but are able to stop, there is a mandatory 
seven day opioid abstinence period before the first dose of naltrexone can be administered 
(Teter & Sherwood, 2016). An additional opioid consideration with naltrexone is the 
potential requirement for emergency opioid therapy. Patients should wear a medical alert 
bracelet indicating naltrexone therapy because, in the event of an emergency, they will 
require otherwise-toxic doses of opioids before any effect will be felt (Teter & Sherwood, 
2016). Furthermore, long-term opioid antagonist therapy can result in opioid hypersensitive 
if the antagonist is stopped, thus increasing the risk of accidental opioid overdose (Teter & 
Sherwood, 2016). 
 Naltrexone costs $5.26 per pill in BC, which is a significant barrier for self-paying 
patients (Province of British Columbia, 2017). However, naltrexone is covered for three 
months under the BC PharmaCare special authority program with a requirement for 
concurrent behavioural intervention therapy (British Columbia Ministry of Health, 2017c). 
For those who have the financial means or additional medication coverage, naltrexone may 
be a good option to assist in the treatment of AUD.  
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Connect to Ancillary and Specialist Services 
 A key component of the Canadian Guideline is to “connect” patients with services 
outside of primary care (Spithoff & Kahan, 2015c). The services specifically mentioned in 
the Canadian Guideline are: residential programs, outpatient day programs, addictions 
medicine specialists, addictions counselors, and support groups (Spithoff & Kahan, 2015c). 
Interestingly, the BC Guidelines only mention coordinating care with a specialist if the 
patient has consented; however, it does not elaborate further on what type of specialist 
service, or which patients, should be referred (British Columbia Ministry of Health, 2013).  
Included below is a discussion about each of the above-mentioned services in 
addition to medical detoxification. Although neither the BC nor the Canadian guideline 
discuss medical detoxification, I will briefly review this service and its availability in 
northern BC because abstinence is a requirement for most alcohol treatment programs. 
Furthermore, the accessibility of specialist services in northern BC will be examined and, 
where available, the general rates of remission associated with these services will be 
included. 
 Residential programs. Residential programs, sometimes referred to as inpatient 
programs, are facility-based extended-stay rehabilitation services. They require the patient to 
live in a facility for a pre-determined amount of time, usually a minimum of 28 days 
(Gifford, 2016). There are a wide variety of theoretical models that create the foundation for 
each program; however, a common theme among all residential programs is that alcohol 
rehabilitation is the primary focus of daily life (Gifford, 2016). Programs that are based in a 
therapeutic community model can be up to 24 months in length (Perryman & Dingle, 2015). 
The treatment services available in day and residential programs can be quite similar, with 
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both offering group therapy, individual therapy, and educational sessions; however, 
residential programs generally include 24-hour supervision, meals, and accommodation 
(Canada Drug Rehab Addiction Services Directory, 2017; Martin & Rehm, 2012). Martin 
and Rehm (2012) suggest that, although empirical evidence is weak, residential programs 
may be most appropriate for patients with severe AUD, concurrent psychopathology, and 
low social stability and social continence. Decision making support is conspicuously absent 
from both the BC and the Canadian Guidelines for primary care providers regarding 
residential treatment for patients with AUD.  
  Abstinence with residential programs. The short- and long-term abstinence 
rates associated with residential programs are difficult to accurately study (Finney, Hahn, & 
Moos, 1996; Perryman & Dingle, 2015). Programs are heterogeneous in theoretical 
foundations, duration of stay, and patient demographics, limiting the generalizability of 
success rates (Finney et al., 1996; Perryman & Dingle, 2015). The Canadian Guideline 
suggests that 33% of day or residential treatment program graduates are abstinent at the one 
year mark (Spithoff & Kahan, 2015c) However, the article cited in the guideline is a review 
of multiple studies with broadly heterogenic interventions, limiting my ability to find 
causation from the day or residential programs alone (Miller, Walters, & Bennett, 2001; 
Spithoff & Kahan, 2015c). A somewhat consistent theme in the literature is that dropout rates 
are high among residential program attendants, but again, the effect this has on the overall 
success is unclear (Perryman & Dingle, 2015). The high dropout rate supports Spithoff and 
Kahan’s (2015a) assertion that primary care management can be as successful as referral to 
specialist care.  
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  Residential programs in British Columbia. Residential programs are often 
designed for certain demographics. They may admit patients based on abstinence, gender, 
age, or ethnicity, and may or may not allow children to join their mothers (Canada Drug 
Rehab Addiction Services Directory, 2017). In BC, all but one program in Kelowna requires 
abstinence prior to admission, indicating that many patients will require medical 
detoxification (Canada Drug Rehab Addiction Services Directory, 2017). Outside of 
demographic restriction, the waitlist may also impair access to residential programs in BC. 
Programs that are publicly funded by the BC Ministry of Health often have wait lists that are 
many weeks in duration, which can be a barrier for some patients.  
 In BC’s Northern Health Authority, there are only two municipalities that have 
residential programs available to the general public, Fort St. John and Prince George (Canada 
Drug Rehab Addiction Services Directory, 2017). Funding is provided through the BC 
Ministry of Health for patients who are eligible for income or disability assistance (Ministry 
of Social Development and Social Innovation, 2017). For patients who are considered the 
“working poor” or “lower middle class,” financial constraints may be a significant barrier to 
treatment. People of Aboriginal descent have separate funding and can receive financial 
coverage to attend any residential program in BC through the First Nations and Inuit Health 
Branch (FNIHB) (Health Canada, 2016b). A complete and current list of inpatient residential 
treatment programs can be found at the Canadian Alcohol & Drug Rehabilitation Centres & 
Programs’ (2017) website.  
 In BC, people of Aboriginal descent have access to residential programs that provide 
culture-specific care. There are four of these programs in the Northern Health Authority, 
located in Vanderhoof, Kitwanga, Haisla (Kitimat), and Dawson Creek (Health Canada, 
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2016b). Funding is provided by the FNIHB and is not generally a barrier to accessing 
treatment (Health Canada, 2016b). 
 Outpatient day programs. Outpatient day programs are as diverse in theoretical 
underpinnings as residential programs (Martin & Rehm, 2012). Outpatient day programs 
allow patients to continue to live at their own home while maintaining close contact with the 
treatment program (Gifford, 2016). The advantage of these programs is that they allow 
patients to better protect their privacy because there is not a long absence from work, family, 
or educational commitments (Gifford, 2016). From a systemic point of view, outpatient day 
programs are less expensive to provide than the more intensive residential programs (Martin 
& Rehm, 2012). The main challenge associated with this type of program is that patients are 
not removed from their normal environment, necessitating self-imposed abstinence, which 
can be major barrier for some patients (Gifford, 2016). 
  Abstinence with outpatient day programs. Rates of remission associated with 
outpatient day programs are difficult to obtain because of significant between-program 
heterogeneity. There is not enough generalizable empirical data to make assertions regarding 
remission rates; however, outpatient day programs have been found to be comparable in 
effect to residential programs (Martin & Rehm, 2012; Raistrick, Heather, & Godfrey, 2006). 
In contrast to residential programs, patients recommended for outpatient day programs 
should have less severe AUD, lower-risk social factors (living arrangements, criminal 
involvement, and other drug involvement), limited concurrent psychopathology, and shorter 
duration of AUD (Martin & Rehm, 2012; Raistrick et al., 2006).  
  Outpatient day programs in British Columbia. In BC, many smaller 
municipalities have outpatient day programs available, including many municipalities in the 
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Northern Health Authority (Canada Drug Rehab Addiction Services Directory, 2017). A 
complete and current list of these programs can be found at the Canadian Alcohol & Drug 
Rehabilitation Centres & Programs’ (2017) website. Patient access to outpatient day 
programs is generally easier than residential programs because there are a multitude of sites 
across BC. Additionally, these programs are publicly funded under the Medical Services Plan 
of BC and administered by the five Health Authorities and the Provincial Health Services 
Authority (British Columbia Ministry of Health, 2017d). Public funding removes the 
financial barrier for those not on income or disability assistance, and may promote outpatient 
day programs as a treatment choice for primary care providers.  
 Medical detoxification. Medical detoxification, commonly referred to as ‘detox’, is 
medically supervised withdrawal from alcohol. The use of medications, usually 
benzodiazepines, and patient monitoring helps to alleviate some of the symptoms and risks 
associated with alcohol withdrawal (British Columbia Ministry of Health, 2013). Medical 
detoxification can be performed in a residential treatment program, in the outpatient setting, 
and in an inpatient or hospital setting (Canada Drug Rehab Addiction Services Directory, 
2017). Patients can also withdraw from alcohol without medical care, but this is then not 
classified as medical detoxification.  
 The BC Guidelines suggest that most patients with AUD can be safely withdrawn 
from alcohol in the outpatient setting (British Columbia Ministry of Health, 2013). 
Medication dosing schedules are easily accessible for primary care providers in both the 
United States and Canada (British Columbia Ministry of Health, 2013; Muncie, Yasinian, & 
Oge, 2013). The contraindications to outpatient medical detoxification are numerous and 
include: acute illness, previous withdrawal seizures or delirium, failed attempts at outpatient 
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withdrawal, unstable comorbidities (cardiovascular disease or diabetes), comorbid 
psychiatric illness, concurrent sedative dependence, liver compromise, pregnancy, failure to 
respond after one to two days of medications, advanced withdrawal state, and absence of 
support network (British Columbia Ministry of Health, 2013; Muncie et al., 2013). In the 
presence of any of these conditions inpatient medical detoxification is suggested.  
  Medical detoxification in British Columbia. Medical detoxification in BC has 
varied availability depending on location. There are numerous detoxification units in the 
southern half of the province, but less in the north. In the Northern Health Authority, there is 
a regional adult withdrawal management unit in Prince George that services most of northern 
BC (Northern Health Authority, n.d.). This unit has 14 beds, six acute, six non-acute, and 
two transitional (Northern Health Authority, n.d.). There is also a five-bed medical 
detoxification unit in Quesnel (Canada Drug Rehab Addiction Services Directory, 2017). 
These two units service the entire northern portion of BC. Barriers to accessing these 
treatment services include the significant coverage areas, the expense of travel to and from 
the facility, and bed availability. A complete and current list of medical detoxification units 
can be found at the Canadian Alcohol & Drug Rehabilitation Centres & Programs’ (2017) 
 Addictions medicine specialists. Addictions medicine specialist are physicians who 
have completed specialty training and are certified under the American Board of Addiction 
Medicine (ABAM), or are psychiatrists who are certified under the American Board of 
Psychiatry and Neurology (ABPN) (American Society of Addiction Medicine, 2017). There 
is no equivalent Canadian certification in addictions medicine available from the Royal 
College of Physicians and Surgeons of Canada, or the College of Family Physicians of 
Canada, meaning that Canadian physicians are required to complete the American board 
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exams (College of Family Physicians of Canada, 2017; McEachern et al., 2016; Royal 
College of Physicians and Surgeons of Canada, 2014). Addiction medicine specialists deliver 
medical care for those with a variety of addictions including tobacco, prescription 
medication, illicit drugs, and alcohol (American Society of Addiction Medicine, 2017). The 
goal of addictions medicine is to address an unmet need in addictions treatment, especially 
with medically complex patients (McEachern et al., 2016; Wood, Samet, & Volkow, 2013).  
Similar to the other treatment options discussed above, deciding which patients 
should be referred to addictions medicine is a challenge. The Canadian Guidelines suggest 
that patients who are highly complex, such as those with comorbidities, or patient who have 
failed to respond to primary care management should be referred to addictions medicine 
(Spithoff & Kahan, 2015c). This is intuitive to many primary care providers; however, 
accessing addictions medicine services may be particularly challenging to access for many 
patients in rural, remote, and northern communities (McEachern et al., 2016).  
  Addictions medicine specialists in British Columbia. In BC, the highest 
concentration of certified addictions medicine specialists is in the Lower Mainland 
(McEachern et al., 2016). A recent study calculated the provider availability index (PAI) for 
addictions medicine in BC (McEachern et al., 2016). PAI is a ratio of how many providers 
there are per 1000 people affected with a given health concern. During this study, the 
Northern Health Authority and the Island Health Authority both had zero addictions 
medicine specialists per 1000 people affected with AUD, although the authors do state that 
they could only measure those who were ABAM-certified (McEachern et al., 2016). Using 
the ABAM certification only may underestimate those actually practicing in the field of 
addictions medicine (McEachern et al., 2016). For instance, Dr. Gerrard Prigmore is the 
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Medical Lead for Addiction and Harm Reduction in the Northern Health Authority, and his 
practice was not found in the McEachern et al. (2016) study (British Columbia Ministry of 
Health, 2017a). However, even with this potential for underestimation, addictions medicine 
specialists are clearly a limited resource in the Northern Health Authority and are likely 
inaccessible to most patients.  
Another possible approach to gain access to addiction medicine specialist in BC is 
through the Rapid Access Consultative Expertise (RACE) telephone line (RACE, n.d.). The 
RACE line provides consultative only specialist advice Monday to Friday during business 
hours. This service may be beneficial for primary care providers who have a specific health 
care question regarding a patient with AUD, but is limited in availability after hours, and 
does not have the capacity to receive referrals or assume care of patients.  
 Support groups. Support groups are a diverse collection of group gatherings that have 
the common theme of supporting individuals to overcome addiction. Groups can be faith-
based, community-based, or subscribed to the 12-step program philosophy. Some programs 
are professionally lead but the majority are peer-lead (Spithoff & Kahan, 2015c). Support 
groups are easy to access, inexpensive and readily available. Alcoholics Anonymous (AA) is 
perhaps the most well-known support group for AUD. It is a global organization and is 
available in many locations and languages (Alcoholics Anonymous, 2017).  
 Alcoholics Anonymous. AA is a non-professional lead, spiritual-based support group 
(Alcoholics Anonymous, 2017). There are no restrictions on participation, such as age, 
gender, or race, which removes many barriers to access for individual seeking treatment 
(Alcoholics Anonymous, 2017). A recent Cochrane Review of AA and other 12-step 
programs found equivocal effect when compared to other interventions, namely motivational 
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enhancement therapy, cognitive behavioural therapy, relapse prevention therapy (Ferri, 
Amato, & Davoli, 2006). Additionally, the authors did not find a difference in effect linked 
to severity of AUD (Ferri et al., 2006). These findings have been contested by some, citing 
inappropriate interpretation of the data, but overall, the results for these programs seem 
mixed (Kaskutas, 2008). For primary care providers, recommendation of participation in AA 
should be primarily based on patient preference. 
  Alcoholics Anonymous in British Columbia. In large centers, AA meeting are 
usually held daily, while rural communities may have meetings less frequently (although 
they are still usually held multiple times per week). In the Northern Health Authority, there 
are meetings accessible in most of the rural areas, including in many small towns and 
villages (BC/Yukon area 79, 2017). One negative aspect to AA is the lack of confidentiality, 
which may represent a significant barrier to its utilization (Coleman, 2005). Individuals who 
live in small communities may experience disproportionately less confidentiality because, by 
nature of living in a small community, there is reduced anonymity.  
Health Belief Model 
 The Health Belief Model (HBM) originated in the 1950s in an attempt to explain why 
people may choose not to participate in programs that can detect or prevent disease 
(Champion & Skinner, 2008). The HBM has evolved minimally since its conception and its 
key constructs remain relatively intact (Champion & Skinner, 2008). These key constructs 
include perceived susceptibility, perceived severity, perceived benefits, perceived barriers, 
cues to action, and self-efficacy (Champion & Skinner, 2008). By examining each 
component of the HBM, researchers and clinicians can illuminate the complex reasons why a 
person may or may not engage in a given health behaviour. Health behaviours such as 
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smoking cessation, breast self-exams, mammography, condom use, and pertinently, entry 
into alcohol use treatment, all lend themselves well to application of the HBM. The key 
constructs of the HBM will be discussed below. Please see Figure 1 for a depiction of the 
HBM. 
Perceived Susceptibility 
 Perceived susceptibility refers to an individual’s perceived risk of contracting or 
developing a certain health condition (Champion & Skinner, 2008). In this integrative 
review, this refers to how likely a patient is to develop AUD. Perceived susceptibility may 
vary among different populations; for instance, young male patients generally consume more 
alcohol and visit their primary care provider less than other populations and therefore young 
males perceive themselves as less susceptible to alcohol-related harms (Navarro et al., 2011). 
Patients must consider themselves to be susceptible to a health condition before they will 
participate in a health behaviour designed to mitigate risk of that condition (Champion & 
Skinner, 2008). 
Perceived Severity 
 Perceived severity refers to the clinical consequences of contracting or developing a 
health condition or to the repercussions from leaving a known condition untreated 
(Champion & Skinner, 2008). In the case of AUD, consequences refer to sequelae such as 
liver cirrhosis, gastritis, cardiovascular disease, and many other potential adverse health 
effects. Perceived severity can also refer to social consequences, such as losing family or 
employment, both of which are pertinent to AUD (Champion & Skinner, 2008). Perceived 
severity and perceived susceptibility can be combined into the single term ‘perceived threat’, 
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which provides a more complete description of how a person may assess the possibility of 
harm from a given health condition (Champion & Skinner, 2008). 
Perceived Benefit 
 Perceived benefit refers to a person’s beliefs regarding the benefit of a given health 
behaviour (Champion & Skinner, 2008). Despite being susceptible to a severe health 
condition, the individual needs to believe there is benefit to changing before they are likely to 
undertake a health behaviour. For example, if patients with AUD do not perceive that they 
will benefit from treatment, they are unlikely to seek out treatment options.  
Perceived Barriers 
 Perceived barriers are obstructions that a person believes will prevent them from 
participating in a given health behaviour (Champion & Skinner, 2008). For rural, remote, or 
northern patients with AUD, perceived financial constraints, geographical isolation, or social 
stigma may be seen as barriers to seeking help. Perceived barriers are considered to be the 
most significant single aspect of the Health Belief Model (Champion & Skinner, 2008). 
Meaning, that if an individual perceived a significant barrier to participating in a health 
behaviour, they are unlikely to overcome the barrier regardless of the perceived threat and 
perceived benefit. 
Cues to Action 
 Cues to action are a non-descript group of motivating factors that are not defined 
within the perceived benefits (Champion & Skinner, 2008). Cues to action can include a 
bodily event or environmental event that triggers the need for change. For patients with 
AUD, a cue to action could include a family member mentioning their drinking, the 
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development of tremors when abstaining from alcohol, or a driving while intoxicated charge. 
These events may cue the patient to take action and seek out treatment.  
Self-efficacy 
 Self-efficacy is the self-belief that an individual is capable of completing a given 
health behaviour to produce a desired outcome (American Psychological Association, 2017). 
In patients with AUD, self-efficacy could refer to their belief that they can decrease their 
drinking or that they can remain abstinent. Without self-efficacy, they are unlikely to attempt 
to address their AUD.  
Other Variables 
 Other variables that affect the likelihood of an individual undertaking a health 
behaviour are listed in Figure 1 as “Modifiable Factors.” These variables include the social, 
economic, psychological, and demographic components of their life. Individuals can be 
influenced by these variables in both their perceptions of health and disease, as discussed 
above, and in the decision to participate in a health behaviour.   
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Figure 1 Health Belief Model 
 
From Health behavior and health education: Theory, research, and practice (4th ed.) (p. 49), 
by V. L. Champion, & C. S. Skinner, 2008, San Francisco, CA: Jossey-Bass. 2 Copyright (c) 
by Wiley Publishing. Reproduced with permission.  
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CHAPTER TWO: METHODS 
An integrative literature review is a specific research methodology that synthesizes 
previous literature for the purpose of addressing a new or unique research question (Torraco, 
2005). Inclusion of both experimental and non-experimental evidence reinforces conclusions 
drawn from within the integrative review, and encourages the application of findings to 
evidence-based practice. Furthermore, integrative reviews have the potential to influence 
theory development and policy makers alike (Whittemore & Knafl, 2005).      
 An integrative literature review was conducted to address the research question: “In 
the setting of rural, remote, and northern primary care, what is the most appropriate treatment 
for adults with alcohol use disorder?” This question was explored in detail because AUD is 
quite prevalent in northern BC and its associated sequelae pose significant health risks to the 
individual drinker and to the general public (Public Health Agency of Canada, 2016; 
University of Victoria, 2017a, 2017b). Furthermore, individuals with AUD who live in rural, 
remote, and northern areas suffer disproportionately greater barriers when attempting to 
access treatment, especially for services that require referral outside of their home 
community. The goal of this integrative review is to utilize current research to guide primary 
care treatment of AUD in rural, remote, and northern regions. An additional aim is to 
illuminate areas of weaknesses in the current body of evidence that may benefit from further 
research.   
 The literature selection and analysis took place in multiple stages. A preliminary 
literature search was conducted, followed by a focused search with the application of 
inclusion and exclusion criteria, and finally a comprehensive analysis of the selected 
literature was executed. Each of these stages will be addressed in detail below. 
51 
 
Search Strategy 
 To begin the literature search, the research question listed above was converted into 
the population-intervention-outcome (PIO) question format. The general concepts were rural-
remote-northern, primary care, AUD, and treatment. Once in the PIO format, search 
terminology was developed through the use of a concept map. 
The outcome component - treatment - appears to be intrinsic within the literature. 
Meaning, that articles written about AUD generally focused either on epidemiology or on 
treatment. Both of these outcomes are applicable to this integrative review; therefore, the 
search terminology concentrated on the population and the intervention aspects of the PIO 
question.  
 Initially, all population and intervention components were included in the database 
searches, but this lead to very few results. In particular, the search terms ‘north” and 
“northern” limited the results. These two terms limited search results to less than 20 articles 
in most databases, and the results did not equate well with what is considered northern in a 
Canadian context. In Canada, northern is synonymous with rural and remote, but also 
suggests an aspect of harshness, such as long and cold winters. The search results did not 
reflect the essence of the Canadian meaning of northern; for example, results included 
“Northern Africa,” or “North America” in the titles but were not applicable to the research 
question. Consequently, the northern terminology was removed from the searches. 
The concept of “primary care” also significantly reduced the number of search 
results. However, since primary care is a crucial concept within the integrative review, 
searches were performed both including this concept and excluding it. The two sets of results 
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were screened separately using a focused search, which is described in the focused search 
heading below.  
Initial Literature Searches 
 The initial literature searches were conducted in five databases: CINAHL 
(EBSCOhost), PsychINFO (EBSCOhost), MEDLINE (Ovid), PubMed, and Cochrane 
Database of Systematic Reviews ([CDSR] Ovid). These databases were accessed 
electronically through the University of Northern British Columbia library. These five 
databases were chosen because they are well-known academic databases that include peer-
reviewed literature from multiple disciplines. To ensure a complete representation of AUD in 
rural, remote, and northern settings, and given that AUD is a topic that has been researched 
by a range of social and health care professions, it was imperative to search a variety of 
databases.  
 With the exception of the CDSR, PsychINFO, and CINAHL databases, Medical 
Subject Headings (MeSH) were exclusively used. Keyword searches with truncation were 
added to the CINAHL and the PsychINFO searches to elicit additional results. CDSR does 
not utilize MeSH in its archival algorithm so keyword searches with truncation were used. 
When available, the MeSH search terms were exploded to include all subheadings. 
Exploding the MeSH term facilitated a more comprehensive search because it reduced the 
risk of omitting pertinent articles archived within a subheading that might have otherwise 
been missed. 
Reference lists of the selected articles were also searched for additional literature 
pertinent to the research question. These articles were retrieved from the Google Scholar 
database. Please refer to Table 4 for the specific search terms that were used.  
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Table 4 MeSH and Keyword Search Terms 
CINAHL 
(EBSCOhost) 
PsychINFO 
(EBSCOhost) 
MEDLINE 
(Ovid) 
PubMed CDSR 
• Rural Health 
Personnel 
• Rural Health 
Centers  
• Hospitals 
Rural 
• Rural 
Populations 
• Rural Health 
Services 
• Rural Health 
Nursing 
• Rural Areas 
• Rural Health 
• “Rural” 
• “Remote” 
• “Isolat*” 
• Rural 
Environments 
• “Rural” 
• “Remote” 
• “Isolat*” 
• Rural Health 
• Rural 
Population 
• Hospitals, 
Rural 
• Rural Nursing 
• Rural Health 
services 
• Rural Health 
• Rural Nursing 
• Rural 
Population 
• Rural Health 
Services 
• Hospitals, 
Rural 
• “Rural” 
• “Remote” 
• “Isolat*” 
• Alcohol-
Related 
Disorders + 
Rehabilitation 
+ Drug 
Therapy + 
Therapy 
• Alcohol 
Rehabilitation 
Programs 
• Alcoholism 
• Alcohol 
Rehabilitation 
• Alcoholics 
Anonymous 
• Detoxificatio
n 
• Alcohol 
Abuse 
• Alcohol-
Related 
Disorders + 
Diet Therapy 
+ Drug 
Therapy + 
Rehabilitation 
+ Therapy 
 
• Alcohol-
Related 
Disorders + 
Rehabilitation 
+ Therapy 
• “Alcohol adj3 
Drink*” 
• “Alcohol adj3 
Abuse” 
• “Alcohol adj3 
Disorder” 
• “Alcohol adj3 
Depend*” 
• Primary 
Health Care 
• Primary 
Health Care 
• Primary 
Health Care 
• Primary 
Health Care 
• “Primary adj2 
Care” 
Note. Search terms within each box were combined with OR. “” indicate a keyword search. * 
indicates truncation. Adj followed by a number indicates the number of words that can 
appear between the search terms. + indicates subheadings within a MeSH.  
  
Focused Search 
 In total, the above searches produced 1099 articles. To narrow these results to only 
the most relevant articles, titles and abstracts were screened using inclusion and exclusion 
criteria (see Table 5). Given the relatively broad research question, minimal inclusion and 
exclusion criteria were applied to try and preserve pertinent articles. No specific criteria 
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related to year of publication were applied because AUD has been researched for a long 
period of time and it was anticipated that some of the older literature might still be relevant 
to the research question. Similarly, no geographical criteria were included because countries 
such as Australia, the United States, and England have comparable health care systems to 
Canada, and may have produced relevant research to this integrative review. Study design 
criteria were also avoided because, although the research question does lend itself well to 
quantitative research, it was felt that qualitative studies had the potential to enrich the 
integrative literature review with the experience of both the patient and the health care 
provider. Please see Table 5 for the inclusion and exclusion criteria. The detailed disposition 
of the articles from the preliminary searches can be found in Figure 2. 
Table 5 Search Inclusion and Exclusion Criteria 
Inclusion Exclusion Reason 
Adult (18 years 
and older) 
Youth (younger than 18 
years) 
I chose to exclude younger populations 
because AUD is less common in children 
and adolescents.  
Published in 
English 
Published in any language 
other than English 
Limited resources to translate articles given 
time restraints and scope of the capstone 
project. 
Specific to 
alcohol use 
disorder.  
Concurrent disorders and 
other substance use 
issues. 
Focuses on alcohol and avoids concurrent 
disorders (e.g. cocaine use, opioid use).  
Peer-reviewed 
research articles 
Non-peer reviewed 
articles 
Limits results to academic journals. Avoids 
non-scientific articles. 
 
Analysis of Selected Literature 
 The final step in the integrative review process was to complete a comprehensive 
analysis of the selected literature. A literature review matrix was created as the primary tool 
to analyze the articles and elicit themes between and among them. The headings within the 
literature review matrix were chosen based on recognized appraisal tools found on the 
Critical Appraisal Skills Programme’s (2013) website. The matrix headings include a 
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description of the study, study design, strengths, limitations, important findings, and utility, 
all of which are integral parts of an integrative literature review.  
 An additional tool used to analyze the literature results was the Johns Hopkins 
Research Evidence Appraisal Tool (Johns Hopkins University, n.d.). This tool provides rigid 
criteria for grading all types of evidence from levels one to three, with level one being the 
highest level of evidence. The Johns Hopkins Research Appraisal Tool was chosen as an 
additional analysis method because of the significant study design heterogeneity included in 
the integrative review. 
 The literature analysis resulted in a number of common themes being elucidated. 
These findings will be discussed in detail in the Findings chapter, with further analysis to 
follow in the Discussion chapter.  
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Figure 2 Disposition of Articles 
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CHAPTER THREE: FINDINGS 
 An integrative review was conducted to examine the treatment options available to 
primary care practitioners within rural, remote, and northern settings, with the aim of 
increasing treatment success and to highlight those areas that could be improved. To guide 
this analysis, the following research question was posed: in rural, remote, and northern 
primary care settings, what is the optimum treatment for adults with AUD? A literature 
search returned 18 pertinent articles for inclusion in the integrative review. To examine each 
of these selected articles in detail, a literature review matrix was constructed. This literature 
review matrix provided a uniform format through which each of the articles was scrutinized. 
Six themes were elucidated from the selected literature. These themes were: (a) 
comorbidities; (b) rural versus urban AUD; (c) screening for AUD; (d) primary care 
management of AUD; (e) specialist management of AUD; and (f) interventions applicable to 
primary care. Within each of these six themes, a critical review of the 18 included articles, 
including literature gaps, is provided below. The Johns Hopkins Evidence Appraisal Tool 
(n.d.) will be referenced throughout this chapter as “evidence level” one, two, or three. 
Evidence level one is considered to be the most robust, while evidence level three is the least 
robust (Johns Hopkins University, n.d.). A detailed review of all 18 articles is presented 
within the literature review matrix found in the Appendix. 
 None of the articles included in the review addressed the research question directly; 
however, the articles included in the integrative review did tackle various elements of the 
research question and provided opportunity for further synthesis within the Discussion 
chapter.  
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Comorbidities 
 Comorbidities are commonly found in patients suffering from AUD and can include 
disease of almost all bodily systems; these various diseases can pose a significant threat to an 
individual’s health and well-being. In the literature sample included in this review, the most 
commonly cited comorbidities associated with AUD were mental health problems and 
emotional trauma. From this point forward in the review, emotional trauma will be referred 
to simply as trauma. Four articles specifically stated that mental health, trauma, and AUD 
were commonly found in coexistence; however, none of these articles assessed this 
relationship as a primary focus (Allan, 2010; Slaunwhite & Macdonald, 2015; Spithoff & 
Kahan, 2015b, 2015c).  
 Slaunwhite and Macdonald (2015) examined the experience of “isolated” primary 
care physicians (n = 67) in BC who treated people with alcohol-attributed disease processes. 
The authors utilized an evidence level three, qualitative cross-sectional survey design. In this 
article, the term ‘isolated’ is used synonymously with the terms ‘rural, remote, and northern’ 
that are used within this integrative review. The authors utilized the Rural Coordination 
Centre (RCC) of BC’s (2017) scoring system to quantify rurality, remoteness, and isolation 
of physician practices. The RCC’s system is the mechanism by which physicians in BC 
receive additional funds for engaging in rural practice. This system was an appropriate 
method to ensure that only physicians from the desired rural, remote, and isolated 
backgrounds received the survey. The physicians in the study population had an average of 
15.8 years of experience in the primary care setting, which fostered confidence in the validity 
of their reports. Another strength of this study was the use of an inductive theoretical model 
to guide data analysis, which allowed taxonomies and themes to be derived from the survey. 
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The primary weakness within this study was the low response rate (22% of eligible 
physicians in BC), which significantly limited its generalizability. However, given the 
sample population the authors studied, it did provide some insight into the real-world 
challenges of AUD treatment in rural, remote, and northern BC. The authors found that 
mental health was reported as the most common alcohol-related harm, and that causation was 
indicated in both directions (Slaunwhite & Macdonald, 2015). In other words, those with 
AUD were more prone to developing mental health disorders, and those with mental health 
disorders were more prone to developing AUD (Slaunwhite & Macdonald, 2015). No 
analysis was provided regarding the types of mental health issues involved or their respective 
prevalence rates.  
 Trauma services were specifically mentioned as a gap in services available within 
rural, remote, and northern BC, specifically for First Nations peoples impacted by residential 
school system, assimilation, and historical trauma (Slaunwhite & Macdonald, 2015). This 
concern was highlighted by only 10% (n = 4) of the surveyed physicians; however, it 
remains important to this integrative review since trauma is a frequent reality in rural, 
remote, and northern patients who develop AUD (Slaunwhite & Macdonald, 2015).  
 Spithoff and Kahan (2015b, 2015c) provided a two-part series of non-systematic 
literature reviews that resulted in clinical recommendations for primary care providers. Part 
one of the series addressed screening and assessment of AUD (Spithoff & Kahan, 2015b) 
whereas part two of the series addressed counseling, prescription medication, and 
connections to specialist for patients with AUD (Spithoff & Kahan, 2015c). The authors also 
cited mental health and trauma as common comorbidities among patients with AUD. These 
findings were evidenced with a somewhat dated (2002) Canadian Best Practice Guideline on 
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concurrent substance use and mental health, and a retrospective cross-sectional survey of 
adult patients’ who had experienced adverse childhood events (trauma), in order to better 
understand their current substance abuse practices (Spithoff & Kahan, 2015b, 2015c). The 
retrospective study suggested that those children who experienced one or more adverse 
childhood events were at a two- to four-fold risk for developing AUD as an adult, indicating 
a strong causal relationship (Spithoff & Kahan, 2015c). Accordingly, Spithoff and Kahan 
(2015b, 2015c) suggested that concurrent mental health treatment and trauma informed 
services were an integral component of AUD management.  
 Spithoff and Kahan (2015b, 2015c) highlighted the importance of mental health and 
trauma services but they did not account for the limited availability of these services in rural, 
remote, and northern locations. Instead, the authors suggested that the primary care provider 
should assess and treat for mental health and trauma as required. This strategy may 
undervalue the impact that mental health and trauma have on patients with AUD because, 
although the authors suggested that primary care providers had the capacity to take on this 
role fully, it is clear from their own articles that AUD, mental health, and trauma remain 
significant comorbid concerns in patients with AUD (Spithoff & Kahan, 2015b, 2015c). Both 
of these non-systematic review articles were evidence level three, with their 
recommendations supported by a number of randomized controlled trials, systematic 
reviews, and meta-analyses (Spithoff & Kahan, 2015b, 2015c). The major limitation 
associated with these articles was that there was no explanation of their literature search or 
analysis techniques.  
  Allan (2010) utilized a qualitative, social action research design to assess the 
challenges of implementing drug, alcohol, and mental health treatment programs in rural 
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Australia. This evidence level three study utilized in-depth, semi-structured interviews of a 
variety of health care workers to elucidate themes and develop strategies to overcome the 
barriers identified. Although the aim of the study was not to address the characteristics of 
patients with AUD, a common theme noted by the authors was that AUD patients were 
“more likely than not” (Allan, 2010, p. 315) to suffer from comorbid mental health problems 
or trauma. Strengths of this study included a moderate sample size (n=47) and computerized 
data analysis. Although manual-coding techniques would have been possible in this study, 
each interview lasted up to 90 minutes, suggesting that computerized data analysis was likely 
a more appropriate method to allow thorough and rigorous coding. However, it is difficult to 
exclude bias from this study because some of the subjects were actually employees of the 
agency conducting the study. The power differential between employee and employer is 
likely to have influenced the study participants’ responses, which limited the validity of this 
study. 
 Although none of the studies listed above were designed to assess comorbidities as a 
primary outcome, Slaunwhite and Macdonald (2015), Spithoff and Kahan (2015b, 2015c), 
and Allan (2010) all suggested that mental health and trauma were common comorbidities in 
patients with AUD. In rural, remote, and northern BC, AUD is common and it follows that 
mental health and trauma are likely to be common as well (University of Victoria, 2017a). 
For primary care providers in rural, remote, and northern settings, consideration should be 
given to patients’ comorbid mental health and trauma histories because this may affect their 
ability to participate in, or access AUD treatment, especially if referral outside of the 
community is required. Furthermore, because a significant portion of Aboriginal people live 
in rural, remote, and northern BC, particular consideration of the trauma suffered in the 
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residential school system is warranted (Foster et al., 2011). This historical trauma continues 
to affect the health of Aboriginal peoples today and is considered a causal factor in the 
prevalence of AUD in this population (Spithoff & Kahan, 2015b). Considering that primary 
care providers are often the only access to health care in many rural, remote, and northern 
communities, both mental health and trauma remain significant factors in the management of 
patients with AUD. Furthermore, Slaunwhite and Macdonald (2015) found that primary care 
providers in these environments do not feel fully equipped to care for individuals with 
comorbid mental health and trauma, and therefore, these providers would likely benefit from 
further training, support, and/or resources.  
Rural Versus Urban Alcohol Use Disorder 
 In BC, AUD is more prevalent in rural, remote, and northern regions (University of 
Victoria, 2017a). Additionally, alcohol-related mortality is more common in these areas of 
BC (University of Victoria, 2017b). The relationship between rurality and AUD is discussed 
below.  
 Malek-Ahmadi and Degiorgio’s (2015) evidence level three study examined rural and 
urban residents of Nebraska who had previously been arrested for exceeding the legal 
alcohol limit while driving a vehicle while intoxicated. The authors defined rural residency 
by using the Rural-Urban Continuum Codes from the United States Department of 
Agriculture Economic Research Service ([USDAERS], 2017). The USDAERS categorized 
counties in nine separate population-based levels. The urban-rural separation is at a 
population of 2,500 within the county (USDAERS, 2017). Given that county sizes in the US 
vary widely, a direct comparison cannot be made to the rural, remote, and northern 
population in this integrative review; however, this rural definition is congruent with the 
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essence of the study population in this integrative review. This was a large (n=11,066) study 
with robust statistical analyses. The researchers utilized the validated Driver Risk Inventory 
II (DRI-II) to determine if there were significant differences between the urban and rural 
DWI offender. The DRI-II consists of six separate self-reported scales. The Cronbach’s alpha 
method was utilized to confirm internal consistency of the scales, and Cohen’s d was used to 
calculate effect size. Pertinent to this review were the 23-question alcohol survey (α=0.94), 
the 25-question driver risk scale (α=0.88), and a 21-question truthfulness scale (α=0.89). The 
truthfulness scale was used to identify participants who may have under-reported their 
drinking behaviours. Logistical regression in both the unadjusted and the adjusted (for age, 
education, gender, ethnicity, blood-alcohol at time of arrest, and number of prior alcohol 
related arrests) analyses indicated participants with medium (OR 1.43; CI 95% 1.20, 1.71; p 
< 0.001), problematic (OR 1.43; CI 95% 1.19, 1.72; p < 0.001), or severe (OR 1.38; CI 95% 
1.14, 1.67; p = 0.001) alcohol use were significantly more likely to be rural residents (Malek-
Ahmadi & Degiorgio, 2015). The authors reported that, although the results were statistically 
significant, the magnitude of effect was relatively small (d = 0.11). No differences were 
found between urban and rural participants for the truthfulness scale or the driver risk scale. 
In summary, this study demonstrated that, in the central USA state of Nebraska, rural DWI 
offenders were slightly more likely to have more severe AUD than their urban counterparts. 
Malek-Ahmadi & Degriorgio’s (2015) findings were consistent with the statistics found in 
rural, remote, and northern BC (University of Victoria, 2017a, 2017b). The primary 
limitation of this study was its reliance on self-reporting by the study sample. This method 
may have exposed the data to recall bias; however, the authors did attempt to limit 
purposeful deception through the use of the truthfulness scale.  
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 The evidence level three observation pilot study by Brennan et al. (2013) examined 
one model of training remotely-located primary care physicians in screening and the brief 
intervention technique for AUD. This study aimed to assess the physicians’ perceived role, 
knowledge, confidence in screening and management of AUD; to assess satisfaction with the 
training session provided; and to assess the impact of the training session on physician 
practices. The authors utilized the Australian Institute of Health and Welfare’s (2017) 
definition of rural and remote, which is summarized as any resident who lives outside of a 
major city (Brennan et al., 2013). The comparability of this relatively loose definition with 
the study population of rural, remote, and northern BC is uncertain. The uncertainty is routed 
in the definition of a “major city,” which open to interpretation, and may vary greatly from 
Australia to BC. This study was not designed to assess characteristics of rural and urban 
residents; however, the authors reported that rural Australians consumed greater amounts of 
alcohol than their urban counterparts, and they experienced more alcohol-related harms such 
as injury, social problems, mortality, and morbidity. The alcohol consumption data was 
evidenced by Australian governmental statistics, which showed that up to 10% more of the 
rural population was placed in the “high-risk” drinking categories (Australian Institute of 
Health and Welfare, 2005). The assertions regarding alcohol-related harms were evidenced 
by multiple peer-reviewed journals. The utility of this study for the integrative review may 
be limited by the authors’ definition of rural, and by the fact that this was not the primary 
aim of this study. Nonetheless, Brennan et al.’s (2013) findings appear consistent with the 
statistics from BC, and with Malek-Ahmadi and Degiorgio (2015). 
A cross-sectional survey of family physicians (n = 40) in Washington State and Idaho 
State by Ferguson et al. (2003) assessed barriers to AUD treatment by both urban and rural 
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practitioners. This was an evidence level three study that utilized a Likert scale survey 
instrument to categorize answers as “a barrier” or “not as a barrier”. The sample of 
physicians was equally split between rural and urban practices. Three categories were 
elucidated: patient centered barrier, physician centered barrier, and system centered barrier. 
Overall, the patient centered barrier category, which included patient denial of the problem, 
and lack of patient motivation to change, was ranked as the greatest barrier (p < .001). 
Within a subgroup analysis, a greater number of rural than urban physicians ranked distance 
to treatment as a barrier (40% vs 5%, χ2 = 5.16, p = .02). This supports the idea that for rural, 
remote, and northern populations, access to specialist care remains a principal barrier. 
Limiting factors of the study include: a small sample size, a nearly entirely male sample, and 
a lack of randomization with sample selection. 
Screening 
 The recommendations for routine screening for AUD in primary care practice settings 
are inconsistent between the literature reviewed here and the BC and Canadian Guidelines. 
The BC Guidelines suggest selective screening for patients over 19 years of age who exhibit 
signs and symptoms that may be attributed to alcohol use, while the Canadian Guidelines 
suggest that “all” primary care patients should be screened yearly in addition to when there is 
a clinical suspicion of AUD (British Columbia Ministry of Health, 2013; Spithoff & Kahan, 
2015b). Spithoff and Kahan (2015b) provided supporting literature for their 
recommendation, including a large meta-analysis of 48 studies, whereas the source of the BC 
Ministry of Health’s (2013) recommendation is unclear. Given the other screening and health 
maintenance demands on primary care providers’ time, it was important for this integrative 
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review to examine the selected literature regarding the effectiveness of screening, and how it 
relates to AUD in rural, remote, and northern populations.  
 An evidence level three study by Navarro et al. (2011) assessed the effectiveness of 
increased screening and the brief intervention counseling technique for AUD in rural 
Australia. Navarro et al. (2011) utilized a cross-sectional survey design to gather baseline 
alcohol consumption, screening, and brief intervention data for 10 rural communities. This 
data (n=1540) was combined with population data from the Australian Bureau of Statistics to 
estimate the total number of drinkers in each category within the 10 experimental 
communities. These numbers were used to populate a decision making tool to project the 
potential cost savings to the Australian health care system if screening alone, or screening 
and the brief intervention technique, were used more frequently by rural primary care 
providers. The authors found that increasing annual screening rates (without any other 
intervention) to 100% of the patient population was the most cost-effective method for 
reducing heavy drinking to low-risk levels (Navarro et al., 2011). The authors cite that 
reduction in alcohol consumption from screening only was between 11.5% and 46%, 
although the reasons for this reduction remain unclear (Navarro et al., 2011). The 
incremental cost-effective ratio (ICER) for increasing screening to 100% of the patient 
population was $197 (Australian dollars) per patient to reduce their drinking to low-risk 
levels (Navarro et al., 2011). The authors admitted that implementation of universal 
screening may not be acceptable to all primary care providers, and that these interventions 
may not work for some populations with high rates of AUD, such as young males, because of 
a tendency toward more infrequent primary care visits (Navarro et al., 2011). This study did 
suggest that yearly screening of all rural primary care patients was a cost effective method of 
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increasing recognition of, and remission from AUD. Bias cannot be excluded in the Navarro 
et al. (2011) study because the authors did not detail randomization techniques, the sample 
demographics, or the survey tool. A significant methodological weakness in this study was 
that females and older adults were over-represented in their survey data, indicating that the 
survey may not have been completed by a representative sample of the 10 experimental 
communities, thus potentially biasing the results. This article supports the importance of 
screening for AUD in rural Australia, which is likely also true in rural, remote, and northern 
BC. However, what remains unclear is whether the cost-benefit analysis the authors provided 
would be applicable to BC because of the differences between these health care systems.  
Primary Care Management of Alcohol Use Disorder 
 There are up to 350,000 individuals with some degree of AUD living in BC (British 
Columbia Ministry of Health, 2013). Those who live in rural, remote, and northern areas of 
BC have limited access to alcohol treatment beyond what a primary care provider can deliver 
(British Columbia Ministry of Health, 2017a; Canada Drug Rehab Addiction Services 
Directory, 2017; Northern Health Authority, n.d.). The care for these individuals typically 
falls to local primary care providers, who comprise the backbone of rural Canadian health 
care (Slaunwhite & Macdonald, 2015). This section will discuss findings related to both the 
benefits of, and barriers to, primary care management of AUD. 
Benefits of Primary Care Management 
 Of the 18 articles pertaining to the research question, only four directly addressed the 
benefits of primary care management of AUD (Allan, 2010; Slaunwhite & Macdonald, 2015; 
Spithoff & Kahan, 2015c, 2015a). The authors outlined a number of benefits to primary care 
management that can be grouped into three main themes: accessibility; patient to provider 
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relationships; and prescription medications. The accessibility theme was emphasized with a 
number of points: minimal wait times; proximity to home community; convenience; and 
increased opportunities for intervention related to more frequent appointments (Slaunwhite & 
Macdonald, 2015; Spithoff & Kahan, 2015a, 2015c). Slaunwhite and Macdonald (2015) 
added to this by saying that, in rural BC, primary care providers act as the “gate-keepers” to 
specialist treatment, indicating that the first point of contact with the health care system is 
through the primary care provider. This highlights the crucial role that primary care providers 
play in the management of patients with AUD. To support this assertion, the authors 
referenced a peer-reviewed Australian study that explored the concepts that underpin rural 
health care. Although this study was not experimental in nature, it did highlight limited 
access to services beyond a primary care provider as a defining factor or rural health care. 
While Allan (2010) argued that primary health care workers (primary care providers fall into 
this broader category) were in the best position to deliver alcohol treatment, it is unclear 
whether Allan (2010) was referring to physical location or to existing relationships with 
patients seeking treatment. 
 The patient to provider relationship theme appeared to be an important factor in 
primary care management of AUD. Pre-existing relationships between the patient and 
provider foster trust, especially when confronting addictions issues that can be stigmatizing 
for patients (Slaunwhite & Macdonald, 2015; Spithoff & Kahan, 2015a, 2015c). An existing 
relationship also increased success of counseling interventions, patient retention, and 
longitudinal care, which may be particularly salient when considering rural, remote, and 
northern populations in BC (Slaunwhite & Macdonald, 2015; Spithoff & Kahan, 2015a, 
2015c). Access to specialist services in such settings tend to be limited, require a long wait, 
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and/or are located outside the patient’s home community; however, a strong relationship with 
a primary care provider can improve chances of treatment retention and success in the 
primary care setting (Spithoff & Kahan, 2015a).  
Spithoff and Kahan (2015a) provided an evidence level three summary article that 
was meant to highlight some of the limitations of specialist management as well as the 
benefits of primary care management of AUD. The authors cited a recent single-blinded 
randomized controlled trial comparing veterans in the United States who were treated in a 
primary care clinic to those who were under specialist care at an addictions clinic (Spithoff & 
Kahan, 2015a). The primary care cohorts were more likely to refrain from heavy drinking 
than those treated in the specialist care setting (OR = 2.16, 95% CI = 1.27 – 3.66) (Oslin et 
al., 2014). The authors attributed this finding to increased patient engagement with primary 
care (OR – 6.97, 95% CI = 4.04 – 12.05) and to increased naltrexone use (65.9% of primary 
care, and 11.5% of specialist treatment) (Oslin et al., 2014).  
 Spithoff and Kahan (2015a, 2015c) suggested that another benefit of primary care 
management of AUD was the ability to prescribe medications (Spithoff & Kahan, 2015a, 
2015c). They reported that many specialist treatment services rely on psychosocial 
interventions alone whereas a primary care provider can prescribe one of three adjunct 
medications in combination with psychosocial intervention to assist patients with drinking 
cessation (Spithoff & Kahan, 2015a, 2015c). There was some evidence to show that 
medications may improve AUD treatment outcomes; this will be discussed in the 
pharmacotherapy section below.  
 The evidence level three prospective cohort study by Moos and Moos (2006) 
examined individuals (n=461) who initiated help-seeking for AUD by contacting an 
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information and referral line or detox center. To determine rates and predictors of AUD 
remission and relapse, follow-up interviews were completed at one, three, eight, and 16-years 
after entry into the study. Study retention was high with 90% of participants completing at 
least two of the four follow-ups, and over half (n = 276) completing the 16-year follow-up 
(Moos & Moos, 2006). Comparisons were made between participants who had help 
(professional treatment or supports groups), and those who remitted from alcohol on their 
own. The authors found that, at the three-year follow-up, 62.4% of those who had help were 
remitted, compared to 43.4% of the who did not receive help (χ2 < 11.54; p < 0.01) (Moos & 
Moos, 2006). This indicated that the participants who had help were significantly more likely 
to stop drinking. Follow-up at the 16-year mark revealed that, of those who remitted without 
help, 60.5% had relapsed whereas, of those who remitted with help, only 42.9% had relapsed 
(χ2 < 4.48; p < 0.05) (Moos & Moos, 2006). This adds further support to the importance of 
treatment of AUD in the more readily available primary care setting rather than through 
specialist treatment options. Based in the above findings, rural, remote, and northern primary 
patients with AUD will have a greater chance of successful, long-term remission from AUD 
if they receive assistance in remitting from alcohol (Moos & Moos, 2006). The primary 
limitations of the Moos and Moss (2006) study was that study participants were self-selected 
for treatment. Self-selected study participants demonstrated that they were motivated to 
change their drinking behaviours prior to the onset of the study. This makes it difficult to 
know if the benefits found were related to the existing motivation to change or to the help 
received. Furthermore, the lack of specifics regarding what type of help was received limits 
the ability to find causation for AA or professional care. Overall, the Moos and Moos (2006) 
study supports the importance of the primary care provider’s role because those who 
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received help with AUD treatment were more successful in attaining remission, and 
remaining remitted. In rural, remote, and northern BC, the primary care provider is the main 
contact for any patient needing help with their AUD. Access to a primary care provider is 
usually available and, by receiving help with AUD, patients are more likely to succeed in 
overcoming their AUD.  
Barriers to Primary Care Management 
 No specific barriers to primary care management of AUD were identified in the 
literature sample for this integrative review. Although, the Canadian Guidelines suggested 
that individuals who suffer from severe or complex AUD, or who failed to respond to 
treatment, should be considered for referral to an addictions medicine specialist (Spithoff & 
Kahan, 2015c). This recommendation indicates that, although more severe AUD is not a 
specific barrier to primary care management, there may be some benefit to the patient if a 
referral is made to specialist care.  
 For certain individuals, there may be medical or psychosocial barriers to office-based 
management of alcohol withdrawal (British Columbia Ministry of Health, 2013). The BC 
Guidelines provide a list of contraindications to outpatient withdrawal that may require 
medically supervised withdrawal in an inpatient setting (British Columbia Ministry of 
Health, 2013). Some of the contraindications included previous withdrawal seizures; unstable 
medical conditions, such as coronary artery disease or diabetes mellitus; signs of liver 
failure; and pregnancy (British Columbia Ministry of Health, 2013). This list of 
contraindications was minimally supported by one dated non-systematic review article 
(Myrick & Anton, 1998). The authors cite two even more dated articles from the 1980’s, but 
they do state that there is a lack of research-based criteria and a “pragmatic” approach should 
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be taken (Myrick & Anton, 1998). There was no other literature found to support or refute 
these contraindications. In the setting of rural, remote, and northern BC, patient safety is a 
primary concern when considering office-based alcohol withdrawal, and some cases may 
necessitate in-patient detoxification despite its relative lack of availability in rural, remote, 
and northern BC (Northern Health Authority, n.d.).  
Specialist Management of Alcohol Use Disorder 
 A key part of the Canadian Guidelines, and a briefly mentioned part of the BC 
Guidelines, was the referral of patients with AUD to specialist services (British Columbia 
Ministry of Health, 2013; Spithoff & Kahan, 2015c). Specialist services included: residential 
treatment programs; outpatient day programs; medical detoxification; addictions medicine 
specialist; and support groups. The findings related to the benefits of, and the barriers to 
specialist management of AUD are discussed below.  
Benefits of Specialist Management 
 The benefits of specialist services were only briefly discussed in both the BC and the 
Canadian Guidelines (British Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015c). 
Both sets of guidelines suggested that patients with complex psychosocial situations, 
complex medical needs, or contraindications to out-patient alcohol withdrawal should be 
considered for specialist management (British Columbia Ministry of Health, 2013; Spithoff 
& Kahan, 2015c). Both guidelines encouraged specialist psychosocial interventions, such as 
counseling or support groups, in addition to medical management delivered by the primary 
care provider (British Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015c). There 
is no guidance for primary care providers beyond these general recommendations and it was 
suggested that the patient should choose the most appealing modality (British Columbia 
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Ministry of Health, 2013). No other literature included in this integrative review addressed 
the benefits of specialist management of AUD.  
Barriers to Specialist Management 
 A primary theme that emerged from the literature was that numerous barriers could 
impede patients from successfully accessing specialist services. Barrier to specialist 
management were found to be the to be the inverse of the benefits to primary care 
management. Five articles highlighted these barriers (Allan, 2010; Ferguson et al., 2003; 
Jonas et al., 2014; Slaunwhite & Macdonald, 2015; Spithoff & Kahan, 2015a).  
 Spithoff and Kahan (2015a) reported that rates of missed specialist appointments 
ranged from 30% to 75% for the initial appointment and 15% to 50% for follow-up 
appointments. The authors cited two recent large, multi-cite studies that directly examined 
missed specialist appointments in addictions medicine. Reasons for missed appointments 
included ambivalence towards treatment and a lack of therapeutic alliance with the specialist.  
 Slaunwhite and Macdonald (2015) directly cited the difficulty in accessing specialist 
services as a significant barrier to treatment of AUD in rural, remote, and northern BC. The 
authors grouped barriers to specialist treatment into five themes: limited services; wait-lists; 
travel and cost of treatment; service suitability; and patient willingness. Slaunwhite and 
Macdonald (2015) reported that a total of 76% of the surveyed physicians who referred 
patients to treatment (n = 55, or 87.3% of the sample) reported difficulties, especially if 
travel outside of the patient’s home community was required. The most frequently reported 
barriers were limited services, wait-lists, and travel and cost of treatment (Slaunwhite & 
Macdonald, 2015). Pertinently, one participant said, “usually there is a wait for admission [to 
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specialist treatment], during which a patient’s alcohol abuse [sic] problem may relapse” 
(Slaunwhite & Macdonald, 2015, p. 340).  
 Jonas et al. (2014) agree that limited access may be a significant barrier to obtaining 
specialist services. This study was a large (n = 151), evidence level one systematic review 
with meta-analyses of pharmacotherapeutic options for AUD (Jonas et al., 2014). However, 
the authors only briefly mentioned access to specialist services in the discussion section with 
no citation for their assertion. Although this study examined the efficacy of pharmacotherapy 
in-depth, it was not designed to assess barriers to specialized services. Moreover, there was 
no data analysis provided regarding this statement, thus limiting its utility in this context. 
 Monetary costs associated with access to specialist care, and the cost of the treatment 
itself, were found to be significant barriers in two articles (Slaunwhite & Macdonald, 2015; 
Spithoff & Kahan, 2015a). Travel, lost work, and cost of treatment were highlighted as 
primary financial barriers to accessing treatment. Slaunwhite and Macdonald (2015) reported 
that travel and cost of treatment were significant barriers to specialist care in 47.5% of their 
sample. No specific numbers were provided regarding how many patients were prevented 
from accessing specialist care in either of these articles.  
 Patient willingness to access specialist services was a barrier identified in four of the 
included articles (Ferguson et al., 2003; Jonas et al., 2014; Slaunwhite & Macdonald, 2015; 
Spithoff & Kahan, 2015a). Ferguson et al. (2003) found that 88% of the survey sample 
indicated patient denial, and 78% of the survey sample indicated lack of patient motivation, 
as the most significant barriers to accessing treatment. Interestingly, Slaunwhite and 
Macdonald (2015) found that only 7.5% of the respondent physicians (n=3) viewed patient 
willingness as a significant barrier to accessing specialist treatment. The authors stressed that 
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patient willingness “was not viewed in isolation from other factors that negatively impact 
patient adherence to treatment plans” (Slaunwhite & Macdonald, 2015, p. 341). The reason 
for the stark contrast between these two studies is unclear, but both had relatively small 
populations, and they were conducted in different geographical settings. Jonas et al. (2014) 
also reported that patient willingness may be a barrier to accessing specialist care; however, 
this article was focused on the efficacy of pharmacotherapy for AUD and there was no 
analysis or evidence provided. Hence, bias cannot be excluded from this statement.  
 In rural, remote, and northern BC, accessibility of specialist services appears to be a 
significant barrier experienced most of the time (Slaunwhite & Macdonald, 2015). The 
literature reviewed above supports the assertion that management of AUD in rural, remote, 
and northern BC may be heavy reliant on primary care providers. 
Interventions Applicable to Primary Care 
 The literature included in this integrative review revealed three interventions that are 
applicable to rural, remote, and northern primary care. These interventions included 
pharmacotherapy, brief interventions, and tele-health. The pertinent findings related to these 
three intervention techniques will be discussed below.  
Pharmacotherapy 
 Three medicines – naltrexone, acamprosate, and disulfiram – are approved for the 
treatment of AUD in Canada (British Columbia Ministry of Health, 2013; Spithoff & Kahan, 
2015c). The use of pharmacotherapy in AUD treatment appears to be at odds with the current 
evidence for efficacy (Jonas et al., 2014). There is evidence to support the efficacy of both 
naltrexone and acamprosate in certain populations but actual utilization may be limited 
(Jonas et al., 2014). The specific prescription rates of these three medications in BC were 
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unobtainable for this integrative, despite contacting the British Columbia Medical 
association, the College of Pharmacists of British Columbia, and the Medical Services Plan 
Of British Columbia. Prescription rates are only available through Population Data BC, and 
require ethics approval and a research plan submission, which is beyond the scope and 
timeline of this integrative review. The benefits and barriers to pharmacotherapy in AUD 
will be discussed below.  
 Benefits of Pharmacotherapy. Jonas et al. (2014) provided a comprehensive 
systematic review and meta-analysis of pharmacotherapeutic options for AUD. The authors 
examined 151 articles dating from 1970-2013, and excluded studies with unclear biases from 
their analyses. Research was graded utilizing the established guidelines from the Agency for 
Healthcare Research and Quality (Jonas et al., 214). Meta-analyses were conducted on 95 of 
the included articles. Jonas et al. (2014) found that both oral naltrexone and oral acamprosate 
significantly reduced drinking. To prevent the return to any drinking, the number needed to 
treat (NNT) for acamprosate was 12 (95% CI, 8 to 26; risk difference [RD], -0.09; 95% CI, -
0.14 to -0.04) and for naltrexone was 20 (95% CI, 11 to 500; RD -0.05; 95% CI, -0.1 to 
0.002) (Jonas et al., 2014). Naltrexone was also found to be effective for preventing patients 
from returning to heavy drinking with a NNT of 12 (95% CI, 8 to 26; RD -0.09; 95% CI, -
0.13 to 0.04) (Jonas et al., 2014). Both medicines had relatively limited side effects and both 
were generally tolerable to patients (Jonas et al., 2014). The authors found no evidence to 
demonstrate efficacy for disulfiram. The major limitation to the authors’ conclusions was the 
significant between-study heterogeneity (I2 28% to > 60%). Additionally, the studies 
included in this review universally employed co-psychosocial interventions along with the 
pharmacotherapeutic agent. The authors were not able to control for the heterogeneous 
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psychosocial interventions, thereby making it difficult to definitively find causation with the 
drug alone. Pertinent to this integrative review, the authors suggested that their findings 
regarding efficacy of naltrexone and acamprosate may be significant to the primary care 
setting, citing their barriers to accessing specialist services (Jonas et al., 2014). The authors 
suggest this despite the relative lack of study evidence from the primary care setting in this 
systematic review. 
 There is conflicting evidence regarding long-acting injectable (depot) naltrexone, 
which is not currently available in Canada. Jonas et al. (2014) found no evidence that it 
improved abstinence rates or rates of heavy drinking, but did find some evidence that it 
reduced the number of heavy drinking days by 4.6% (95% CI, -8.5% to -0.56%). Marienfeld, 
Iheanacho, Issa, and Rosenheck (2014) conducted a large (n = 101,026) study in the United 
States Veterans’ Health Administration to identify characteristics of patients who received 
depot naltrexone. Of the large sample, only 0.24% (n = 240) received depot naltrexone and 
the majority of those participants had concurrent psychiatric disorders. The authors did not 
assess the efficacy of this naltrexone modality, but they cited three recent randomized 
controlled trials that claim significant improvements in the number of heavy drinking days, 
time to first drink after abstinence, number of drinking days, and abstinence rates 
(Marienfeld et al., 2014). This was an evidence level three study because it was a cross-
sectional study without randomization. Only two of the cited trials were included in the Jonas 
et al. (2014) systematic review and meta-analyses, so there may be some evidence for the 
efficacy of depot naltrexone but it was unclear how much evidence was actually present.  
 In Australia, an evidence level one randomized controlled trial examined what would 
happen to prescription rates of naltrexone and acamprosate, and alcohol-related 
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hospitalizations, if rural primary care physicians were mailed feedback letters regarding 
AUD statistics and general information regarding acamprosate and naltrexone (Navarro, 
Shakeshaft, Doran, & Petrie, 2012). There were 20 rural communities within the study area 
that satisfied the inclusion criteria for the study (population of 5,000-20,000, at least 100km 
away from an urban centre [>100,000 population], and were not involved in any other large-
scale alcohol-related projects). The communities were paired according to demographics, and 
one of each pair was randomly allocated (randomization not detailed) to the control group 
and one to the experimental group. All of the primary care physicians in these communities 
were mailed the information package. After the intervention, the authors found that, relative 
to the control group, the experimental group increased prescription rates for acamprosate 
(0.24; CI 95%, 0.13 to 0.35; p < 0.001), slightly decreased prescriptions of naltrexone (-.012; 
CI 95%, -0.17 to -0.06; p < 0.001) and decreased alcohol-related hospitalizations per 10,000 
population (-0.07; 95% CI 95%, -0.13 to -0.01; p < 0.05) (Navarro et al., 2012). The authors 
also found ICER for the intervention was $3,243 Australian dollars (including reductions in 
hospital expenditures). That means that for every extra person prescribed medication for 
AUD, the overall health care costs were reduced by $3,243 Australian dollars. These findings 
suggested that increasing rural pharmacotherapeutic utilization could decrease alcohol-
related harm. It also provided a model that may be adaptable to rural, remote, and northern 
BC populations. 
 Barriers to Pharmacotherapy. Utilization rates of pharmacotherapy for AUD in BC 
are unclear; however, Jonas et al. (2014) indicated that pharmacotherapy was generally 
under-utilized to treat AUD. Reasons for medication under-utilization were examined by 
Mark et al. (2003). This was a small, evidence level three, qualitative study of both 
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physicians who had treated AUD (n = 11) and patients who had been treated for AUD (n = 
11). The study aimed to understand attitudes towards naltrexone use for AUD. Both groups 
identified “lack of knowledge” as the primary reason for under-utilization (Mark et al., 
2003). The patient group reported that they were unaware that naltrexone existed and were 
unaware of its uses. The physician group reported skepticism about the amount of research 
done on naltrexone and reported a perceived lack of efficacy. Recommendations of how to 
overcome the barriers identified by the physician and patient focus groups were absent from 
this study; however, the authors suggested that both physicians and patients must be 
persuaded not only that naltrexone is effective, but that it is effective enough to offset the 
costs (Mark et al., 2003). The authors suggested that the financial cost, the risk of medical 
complications (such as liver injury), and the side effects (such as nausea) are all reasons for 
the limited use of naltrexone; this is further discussed below. Given the very small sample 
size, and the fact that the authors only examined naltrexone, generalizability of this study is 
quite limited.  
 As indicated above, additional barriers to medication use are the actual cost of the 
medication, intolerable side effects (as described in the Background chapter), and medical 
comorbidities that are contraindications for pharmacotherapy (as described in the 
Background chapter). The most cost-prohibitive medication for AUD is naltrexone. Costs are 
$5.26 per tablet ($158 per month) in BC, and a reported similar cost in the United States 
(Mark et al., 2003; Province of British Columbia, 2017). Acamprosate only costs $0.80 per 
tablet but it must be taken three times per day ($72 per month), making it also quite 
expensive for patients who have to self-pay (Province of British Columbia, 2017). Disulfiram 
is the least expensive, costing between $0.30 and $0.80 per pill ($9 to $24 per month); 
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however, because of the lack of proven efficacy, it is likely a poor choice in most clinical 
situations (Province of British Columbia, 2017). In BC, some of the financial constraints for 
both naltrexone and acamprosate can be alleviated with special authority coverage for the 
medication; however, coverage only lasts for three months and may not be renewed (British 
Columbia Ministry of Health, 2017b, 2017c). Similarly, for Aboriginal patients covered 
under the Non-Insured Health Benefits (NIHB) program, naltrexone is not listed on the drug 
benefits list, indicating that an application for special coverage would have to be completed 
(Health Canada, 2016a). Acamprosate is listed on the NIHB drugs list, but does require prior 
approval (Health Canada, 2016a). The BC Guidelines suggest that patients should expect to 
use pharmacotherapy (any of the three medications) for six to twelve months at a time, 
potentially making cost an insurmountable barrier to longer-term naltrexone or acamprosate 
use (British Columbia Ministry of Health, 2013). 
 In some cases, the use of use of pharmacotherapy may be inhibited by the stigma 
associated with AUD. Mark et al. (2003) suggested that patients may be embarrassed to 
retrieve medications for AUD at the pharmacy. The authors also found that, because 
naltrexone was originally used for opioid use disorder, there may be an additional stigma 
associated with it (Mark et al., 2003). For patients in rural, remote, and northern BC, the 
stigma associated with receiving medicine for AUD in a non-anonymous setting may present 
a significant barrier.  
Brief Intervention 
 Psychosocial interventions are a mainstay of AUD management (British Columbia 
Ministry of Health, 2013; Spithoff & Kahan, 2015b, 2015c). The most commonly utilized 
psychosocial intervention in the primary care setting is a counseling technique called a ‘brief 
intervention’ (Kaner et al., 2007; O’Donnell et al., 2014). Brief interventions can be 
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performed in five to fifteen minutes over a series of consecutive appointments. The number 
of appointments is not specified and can be tailored to the amount of reinforcement and 
support the patient requires (Kaner et al., 2007; O’Donnell et al., 2014). The goal of the brief 
intervention technique is for the patient to recognize his/her own drinking behaviours and to 
develop self-efficacy to overcome them (Barry, 2012). Both the BC and Canadian Guidelines 
include brief interventions in their recommendations for treating AUD; however, both sets of 
guidelines advise that patients with severe AUD may not respond to brief interventions alone 
(British Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015c). The benefits of, and 
barriers to utilizing brief interventions in the rural, remote, and northern setting will be 
discussed below. 
 Benefits of brief interventions. Bertholet et al. (2005) performed a systematic review 
and meta-analysis examining the reduction of alcohol consumption related to brief 
interventions in primary care. This was an evidence level one study with robust statistical 
analyses. After inclusion and exclusion criteria had been applied, 24 articles were included in 
the review (n = 5639 total subjects) (Bertholet et al., 2005). The authors found the brief 
intervention counseling technique to be effective for both men and women in that it helped to 
reduce alcohol consumption for up to 12 months after the intervention (Bertholet et al., 
2005). Pooled reductions were 50g of alcohol (95% CI, -65 to -34) per week, which equates 
to five standard drinks less per week, or a 15% reduction (Bertholet et al., 2005). Minimal 
between-study heterogeneity was found, and it accounted for one-fourth of the variance (I2 = 
25.8%) (Bertholet et al., 2005). The authors concluded that brief interventions demonstrated 
significant reductions in alcohol consumption, and they recommended widespread use of 
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brief interventions for AUD. Furthermore, there were no negative effects reported when 
using the brief intervention technique in any of the included studies.  
  The Australian study by Navarro et al. (2011) reported that, at baseline, 0.7% of 
those who reduce their alcohol consumption to low-risk level, did so because a primary care 
provider screened them for AUD and performed a brief intervention. The authors found that, 
if screening was completed with 100% of the patient population, and brief interventions were 
performed every time AUD was detected, 36% of the risky-drinkers (synonymous with the 
definition of “heavy-drinkers” used previously in this review) would reduce their 
consumption to low-risk levels (Navarro et al., 2011). The combination of screening and 
brief intervention was marginally more expensive than screening alone (ICER $216 
Australian dollars versus $197). The increased cost was incurred because of increased time 
required to perform a brief intervention and increased training costs for primary care 
providers. The authors qualify these findings by stating that increasing screening and brief 
intervention ubiquitously to 100% would be difficult (discussed in the Barriers to brief 
intervention section below).  
 A recent Australian pilot study examined a model for training remotely located 
general practice physicians in AUD screening and brief intervention techniques (Brennan et 
al., 2013). This pilot study was a small (n= 8), evidence level three study that provided a 
specialized clinical psychologist-lead one-hour training session for brief interventions. Pre- 
and post- test evaluations were performed by study participants. Respondents reported that, 
after the training session, their understanding of the brief intervention technique had 
increased by a moderate (n = 4) or significant (n = 4) degree (Brennan et al., 2013). Six 
months after the training session, approximately half of the physicians reported modest to 
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moderate increases in actual use of screening and brief intervention in their practices 
(Brennan et al., 2013). Given the extremely small size of this pilot study, generalizability is 
limited; however, this study does indicate that, when provided with additional training, 
primary care providers have the capacity to perform brief interventions in rural locations, 
develop the confidence to do so, and increase their use of brief intervention strategies.  
 Two articles included in this literature review addressed the potential for 
electronically-delivered treatment services (Finfgeld-Connett, 2006; Staton-Tindall et al., 
2012). Finfgeld-Connett (2006) provided an evidence level three, non-systematic review of 
multiple web-based treatment programs. The web-based treatment programs utilized 
motivational interviewing as the foundation for the patient interactions, which is also used in 
the brief intervention technique discussed above. A primary theme highlighted by the authors 
was that women accessed web-based treatment programs more often than men (Finfgeld-
Connett, 2006). The author suggests that women with AUD experience greater stigma then 
men do, and that the anonymity offered by electronic access may be a reasons for their 
increased use (Finfgeld-Connett, 2006). Finfgeld-Connett (2006) asserted that the use of 
home computers facilitated confidentiality and, because of this improved confidentiality, 
women felt more comfortable to utilize web-based treatment than other more public forms of 
treatment. Advantages of a web-based format were that geographical location was not a 
barrier as long as the individual had Internet access; importantly, marginalized populations 
could use free public Internet access to obtain treatment. The principal barriers to the web-
based treatment modality were that English literacy was required, and that confidentiality 
could be compromised if public Internet access were required. Limitations of this study were 
that no details for statistical analyses, search methodology, or inclusion or exclusion criteria 
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were provided. Furthermore, this article was published in 2006 which, because of the 
advancements of technology made since that time, makes it somewhat dated.  
 The second article that addressed electronically-delivered treatment modalities was a 
preliminary report on a study that examined tele-health-based motivational interviewing for 
AUD in rural, previously incarcerated individuals in Kentucky, USA (Staton-Tindall et al., 
2012). This was an evidence level one study, with a study sample of individuals with very 
heavy drinking behaviours (average of 15.3 drinks per day). The study sample primarily 
consisted of ex-inmates who were currently on probation or parole or had recently been 
released. The researchers used a video conferencing tele-health machine to connect patients 
with therapists trained in motivational interviewing. Unfortunately, the focus of the 
preliminary report was not on efficacy of the intervention but rather on profiling the study 
sample and on describing the feasibility of the intervention. Preliminary results indicated that 
tele-health-based motivational interviewing may be feasible, with 72.7% of the group 
completing part of the sessions, and 50% of the group completing all of the sessions (Staton-
Tindall et al., 2012). Limitations of this study were that rurality was not specifically defined 
in this study and the sample population was almost homogenously Caucasian males. 
Furthermore, the study participants may have felt compelled to complete the intervention, 
given their recent incarceration, to appease their parole officers and the judicial system. This 
may have inflated the completion rates beyond what they otherwise might have been with a 
different population. Nonetheless, this preliminary report does indicate that tele-health may 
be a viable alternative for individuals in rural, remote, and northern BC who require 
specialist services. 
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 Barriers to brief interventions. There are a few notable barriers to the utilization of 
brief interventions by primary care providers. Navarro et al. (2011) highlighted that 
individual primary care provider styles and preferences may be a barrier to universal 
implementation of this counseling technique. The authors also suggest that treatment 
adherence is generally low among individuals with AUD; therefore, the brief intervention 
technique may be difficult to utilize (Navarro et al., 2011). Additionally, Navarro et al. 
(2011) emphasized that young males demonstrate disproportionate amounts of AUD, which 
is consistent with Canadian statistics, but that this population rarely accesses health care 
(Statistics Canada, 2014). The authors indicate that not seeking health care is a barrier to 
utilizing brief interventions; however, this would represent a barrier to any kind of treatment, 
not solely brief interventions.  
 The final barrier to utilizing brief interventions in the treatment of AUD is the 
logistics of training rural, remote, and northern primary care providers (Brennan et al., 2013). 
By definition, these primary care providers are dispersed across a large geographical area, 
increasing the challenges and costs associated with training them. Brennan et al. (2013) 
suggest this barrier may, at least in part, be alleviated through the use of Internet-based 
training modalities. Primary care providers could participate in scheduled training sessions 
from their respective home community’s. This method could alleviate some of the 
difficulties associated with training rural, remote, and northern primary care providers in the 
brief intervention technique.  
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CHAPTER FOUR: DISCUSSION 
 In Canada, the scope of practice of nurse practitioners includes autonomously 
diagnosing and managing client health conditions (Canadian Nurses Association, 2017). In 
BC, nurse practitioner practice is regulated by the College of Registered Nurses of British 
Columbia (2017b), which provides standards, limits, and conditions for nurse practitioner 
scope of practice. All aspects of diagnosis and treatment of AUD fall within the nurse 
practitioner scope of practice in BC (College of Registered Nurses of British Columbia, 
2017b). This includes the diagnosis of AUD using the DSM-V criteria as well as patient 
counseling, ordering of prescription medications, and consulting and/or referring patients to 
specialist services.    
 This literature review was tailored to be applicable to all primary care providers, 
particularly those who work in rural, remote, and northern BC, including both nurse 
practitioners and physicians. This chapter will include discussions on: the HBM as it applies 
to the common themes elucidated from the literature; common themes drawn from the 
literature regarding the role of primary care providers in rural, remote and northern BC; 
recommendations for nurse practitioner education pertaining to AUD; and gaps in current 
research pertaining to AUD treatment in rural, remote and northern Canadian communities 
(specifically BC).  
The Health Belief Model as it Applies to the Common Themes  
 The HBM is a theoretical model that originated in the 1950’s but remains pertinent to 
health care today. It endeavours to explain why patients may or may not participate in 
behaviours that can help detect or treat disease processes and to predict future behaviours 
(Champion & Skinner, 2008). There are six key constructs within the HBM: perceived 
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susceptibility; perceived severity; perceived benefits; perceived barriers; cues to action; and 
self-efficacy. Please refer to the Background chapter and Figure 1 for further details 
regarding the individual constructs. 
 The HBM was selected as the supporting theoretical model in this literature review 
because it explains why individuals may not address their AUD, and therefore it highlights 
areas where changes can be implemented to increase treatment uptake and improve patient 
outcomes. By applying the HBM to the research question “in the setting of rural, remote, and 
northern BC, what is the optimum treatment for adults with AUD,” the importance of the 
primary care provider’s role is emphasized because many of the changes that could improve 
treatment uptake could be completed at the primary care level. Furthermore, when viewed 
through the six constructs of the HBM, areas of weakness in the current status quo for AUD 
treatment are underscored.  
 In this integrated literature review, there are five discussion themes regarding the 
treatment of AUD in rural, remote and northern BC. These themes are: screening for AUD; 
brief intervention; electronically delivered counseling; pharmacotherapy; and universal 
trauma-informed practice. The HBM will be applied to the five discussion themes to 
highlight areas that can be improved for both the patient and primary care provider regarding 
the recognition and treatment of AUD. When these areas for improvement are elucidated 
using the HBM, primary care providers will be better positioned to create tangible goals that 
will help move patients towards treatment for, and eventual recovery from, AUD. 
 When referring to the six constructs of the HBM in the discussion below, the relevant 
construct will be italicized. The following discussion will outline the ways in which 
adjustments within each of the five themes can support improved primary care treatment 
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outcomes. Additional discussion will be provided regarding how the constructs of the HBM 
can be used to achieve treatment success and reinforce the roles of the patient and the 
primary care provider. 
Common Themes Drawn from the Literature Regarding the Role of Primary Care 
Providers in Rural, Remote and Northern BC 
 For rural, remote, and northern BC populations, a primary care provider tends to be 
the initial (and sometimes only) access point to the health care system (Slaunwhite & 
Macdonald, 2015). This means that the primary care provider will be responsible for the 
initial recognition and diagnosis of AUD in patients and will likely be responsible for 
planning and overseeing the majority of the patient’s treatment regime. Spithoff and Kahan 
(2015a) argued that primary care providers have the capacity, knowledge, and skills to 
manage the majority of AUD cases; however, research from rural, remote, and northern BC 
demonstrates that primary care providers often encounter barriers to effective treatment of 
patients with AUD (Slaunwhite & Macdonald, 2015). By addressing these barriers, primary 
care providers could deliver more meaningful and effective treatment for patients with AUD. 
Considering that, on average, people in rural, remote, and northern BC drink more alcohol 
than the Guidelines for Low-Risk Drinking suggest, it is essential to examine treatment 
modalities in order to minimize the prevalence AUD in this specific population (Butt et al., 
2011; University of Victoria, 2017a, 2017b). 
 The goal of this chapter is to discuss current evidence for the care of patients with 
AUD in the context of the barriers faced within rural, remote and northern BC. The 
following sub-sections will discuss the five pertinent themes from the included literature in 
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relation to: screening for AUD; the brief intervention technique; electronically delivered 
counseling; pharmacotherapy; and universal trauma-informed practice.   
Theme One: Screening for Alcohol Use Disorder 
 Due to differing screening recommendations between the BC and Canadian 
Guidelines, it was important for this integrative review to examine the supporting evidence 
for each of the screening recommendations and to apply this evidence to the rural, remote, 
and northern BC setting specifically. The Canadian Guidelines recommend at least annual 
AUD screening with a validated screening tool for all primary care patients, whereas the BC 
Guidelines recommend screening with a validation screening tool only in the presence of 
clinical triggers and red flags (British Columbia Ministry of Health, 2013; Spithoff & Kahan, 
2015b, 2015c). Considering the cumulative time investment required by the primary care 
provider to screen all patients annually, the benefit of universal screening should be made 
clear before such a practice is undertaken. 
 Both the BC and Canadian Guidelines suggest using a single question to initially 
screen for AUD (British Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015b). The 
single screening question, “how many times in the past year have you had four or more 
drinks (women), or five or more drinks (men) in a single day?’ has been found to be 82% 
sensitive and 79% specific for identifying unhealthy drinking patterns (Smith et al., 2009). If 
a patient reports that they have exceeded these sex-specific amounts for even a single day on 
one occasion in the preceding year, the screening question is considered positive and an in-
depth assessment for AUD should be undertaken by the primary care provider (British 
Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015b).  
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 In addition to helping to identify AUD, annual screening also addresses two of the 
key constructs of the HBM: perceived susceptibility and cues to action. The HBM indicates 
that, prior to a change in behaviour, the person must first recognize that they are susceptible 
to the disease (Champion & Skinner, 2008). Annual screening promotes perceived 
susceptibility to AUD, especially if the screening tool is positive. In the case of a positive 
screening result, there is an opportunity for discussion between the primary care provider and 
the patient regarding their unhealthy drinking patterns and any potential associated health 
consequences. Interestingly, Navarro et al. (2011) found that screening alone increased 
recovery rates for AUD, demonstrating that, by virtue of the act of screening, patients 
reduced their alcohol consumption without any formal AUD treatment. This indicates that 
the patient’s perceived susceptibility to AUD had been effectively highlighted through the 
screening questions. In the Navarro (2011) study, screening for AUD may also have acted as 
a cue to action, or a “wake-up call”. If patients were previously unaware that their drinking 
habits were placing their health at risk, the discussion between the primary care provider and 
the patient regarding the screening results may have acted as a stimulus for change. These 
findings suggest that universal screening may be an appropriate method for rural, remote, 
and northern BC primary care providers to increase detection of AUD, and to simultaneously 
begin the treatment process in some patients.  
 Both the Canadian and the BC Guidelines recommend the single screening question 
as a reasonably sensitive and efficient method to initially detect cases of AUD (British 
Columbia Ministry of Health, 2013; Spithoff & Kahan, 2015b). Additionally, the AUDIT 
and CAGE screening tools are suggested by both sets of guidelines for adult patients as 
additional or alternative options for identifying patients at risk for AUD. There was no 
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further guidance provided in either set of guidelines regarding which tool is the most 
appropriate tool to use in a given situation. For the identification of hazardous or harmful 
drinking, the 10-question AUDIT score is 92% sensitive and 94% specific whereas the four-
question CAGE is 71% sensitive and 90% specific (Schorling, 2005; Spithoff & Kahan, 
2015b). Spithoff and Kahan (2015b) suggest that this lower sensitivity of the CAGE may 
mean a failure to detect patients with less severe drinking habits. The higher sensitivity and 
specificity of the AUDIT score over the CAGE tool makes it appealing to primary care 
providers as a screening tool but it is also recognized that it requires more time to complete. 
Some primary care providers may be deterred by the additional time commitment to use the 
AUDIT score given a tendency toward shorter appointment times and significant pressure to 
see a large volume of patients. There was no additional evidence found in this integrative 
review to suggest which screening tool would be best suited for rural, remote, and northern 
BC in particular. The literature included in this integrative review suggested that, if primary 
care providers had sufficient time available to complete the AUDIT score, that more patients 
with AUD could be accurately identified.  
 There was very limited evidence in the articles included in this integrative review to 
support using clinical suspicion alone to detect AUD. One meta-analysis from the United 
Kingdom found that primary care providers were only 41.7% sensitive and 93.1% specific 
for the detection of AUD in situations where a screening tool was not used (Mitchell et al., 
2012). The low sensitivity of clinical suspicion alone suggests that primary care providers 
who use this method may not recognize AUD in more than half of their affected patients. It is 
unclear if the low sensitivity reported by Mitchell et al. (2012) directly translates to the use 
of clinical suspicion followed by a validated screening tool. Unlike the situations tested by 
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Mitchell et al. (2012), the BC Guidelines do recommend the use of a validated screening 
tool; however, this usage is only recommended after clinical suspicion of AUD has already 
been aroused. There was no evidence found in the reviewed studies that directly examined 
the sensitivity of clinical suspicion followed by the application of a validated screening tool.  
 Overall, the studies included in this integrative review demonstrated that there is 
strong evidence to support the efficacy of validated screening tools for the detection of AUD 
(Schorling, 2005; Smith et al., 2009; Spithoff & Kahan, 2015b). There was a lack of 
evidence found to support the use of only clinical suspicion to prompt the primary care 
provider to utilize a screening tool. This suggests that, despite the cumulative time 
requirement involved in annual screening, the best method for identifying patients with AUD 
is annual screening of all adult patients using a screening tool; this is consistent with the 
recommendations made in the Canadian Guidelines (Spithoff & Kahan, 2015b). There was 
no source provided within the BC Guideline to support its recommendation of clinical 
suspicion, followed by a screening tool, and there was no further evidence found through this 
integrative review for this method. 
 It is important that primary care providers in rural, remote and northern BC employ 
annual screening for adult patients as part of their practice. Individuals living in these areas 
tend to drink more alcohol per capita than the Guidelines for Low-Risk Drinking suggest, 
suffer significant rates of alcohol-related death, and utilize significant health care resources 
because of their alcohol consumption (University of Victoria, 2017a, 2017b). The time 
commitment required for the primary care provider to ask the single screening question is 
relatively minimal and the benefits could be significant. The completion of the single 
screening question for all adult patients in rural, remote, and northern BC could help to 
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improve AUD detection rates without significantly increasing the burden on the primary care 
provider, and it could act as a precursor to the final diagnosis of AUD being made using the 
DSM-V (American Psychiatric Association, 2013).   
 Once a patient has been diagnosed with AUD, the next challenge for the primary care 
provider is determining the most appropriate therapeutic management of that particular 
patient. The following section will discuss the brief intervention counseling technique, as it 
was found to have robust evidence in the literature and is particularly applicable in the rural, 
remote, and northern BC setting. 
Theme Two: Brief Intervention 
 The brief intervention technique is a form of motivational interviewing that highlights 
substance use behaviours so that patients can learn to recognize and overcome these 
behaviours (Barry, 2012). Within the brief intervention framework, the primary care provider 
works with the patient to highlight their perceived susceptibility to, and perceived severity of 
AUD. According to the HBM, patients must believe that they are susceptible to AUD, and 
that it is a serious threat to their health, before they are likely to make the changes necessary 
to overcome it (Champion & Skinner, 2008). In the brief intervention technique, patients 
undergo a series of sequential appointments. These appointments assist the patient to develop 
self-efficacy, which is the self-belief that they can overcome triggers to drink, maintain 
abstinence, and transition into remission (Barry, 2012). Perceived barriers that may inhibit 
patients from addressing their AUD are addressed by making strategies to overcome and 
avoid triggers for drinking, such as avoiding parties, replacing social drinking with other 
social activities, and spending time with people other than their usual drinking partners. 
Finally, self-efficacy is achieved through progressive goal setting, in conjunction with 
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guidance from the primary care provider on how to achieve these goals. The brief 
intervention technique is particularly amenable to the primary care setting because the 
individual sessions typically last between five and fifteen minutes and are normally repeated 
over multiple visits (Barry, 2012; Bertholet et al., 2005). There is no specified number of 
sessions that constitute a brief intervention because the number of sessions required will 
depend on the needs of each individual patient. Although the brief intervention technique can 
be applied to a number of substance use disorders, it was only examined in the context of 
AUD for this integrative review (Barry, 2012). 
 Through meta-analysis, the brief intervention counseling technique was found to be 
effective in reducing drinking by 50g of ethanol (five standard drinks) per week in patients 
with AUD (Bertholet et al., 2005). The evidence is most robust for males, and for those with 
less severe AUD, but is less clear for women and for those with severe AUD (Bertholet et al., 
2005; Spithoff & Kahan, 2015c). The literature is unclear as to whether the results of a brief 
intervention will typically be noted immediately or if effects are only found after the patient 
completes a number of sessions. Additionally, it is unclear how enduring the reductions in 
drinking have proven to be.  
 For rural, remote, and northern BC, the brief intervention technique could help 
patients to develop self-efficacy to overcome AUD and, in turn, reduce AUD-related disease 
and harm. Additionally, expansion of primary care providers’ ability to perform brief 
interventions could minimize some of the 3.3 billion dollars spent per year in Canada on 
direct health care expenditures associated with AUD (Thomas, 2012). By providing effective 
management of AUD, the overall health care costs would be reduced because there would be 
less intoxication-related injury and disease, such as FASD, liver cirrhosis, and depression, 
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associated with increased alcohol consumption. Furthermore, if more primary care providers 
were trained in the brief intervention technique, then it could be effectively utilized within 
the patient’s home community. This would address one of the perceived barriers to treatment 
in these settings, and there would be far less incurred costs associated with transport and 
housing of patients during their treatment process. In BC’s Northern Health Authority in 
particular, there is a relatively small population spread over a large geographical area, with 
specialized alcohol services centralized within only a few major centres (Northern Health 
Authority, n.d.). This sparse population and geographical isolation acts as a perceived barrier 
to treatment and therefore the brief intervention technique, when applied in the context of a 
rural, remote, and northern BC primary care setting, could provide many benefits, including 
improving remission rates and reducing travel costs.  
 One challenge with the brief intervention technique is that its utilization remains 
highly dependent upon the knowledge and comfort with the technique of an individual 
primary care provider. Brennan et al. (2013) found that many primary care providers lacked 
knowledge about the brief intervention technique and therefore did not use it as a treatment 
strategy for AUD patients. Fortunately, a one-hour face-to-face training session with a brief 
intervention specialist was found to improve primary care providers’ knowledge and 
confidence regarding brief interventions for patients with AUD (Brennan et al., 2013). The 
one-hour training session increased clinical use of the technique once the primary care 
providers returned to their home communities, suggesting that, with additional focused 
training, primary care providers could gain the ability and the confidence to utilize the brief 
intervention technique for patients with AUD. A brief intervention conducted by a trained 
primary care provider could be a cue to action for patients, because a primary care provider 
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can highlight behaviours and address motivations for change. Increasing the utilization of the 
brief intervention technique in rural, remote and northern BC has the potential to positively 
influence patients in a number of ways; this is well-highlighted using a number of key 
constructs within the HBM. In addition, expanding the use of the brief intervention technique 
in this setting could help patients to reduce the amount of alcohol consumed, reduce adverse 
health effects related to alcohol consumption, and reduce alcohol-related costs to the health 
care system.  
Theme Three: Electronically Delivered Counseling 
 As discussed in the preceding sub-section, counseling patients is a mainstay of 
current AUD treatment and has been found to effectively increase rates of remission 
(Bertholet et al., 2005). Counseling patients within their home community provides an 
alternative to referring them to specialist services in a larger centre for counseling. 
Unfortunately, primary care providers are not always confident in the counseling techniques 
available for patients with AUD and, in the case of rural, remote, and northern BC, specialist 
services may be more difficult to access because of the sparse population distributed over a 
large geographical area. Utilization of electronically delivered counseling services may be 
one method to address the perceived barriers associated with accessing counseling services in 
the remote locations. Physical distance to treatment, costs of treatment, costs of lost work 
and time away from family could all be reduced by improving access through electronically 
delivered counseling services within the home community. Increasing access to specialist 
services in rural, remote, and northern BC could reduce perceived barriers to treatment and 
improve the chances that a patient with AUD would consider and engage with treatment.   
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 Two articles included in this integrative review addressed the possibility of using 
electronically delivered counseling services (Finfgeld-Connett, 2006; Staton-Tindall et al., 
2012). The Finfgeld-Connett (2006) article reviewed a number of studies that assessed 
Internet-based programs aimed at treating AUD. These computerized programs were mainly 
based in a motivational interviewing model, which included the brief intervention technique. 
These programs were hosted on the Internet and required the patient to log on to a specific 
website to participate in the counseling service. The electronically delivered counseling 
programs were produced by a variety of different manufacturers, making the programs 
themselves quite heterogeneous and limiting the researchers’ ability to draw conclusions 
regarding the efficacy of this treatment modality more broadly. Receiving counseling 
services for AUD by logging onto a website does have some potential benefits, particularly 
in areas where there are geographical barriers to accessing treatment, such as in rural, 
remote, and northern BC. The primary advantage associated with heightened electronically 
delivered counseling is increased accessibility because Internet access has become almost 
ubiquitous. An additional advantage of this modality is that, when private Internet access can 
be made available, confidentiality in the physical space is relatively certain (Finfgeld-
Connett, 2006). However, a worthwhile consideration for any Internet-based treatment 
modality is the risk of confidential data being “hacked” or viewed by an unauthorized party. 
The risks relating to confidential patient information being compromised was not specifically 
mentioned in the study; nonetheless, this risk warrants consideration prior to a primary care 
provider recommending an Internet-based treatment modality. Finfgeld-Connett (2006) 
suggestion that private Internet access improves confidentiality could be seen as a perceived 
benefit to a patient with AUD in a rural, remote and northern BC community because it 
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could allow the patient to receive treatment without fear of being stigmatized by their peer 
group. With public Internet access in most communities, access to this type of counseling 
should be nearly universal; however, due to the sensitive nature of the counseling and the 
public space, patients may prefer to access online treatment in a private location (Finfgeld-
Connett, 2006). With an Internet-based modality, a primary care provider could refer patients 
to a specific website, thereby facilitating appropriate AUD treatment without the patient 
being required to leave their home community.  
 The online counseling programs included in the Finfgeld-Connett (2006) article were 
quite heterogeneous in origin, with no discussion regarding the validity of the treatment and 
counseling information provided within each program. Nonetheless, the potential for an 
Internet-based treatment program that primary care providers could prescribe is very 
intriguing, as referral outside of a patient’s home community is an ongoing and recognized 
barrier to treatment (Slaunwhite & Macdonald, 2015). Prior to being recommended to 
patients, the specific Internet-based treatment program would likely need to be validated by 
the local Health Authority to ensure that the information provided is congruent with the 
current standard of care.  
 The article by Staton-Tindall et al. (2012) also addresses electronically delivered 
counseling services; however, in this particular study the counseling was delivered via a 
Telehealth video link with a live specialist counselor present in another location. Telehealth 
is a proprietary secure video conferencing system that facilitates consultation between rural 
patients and urban health care providers; it is already widely available for various health 
services in BC (Provincial Health Services Authority, 2017). The Provincial Health Services 
Authority (2017) website lists a number of specialist services that are available via 
99 
 
Telehealth, including adult mental health, but addictions medicine and addictions counseling 
are not currently included in this list.  
 For rural, remote, and northern BC populations, Telehealth-delivered counseling 
represents a sensible option for providing AUD treatment services. A similar format to the 
current Telehealth system, one that is already being utilized for various specialist services in 
BC, could enable patients to visit their provider’s clinic for regularly scheduled counseling 
sessions. This could facilitate expert specialist counseling services in a local setting via the 
secure Telehealth video conferencing system. Two salient reasons to consider Telehealth-
delivered counseling would be if a primary care provider does not have the training to 
perform a brief intervention or if the patient suffers from particularly severe AUD/AUD that 
is proving more resistant to other therapies. A potential downfall to this counseling modality 
is the availability of the Telehealth system. This system is widely available in BC but this 
does not mean it is available everywhere that patients require counseling services for AUD, 
and patients may still be required to travel to a clinic location to access the necessary 
Telehealth equipment.  
Theme Four: Pharmacotherapy 
 Pharmacotherapy for AUD has been available but underutilized for a number of years 
because there has been some question in the past as to whether these medicines were 
effective (Jonas et al., 2014; Mark et al., 2003). Evidence from this integrative review 
demonstrated that pharmacotherapy significantly improves outcomes for patients with AUD, 
although it is not recommended for all patients because there are contraindications in some 
cases (British Columbia Ministry of Health, 2013; Jonas et al., 2014; Spithoff & Kahan, 
2015c). The three on-label medications for AUD in Canada are disulfiram, acamprosate, and 
100 
 
naltrexone (British Columbia Ministry of Health, 2013). Both acamprosate and naltrexone 
demonstrated significant improvement in alcohol abstinence rates (NNT 20 and 12 
respectively), and naltrexone alone significantly improved remission from heavy-drinking 
(greater than, or equal to, four drinks per day for women; greater than, or equal to, five 
drinks per day for men) (NNT 12) (Jonas et al., 2014). For patients with no medical reason to 
avoid pharmacotherapy, acamprosate or naltrexone could be considered as a part of the AUD 
treatment plan. There was no compelling evidence found for the usage of disulfiram in this 
integrative review, and as such, it does not appear to be a recommended agent.  
 Actual utilization rates of pharmacotherapy for AUD in BC were not obtainable for 
this integrative review; however, the literature suggested that pharmacotherapy strategies are 
generally underutilized in the treatment of AUD (Jonas et al., 2014; Mark et al., 2003). It is 
unclear why pharmacotherapy has traditionally been underutilized for AUD, but Mark et al. 
(2003) suggest that there is a combination of reasons why providers have been unlikely to 
suggest using medicines for AUD. Principally, the small effect size was discussed as a 
primary reason for medication underutilizations, meaning that prescribers were unsure if the 
benefits of using such medications outweighed their risks (Mark et al., 2003). This 
integrative review found convincing evidence to the contrary of these perceptions. There is 
robust evidence that both acamprosate and naltrexone significantly reduce drinking, and do 
so with minimal adverse effects (Jonas et al., 2014). It is unclear why there is a reluctance of 
primary care providers to prescribe these medicines when primary care providers could 
expand the available treatment options in their communities by prescribing acamprosate or 
naltrexone to appropriately selected patients. Expansion of treatment options could improve 
remission rates from AUD, reduce patient transport expenditures incurred because of the 
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necessity to travel for treatment, and avoid disruption to family and employment 
commitments when patients are required to travel to access other treatment options. 
 One of the challenges faced in BC involves changing the culture that already exists 
regarding pharmacotherapy for AUD treatment. Navarro (2012) found that increasing 
primary care providers’ knowledge regarding AUD prevalence and the efficacy and safety of 
pharmacotherapy increased the overall medication prescription rates for AUD. 
Pharmacotherapy options, when presented to a patient by a well-informed primary care 
provider, would address the perceived benefit construct of the HBM. If primary care 
providers accurately portrayed the efficacy statistics and the rates of adverse reactions for 
pharmacotherapy, then patients may be more likely to acknowledge the potential benefits of 
this treatment modality and consent to a trial of pharmacotherapy. Navarro (2012) found an 
association between increased pharmacotherapy prescription rates and a reduction in alcohol-
related hospitalizations and health care costs (Navarro et al., 2012). Navarro’s (2012) 
findings suggest that it is possible to increase the use of pharmacotherapy by educating 
primary care providers about the evidence supporting the prescription of these medications. 
These finding suggest that if a similar strategy were put in place in rural remote, and northern 
BC, an increase in prescription rates and a corresponding reduction in AUD prevalence could 
be anticipated. 
Theme Five: Universal Trauma-informed Practice 
 Trauma-informed practice is a framework that enables a health care practitioner to 
acknowledge trauma that patients have experienced and places priority on the individual’s 
safety and autonomy (Authur et al., 2014). Trauma-informed practice seeks to rebuild a 
patient’s sense of control, while not requiring them to disclose specifics about the trauma. 
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Primary care providers who utilize trauma-informed practice can facilitate health care 
delivery in a manner that supports the physical and emotional safety while promoting patient 
autonomy within health care (Authur et al., 2014).  
 Trauma is a common comorbidity found in patients with AUD (Slaunwhite & 
Macdonald, 2015; Spithoff & Kahan, 2015b, 2015c). Trauma, irrespective of the cause, can 
overwhelm an individual’s available coping mechanisms and have deleterious effects on 
their life (Authur et al., 2014). The literature included in this integrative review highlighted 
the frequent co-existence of AUD and trauma, but did not link trauma as a definitive 
precursor to AUD (Allan, 2010; Slaunwhite & Macdonald, 2015; Spithoff & Kahan, 2015b). 
The included literature also highlights that Aboriginal Peoples of BC have been particularly 
affected by historical trauma associated with the residential school system (Slaunwhite & 
Macdonald, 2015). Considering that AUD and trauma frequently coexist, it was important 
for this integrative review to address trauma within the context of AUD treatment in rural, 
remote, and northern BC, by means of trauma-informed practice. By universally applying 
trauma-informed practice, primary care providers could ameliorate some of the perceived 
barriers experienced by patients seeking care for AUD. 
 Implementation of universal trauma-informed practice for all primary care providers 
in rural, remote, and northern BC could help remove perceived barriers to AUD treatment 
and facilitate the development of a safer and more therapeutic environment for patients. 
Without applying utilizing trauma-informed practice, primary care providers risk 
misdiagnosing trauma coping mechanisms, such as AUD, as organic mental health disorders 
(Authur et al., 2014). Furthermore, by utilizing trauma-informed practice, primary care 
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providers can avoid re-traumatizing patients and closing off opportunities to help individuals 
overcome their AUD.  
 Perhaps the most crucial step in enacting any primary care intervention is being able 
to therapeutically and compassionately engage with patients. If patients avoid visiting their 
primary care provider because they feel re-traumatized every time they access health care, 
they are unlikely to seek care again and they are unlikely to subscribe to any recommended 
treatment modality. In order to facilitate therapeutic interactions and to avoid re-traumatizing 
patients, the evidence included in this review suggests that primary care providers should 
utilize a trauma-informed practice (Authur et al., 2014).  
 It would appear from the available evidence that trauma-informed practice should 
already be employed ubiquitously in today’s health care system. The studies included in this 
integrative review demonstrate that this is not currently happening in practice and that 
patients often continue to feel stigmatized by primary care providers because of their 
drinking (Allan, 2010; Mark et al., 2003; Slaunwhite & Macdonald, 2015). Considering that 
AUD and trauma frequently coexist, a much stronger emphasis should be placed on trauma 
training within primary care provider education. Methods to increase utilization of universal 
trauma-informed practice in the primary care context will be discussed in the education 
section below.  
Recommendations for Nurse Practitioner Education Regarding Alcohol Use Disorder 
 Nurse practitioners are educated at a graduate level in BC and throughout Canada 
(Canadian Nurses’ Association, 2010; College of Registered Nurses of British Columbia, 
2017a). Nurse practitioner graduate education programs are accredited by the Canadian 
Association of Schools of Nursing (CASN), which ensures a national standard of excellence 
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in nursing education (CASN, 2015). In order to affect change for the future of AUD 
treatment in rural, remote, and northern BC, it was important for this integrative review to 
discuss four of the five main themes from this literature review in the context of nurse 
practitioner education. The four themes that will be discussed as topics for nurse practitioner 
education are: AUD emphasis and pathophysiology; the brief intervention technique; 
pharmacotherapy specifically related to AUD; and, comorbid mental health and trauma 
associated with AUD. The fifth theme, electronically delivered counseling, will not be 
discussed in the context of graduate nurse practitioner education because further research is 
needed to validate this particular method of AUD treatment. 
 The following discussion regarding nurse practitioner education will be supported 
using the framework set out by CASN. This framework contains six over-arching domains: 
knowledge; research, methodologies, critical inquiry, and evidence; nursing practice; 
communication and collaboration; professionalism; and leadership (CASN, 2015). These 
domains are further broken down into ‘essential components’ that are “core domain-related 
outcomes expected of students” (CASN, 2015, p. 9). The CASN domains and their essential 
components ensure that nurse practitioner education programs will adequately prepare 
students for the rigorous expectations upheld by both the nurse practitioner profession and 
Canadian society.   
 The first educational topic found in this integrative review is the need for further 
emphasis on AUD and its pathophysiology within nurse practitioner education. It is clear 
from this integrative review that AUD is common across Canada, and is even more common 
in rural, remote, and northern BC populations (Statistics Canada, 2014, 2016b; University of 
Victoria, 2017a). In these locations, primary care providers routinely face multiple 
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challenges associated with treating patients with AUD. Given the prevalence of AUD and the 
severity of its sequelae, nurse practitioner education could benefit from an additional 
educational emphasis pertaining to AUD. In my own nurse practitioner education, AUD was 
primarily discussed in reference to sequelae, such as liver cirrhosis, but there was limited 
discussion related to AUD pathophysiology and treatment as its own disease process. It is 
unclear from the literature included in this integrative review whether or not in-depth AUD-
specific education is provided for nurse practitioner students at other Canadian educational 
institutions. Considering the seriousness of the health, social, and financial consequences 
related to AUD, a specific educational emphasis is warranted. The suggested education 
proposed by this integrative review include: the pathophysiological processes; adverse health 
effects, adverse social effects; and current evidence-based treatment modalities. By 
emphasizing AUD within formal nurse practitioner educational, AUD could be further 
legitimized as a medical condition and stigmatization of patients by providers could be 
reduced (Slaunwhite & Macdonald, 2015).  
 The CASN knowledge domain requires that “programs provide a comprehensive and 
substantive understanding of nursing knowledge, and a critical awareness of complex 
problems and/or new insights” (CASN, 2015, p. 10). The evidence included in this 
integrative review suggests that nursing knowledge could be bolstered, to the benefit of 
patients, if a more substantive and comprehensive understanding of AUD were included 
within the graduate nurse practitioner education process. One option to achieve this 
educational goal could be the implementation of a standardized addictions medicine module 
and a brief, but focused, practicum that is relevant to AUD practice. 
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 The second education topic to be addressed within this integrative review is the need 
for formal education in the brief intervention technique. As discussed in the Findings 
chapter, brief interventions have been found to be effective at reducing alcohol consumption 
in patients with AUD and are particularly conducive to the primary care setting because of 
their brevity and longitudinal format (Bertholet et al., 2005). It is unclear if any nurse 
practitioner programs in Canada currently educate their students in the brief intervention 
technique. However, because of the significant rates of AUD found in rural, remote, and 
northern BC, evidence included in this integrative review underlined the importance of 
comprehensive AUD treatment within patients’ home communities (Slaunwhite & 
Macdonald, 2015). The CASN framework supports the inclusion of the brief intervention 
technique in formal nurse practitioner education because an essential education component 
within the CASN framework is “the ability to exercise the full scope of extended RN practice 
as defined by the provincial/territorial regulatory body” (CASN, 2015, p. 13). By enhancing 
nurse practitioners’ ability to comprehensively treat patients with AUD through education in 
the brief intervention technique, educational institutions would further support nurse 
practitioners in practicing to their full scope. By fostering full-scope nurse practitioner 
practice in rural, remote, and northern BC, the capacity to treat patients with AUD within 
their home communities could be expanded and result in greater numbers of patients 
engaging in treatment. Increasing the number of patients who participate in treatment for 
AUD could improve rates of remission and reduce disease burden. 
 The third educational topic found in this integrative review is for nurse practitioner 
education to include medications for AUD. Both naltrexone and acamprosate were shown to 
significantly reduce drinking in patients with AUD (Jonas et al., 2014; Mark et al., 2003). 
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Although the actual utilization rates of medication for AUD in BC could not be obtained for 
this review, the literature included in this integrative review suggests that medications are 
generally underutilized in the primary care setting (Jonas et al., 2014; Mark et al., 2003). 
Inclusion of these medications within the formal nurse practitioner education could increase 
prescription rates, as seen in the Navarro (2012) study, thereby improving AUD remission 
rates.  
 The CASN domain of nursing knowledge requires that educational programs provide 
“practice learning experiences to foster the use of best available evidence, theories, and 
expertise in advanced nursing” (CASN, 2015, p. 13). Naltrexone and acamprosate both meet 
the criteria for inclusion in the category of best available evidence for AUD treatment 
because there is robust clinical evidence to support their efficacy (Jonas et al., 2014). This 
integrative review has already established that there are numerous challenges associated with 
referring patients to specialist services from rural, remote, and northern BC (Slaunwhite & 
Macdonald, 2015). Furthermore, this integrative review has also established that expanding 
treatment options for AUD within a patient’s home community could increase treatment 
participation and increase rates of remission. By including medications specifically used for 
AUD treatment in nurse practitioner education, the need for referrals outside of the 
community could be reduced and the remission rates from AUD could be improved.  
 The final educational topic identified by this integrative review is the need for 
education preparation to meet the specific health care needs of Aboriginal Peoples of BC 
(Slaunwhite & Macdonald, 2015). This is a large topic because it encompasses the 
continuing effects of the residential school system and the multi-generational historical 
trauma associated with it (Slaunwhite & Macdonald, 2015). The Provincial Health Services 
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Authority provides an online Indigenous cultural training program, which could be readily 
adopted into nurse practitioner education. The training program is “designed to increase 
Aboriginal-specific knowledge, enhance individual self-awareness and strengthen skills for 
any professional working directly or indirectly with Indigenous people” (Provincial Health 
Services Authority, n.d., para. 5). Inclusion of this program would enrich all future nurse 
practitioners’ understanding of the historical trauma experienced by Aboriginal Peoples in 
BC, and would reduce barriers to AUD treatment through trauma-informed practice. The 
CASN framework also supports this recommendation within the professionalism domain by 
stating that education programs must “prepare students to initiate a model of best practices, 
and to promote their own personal and professional growth in an advanced nursing role” 
(CASN, 2015, p. 16). In the UNBC School of Nursing (2017) mandate, there is currently an 
emphasis on Aboriginal Peoples’ health; however, the inclusion of the Public Health Service 
Authority’s Indigenous cultural awareness course could contribute additional education and 
understanding of AUD for nurse practitioners who plan to practice in rural, remote, and 
northern BC. 
 The four educational topics discussed above are supported by the CASN framework 
and, if applied, would strengthen nurse practitioners’ understanding of AUD and encourage 
evidence-based treatment. This increased educational focus on AUD would reduce barriers 
and result in positive changes in the way that AUD is understood and treated. For nurse 
practitioners working in rural, remote, and northern BC, this enhanced educational 
preparation would provide an opportunity to immediately impact positive changes in the 
patients for whom they provide care.   
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Gaps in Current Research Pertaining to Alcohol Use Disorder in Rural, Remote and 
Northern Canadian Communities 
 This integrative review assessed both domestic and international research from a 
variety of health care disciplines. Conspicuously absent from this integrative review were 
any studies that directly addressed the research question: in rural, remote, and northern 
primary care settings, what is the optimum treatment for adults with AUD? Consequently, 
there are a number of areas for future research that could improve the body of evidence 
available for treating AUD in this population.  
 The evidence examined in this integrative review suggested that primary care 
management of AUD is quite common-place (British Columbia Ministry of Health, 2013; 
Spithoff & Kahan, 2015a, 2015b, 2015c). When examining populations in rural, remote, and 
northern BC, it is clear that there are a significant number of patients with AUD and that 
these populations suffer health problems related to drinking (University of Victoria, 2017a, 
2017b). Furthermore, access to treatment services outside those offered by a primary care 
provider is limited (McEachern et al., 2016; Northern Health Authority, n.d.; Slaunwhite & 
Macdonald, 2015). Studies included in this review suggest that primary care providers have 
the capacity to effectively screen, assess, and treat patients with AUD; however, no studies 
have been undertaken to quantify or describe the success rates of primary care AUD 
treatment in these populations (British Columbia Ministry of Health, 2013; Jonas et al., 2014; 
Spithoff & Kahan, 2015a). In today’s current climate of finite health care funding and health 
care resources, it is important to directly study whether AUD is most effectively treated in 
the primary care setting or if specialized services show superior outcomes. This research 
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would enable policy makers to maximize the health care resources available for AUD 
treatment. 
 Further research is also needed to assess the barriers experienced by primary care 
providers treating AUD in rural, remote, and northern BC. Slaunwhite and Macdonald 
(2015) qualitatively described the experience of family physicians in “isolated” BC, which 
provided some valuable insight into the current challenges facing AUD treatment providers 
in this setting. However, this one article is only a small piece of what is needed to thoroughly 
examine the barriers faced by primary care providers when treating AUD in rural, remote, 
and northern BC. Research to directly assess these barriers would help primary care 
providers to cultivate strategies to work within the current health care system. In addition, 
clear analysis of these barriers would help policy makers develop systemic changes to 
facilitate more effective AUD treatment, with the goal of reducing AUD rates and disease 
burden.  
 There was robust evidence found in this integrative review for some specific AUD 
treatments modalities, including pharmacotherapy and the brief intervention counseling 
technique; however, only two studies included in this review addressed electronically 
delivered counseling modalities (Bertholet et al., 2005; Finfgeld-Connett, 2006; Jonas et al., 
2014; Staton-Tindall et al., 2012). These two articles did not address the efficacy of these 
interventions, indicating that more research is warranted for both Internet-based counseling 
and Telehealth based counseling options. If future research supports the utilization of 
electronically delivered counseling services, patients in rural, remote, and northern BC could 
benefit from improved access to specialist treatment without needing to leave their home 
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community. Furthermore, this research could provide policy makers with the evidence to 
appropriately allocate health care resources in the future.  
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CHAPTER FIVE: CONCLSION 
 Throughout my career as an emergency department RN, I observed many individuals 
who had consumed more alcohol then the Guidelines for Low-Risk Drinking recommend. 
This observation was present for many different populations, and was irrespective of gender, 
age, social status, race or religion. My time working as a RN in northern emergency 
departments compounded the sense that AUD was a much bigger health care, societal and 
financial issue than I had previously realized. During the course of my nurse practitioner 
education, I completed 532 hours of practicum experience in rural, remote and northern 
communities and I commonly observed alcohol-related health problems in these areas. These 
experiences further reinforced my belief that AUD is not only a significant cause of 
morbidity and mortality, but that there may also be areas that could be improved within 
primary care treatment of AUD. These experiences lead me to the research question for this 
integrative review, which was: in rural, remote, and northern primary care settings, what is 
the optimum treatment for adults with AUD? This integrative literature review produced 
some valuable insight into this very complex issue. 
 The focus area for this integrative review was northern BC, primarily because it was 
the site of the author’s nurse practitioner education, but also because it is a large 
geographical area that is sparsely populated. In addition, unlike urban areas of BC, accessing 
specific resources for AUD treatment often proves challenging for patients and primary care 
providers alike. It was important to investigate how best to approach the challenges of 
treating patients with AUD in the primarily care setting because both the BC and Canadian 
Guidelines for AUD include recommendations for referral to specialized AUD services; 
however, it also quickly became evident through the integrated review that one of the most 
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salient barriers to treatment was referral outside of the patient’s home community. Another 
reason that northern BC was chosen as the focus area for this integrative review was because, 
on average, people in this region tend to drink more than is considered safe by the Guidelines 
for Low-Risk Drinking, and they consequently experience higher rates of alcohol-related 
illness and death. Irrespective of the health effects, there is also a significant financial burden 
associated with AUD and, in the current era of finite health care resources, it is increasingly 
important to maximize potential benefits from available resources. 
 This integrative review elucidated five common themes within the literature that 
could provide avenues for improvement in the treatment of AUD in rural, remote, and 
northern BC. These themes were: screening for AUD; the brief intervention technique; 
electronically delivered counseling; pharmacotherapy; and universal trauma-informed 
practice. There was no evidence found to suggest that primary care providers currently 
working within the health care system in rural, remote and northern BC were 
underperforming in their roles; however, there were a number of recommendations for 
improvement that, if implemented, could enhance the AUD-specific health care available to 
patients within their home communities. The HBM was used to further explore and 
substantiate the five common themes found within the literature because it provided a 
foundational understanding of the complexities involved in AUD treatment, and it helped 
identify areas that could be enhanced within the rural, remote and northern primary care 
setting. Through the application of the HBM, this integrative review was able to identify 
barriers that could inhibit patients from participating in AUD treatment as well as identify 
possible methods to overcome these barriers.  
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  Nurse practitioners are becoming responsible for an increasingly larger portion of 
primary care delivery in rural, remote, and northern BC. Accordingly, it was important for 
this integrative review to highlight areas within nurse practitioner education that could be 
enriched in order to improve the care of patients with AUD. The educational topics identified 
for nurse practitioner education were: AUD as a focus in education; the brief intervention 
technique; pharmacotherapy for AUD, and universal trauma-informed practice. These 
educational topics satisfy domains within the CASN accreditation framework, and as such, 
cultivating them could be instrumental in advancing nurse practitioner practice and the care 
of patients with AUD. By implementing these changes within the formal nurse practitioner 
education process, future graduates could gain valuable knowledge and skills to care for 
patients with AUD in rural, remote, and northern BC.  
 Surprisingly, this integrative review did not find any studies that directly addressed 
the research question, which suggests that treatment of AUD is understudied in rural, remote, 
and northern populations. Since the findings from this integrative review indicate that AUD 
is a significant causal factor of morbidity and mortality in rural, remote, and northern 
populations, further research to address optimum treatment modalities in this population is 
warranted. Additional research is also needed to assess remission rates associated with 
primary care management versus specialist management of AUD. This research could assist 
policy makers with resource allocation to improve the care of patients with AUD.  
 Lastly, nurse practitioners hold a unique and privileged position within the current 
health care system in BC. It is my hope that this integrative review will expand knowledge 
and awareness of the primary care treatment options for AUD and thereby improve remission 
rates for individuals with AUD in rural, remote and northern practice settings. 
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APPENDIX 
Literature Review Matrix 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Allan, 2010) 
 
Engaging primary health care 
workers in drug and alcohol 
and mental health 
interventions: Challenges for 
service delivery in rural and 
remote Australia.  
 
New South Wales, Australia. 
 
Qualitative study. Sociological 
action research approach. 
Utilized semi-structured 
interviews.  
 
Evidence level 3 
 
Relatively large sample 
(n=47). 
 
In-depth, semi-structured 
interviews were used.  
 
Sociological action research 
framework was used.  
 
Qualitative data analysis 
software used. 
 
Themes were extracted from 
data sets and two actions were 
planned: 1) Further education 
and support for primary care 
workers. 2) Promote expertise 
in primary care by giving 
specialist primary care 
experience in order to better 
facilitate intervention in 
primary care. 
The study was undertaken by a 
drug and alcohol service 
provider. Some subjects were 
employed by this agency, 
possibly biasing data.  
 
Subjects not employed by the 
agency were made aware of 
the researchers ties to the 
agency. Possibly biasing data. 
 
Australian study – challenges 
faced in rural service delivery 
may be slightly different than 
my research population. 
Mental health problems and a 
trauma history often coexist 
with substance users.  
 
Conflict arises between 
primary care workers and 
specialized drug and alcohol 
services when the other’s 
perspective/professional scope 
is not well understood.  
 
Drug and alcohol problems 
were viewed by primary care 
workers as treatable, but if on 
going, they were viewed as 
weakness in the individual or 
lack of effective treatment 
from the drug and alcohol 
worker. 
 
Missed opportunities for 
change exist in remote areas 
because of long wait times to 
see specialists. 
 
Utility: Elucidates some of the 
experiences of treating 
substance use in the primary 
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and specialist care settings. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Bertholet et al., 2005) 
 
Reduction of alcohol 
consumption by brief alcohol 
intervention in primary care. 
 
Location unspecified 
 
Systematic review and meta-
analysis of (n=19) trials (n=24 
articles). Examines the 
efficacy of brief alcohol 
interventions in the primary 
care setting for patients that 
are not actively seeking 
alcohol-related treatment. 
 
Level of evidence 1 
Extensive database searches 
(n=612 articles screened). 
 
Two authors carried out study 
selection independently and in 
duplicate. A third author 
reviewed studies in dispute. 
 
Large pool of subjects 
(n=5639). 
 
Systematic review analysis 
was completed using a 
Cochrane review tool with 
additional elements from the 
Consolidated Standards of 
Reporting Trials  (CONSORT) 
statement.  
 
Meta-analysis was completed 
for primary outcome of 
alcohol consumption 
(expressed in grams per 
week). 
 
Conservative approach in the 
intention-to-treat analysis 
(missing data assigned to no-
change group). 
 
Some between-study 
heterogeneity was found 
(likely due to lack of detailed 
study-element description). 
 
The use of “standard 
treatment” as the control 
introduces heterogeneity. 
 
Authors unable to assess if the 
intervention was carried out 
effectively. 
 
No grey literature searched. 
BAI is effective to reduce 
alcohol consumption for both 
men and women at 6 and 12 
months post-intervention. 
 
Effect can be sustained for up 
to 48 months. 
 
Pooled reduction of 50g 
alcohol per week (5 drinks, or 
15% mean reduction). 
 
High-quality studies were 
more likely to report positive 
effects from the intervention 
(x2=3.9, p=0.048). 
 
No studies reported negative 
effects of intervention. 
 
No effect difference was 
found between men and 
women. 
 
Minimal between-study 
heterogeneity accounting for 
25.8% of outcome variance.  
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Robust statistical analyses 
(between-study heterogeneity, 
weighted averages, percent of 
outcome variation r/t 
heterogeneity, and publication 
bias). 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Brennan et al., 2013) 
 
Training general practitioners 
in remote Western Australia in 
a method of screening and 
brief intervention for harmful 
use: A pilot study. 
 
Western Australia 
 
Observational pilot study 
examining a model for 
training remotely located GP’s 
in screening and brief 
intervention techniques. 
 
Evidence level 3 
Likert scale used on 
questionnaire.  
 
T-test analysis for pre- and 
post-intervention comparison. 
 
Teaching session was 
conducted by a specialised 
clinical psychologist.  
 
Educational segments 
included standardized 
screening approaches, 
motivational interview 
principles, and the validated 
brief intervention technique 
SLEEP (Setting the stage, 
Listening for change talk, 
Exploring the importance and 
confidence, Exchange of 
information, Putting it all 
together).  
Small pilot study (n=8) 
 
For confidentiality reasons 
(small/remote community), no 
demographic information was 
collected. 
 
Non-validates pre-workshop 
and post-training 
questionnaires.  
 
Response bias could have 
been introduced because post-
intervention surveys response 
rate was low. GP’s that 
utilized the techniques in their 
practices may have been more 
likely to respond.  
 
Australian study – training 
may be different for Canadian 
primary care providers. 
6-months post intervention, 
respondents found training to 
improve knowledge and 
confidence with treat with BI. 
 
The intervention increased 
frequency of screening and BI 
in participants practice. 
 
Internet or tele-health training 
may be a feasible way to reach 
rural and remote GP’s for 
training purposes. 
 
Utility: Training primary care 
practitioners in brief 
intervention and motivational 
interview techniques may 
increase their use in practice. 
Article / Study Design and 
Overview / Evidence Level 
Strengths  Limitations Utility and Important Findings 
(Ferguson et al., 2003) Barriers stratified using Likert Dated article Patient denial and lack of 
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Barriers to identification and 
treatment of hazardous 
drinkers as assessed by 
urban/rural primary care 
doctors.  
 
Washing and Idaho, USA 
 
Cross-sectional survey design. 
 
Aim of the study is to 
determine the nature of 
barriers for family physicians 
to screen, identify, and 
intervene with hazardous 
drinking and alcohol 
dependence. Three groups of 
barriers were evaluated: 
patient centered, physician 
centered, and systemic 
centered. 
 
Level of evidence 3 
 
scale (widely used and 
accepted). 
 
Statistical analyses for 
distributions were performed 
by computerized software. T-
test was used to compare 
dichotomous values and then 
significance was checked via 
the chi-squared test.   
 
 
Small sample size of 
physicians surveyed (n=40).  
 
Most physicians surveyed 
were male (n=37). 
 
Selection bias (no 
randomizations). 
 
Answers from the Likert scale 
were grouped into 
dichotomous values (is a 
barrier, or is not a barrier), 
potentially limiting the depth 
of the conclusions drawn.   
 
Rural Washington and Idaho 
may not represent rural 
Canadian populations. 
patient motivation were 
ranked the highest barriers to 
identification and treatment of 
alcohol problems (patient-
centered category). 
 
Lack of physician time and 
lack of addictions training 
were ranked as lowest on the 
barriers to identification and 
treatment. 
 
The more problematic the 
patient’s denial/lack of 
motivation, the less 
problematic the physician time 
and education were rated 
(negative correlation). 
Potentially limiting physician 
assessment/treatment in more 
severe addiction. 
 
Younger and rural-based 
physicians ranked system 
centered category (ie. distance 
to treatment) highest on the 
barrier list.  
 
Rural patients were believed 
to be in self-help groups or 
treatment significantly less 
than urban patients. 
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Article / Study Design and 
Overview / Evidence Level 
Strengths  Limitations Utility and Important Findings 
(Finfgeld-Connett, 2006) 
 
Web-based treatment for 
problem drinking. 
 
United States 
 
This is a non-systematic  
review of 14 exploratory and 
evaluative studies on web-
based alcohol treatment 
services. 
 
Evidence level 3  
 
Searched multiple academic 
databases (CINAHL, Medline, 
and PsychINFO) 
 
Description of motivational 
interviewing, which is the 
theoretical basis for the web-
based interventions. 
 
Dated article. 
 
Non-systematic review of 
literature.  
 
Not an exhaustive literature 
search.  
 
Does not detail search method, 
databases used, 
inclusion/exclusion criteria, or 
analysis techniques.  
 
No detailing or discussion of 
statistical analyses.  
 
  
Web-based treatment is more 
popular with woman than 
men. Potentially because of 
stigma associated with seeking 
treatment for AUD. Treatment 
groups are typically male 
dominated, which may present 
a barrier for some women to 
utilizing this format.   
 
Web-based treatment can be 
accessed by most members of 
society, including 
marginalized populations. 
 
Internet access can be a barrier 
for those who live rurally, or 
those who would require 
public internet connections, 
such as at the library 
(confidentiality barrier).  
 
English language literacy may 
also be barrier. 
 
More research is suggested to 
elucidate the effects of web-
based treatment of patterns of 
abuse, problem severity, and 
chronicity. 
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Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Hiller et al., 2007) 
 
Client outcomes for rural 
substance abuse treatment. 
 
Kentucky, USA 
 
Six-month cohort study. 
N=604 clients admitted to 
rural substance abuse 
treatment, ≥ 18 years old, not 
admitted for educational 
purposes (eg, DUI), and not 
being admitted for mental 
health or mental retardation 
(sic) purposed. 
  
Evidence level 3 
Addictions Severity Index Lite 
(ASI–Lite) instrument is a 
validated instrument. 
 
Sample size (n=604). 
 
Follow-up interviews were 
primarily by telephone with 
some face-to-face sessions; 
yielding a 95% follow-up rate. 
 
Changes over time were 
analysed for significance using 
the chi-squared test and the t-
test. 
Data collected seven years 
prior to publication date.  
 
Lack of blinding and 
randomization is a weakness, 
which impairs this study’s 
generalizability. 
 
This study relies solely on 
self-reporting (? Response 
bias). 
 
Study participants were mostly 
white males limiting 
generalizability.  
 
Study did not focus on alcohol 
use but incorporated many 
different substances and 
criminality.  
 
Kentucky population studied 
may be affected differently by 
treatment than my research 
population. 
 
Rural inpatient programs are 
likely not available in rural 
Canada. 
Statistically significant 
reductions were noted with 
rural treatment programs for: 
alcohol use to intoxication 
p<.001, and for average 
number of days of alcohol use 
to intoxication p<.05 (these 
were inpatient programs). 
 
Less significant improvements 
were noted in the outpatient 
treatment modality (reasoned 
that the patients referred to 
outpatient services had less 
severe disease at the outset, 
thus had less room to 
improve). 
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Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations  Utility and Important Findings 
(Jonas et al., 2014) 
 
Pharmacotherapy for adults 
with alcohol use disorders in 
the outpatient setting. 
 
USA article including 
international studies. 
 
Systematic Review of RCTs 
with meta-analyses to assess 
the benefits and harms of US 
FDA approved medications 
(naltrexone, acamprosate, and 
disulfiram) for reduction of 
drinking behaviours. Off-label 
medications were also 
included. 
 
Studies: 151 articles from 123 
studies. 95 articles included in 
meta-analysis. Study dates 
from years 1970-2013. 
 
Participants: n=22803 patients 
with alcohol use disorders per 
the DSM criteria (no 
restrictions on age, gender, or 
coexisting conditions). 
 
Evidence level 1 
Large and thorough systematic 
review with meta-analysis. 
 
Robust statistical analysis: 
random-effects model for RCT 
meta-analyses, weighted mean 
difference for continuous 
variables, risk differences for 
binary variables, funnel plots 
for bias, and I2 for 
heterogeneity. 
 
Statistical significance was 
assumed when 95% CIs of 
pooled results did not cross 0. 
 
Studies that were at a high or 
unclear risk of bias were not 
included in the main analysis. 
 
Graded strength of evidence 
by established/validated 
method.   
 
US FDA approved medicines 
are the same as the Canadian 
approved meds for AUD. 
Substantial between-study 
heterogeneity. I2 (28% - 
greater than 60%) 
 
Concurrent psychosocial 
interventions are briefly 
discussed, but not accounted 
for in the meta-analysis due to 
heterogeneity of the 
interventions. 
 
Costs are discussed in terms of 
side effects only, not financial 
costs, or morbidity and 
mortality.  
 
Naltrexone and acamprosate  
NNT to prevent return to any 
drinking was 12 and 20 
respectively.  
 
NNT to return to heavy 
drinking was 20 for 
naltrexone.  
 
No statistical difference in 
affect between acamprosate 
and naltrexone for alcohol 
consumption.  
 
Generally tolerable to patients, 
with acamprosate being more 
tolerable than naltrexone. 
 
Disulfiram results were 
inconclusive. No investigation 
of a supervised delivery 
system. 
 
Naltrexone/acamprosate 
benefits to patients are modest 
but should not be overlooked 
given the relative tolerability 
of these drugs. 
 
Given their current 
underutilization, naltrexone 
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and acamprosate may 
represent a valuable adjunct in 
primary care because patients 
may be unwilling or unable to 
access specialist care. 
 
For patients who adhere 
strictly to the medication 
regime, their results would 
likely be more positive than 
this review demonstrates, 
because dropouts were 
assigned to the relapse 
category. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Malek-Ahmadi & Degiorgio, 
2015) 
 
Risk of alcohol abuse in urban 
versus rural DUI offenders. 
 
Nebraska, USA 
 
This is a cross-sectional study 
that examines the relationship 
between living in an urban or 
rural setting, and the 
difference in alcohol use 
behaviours in previous DUI 
offenders. 
 
Evidence level 3 
Large sample size (n=11,066) 
 
Use of validated tool to 
stratify substance-related risky 
driving behaviours (Driver 
Risk Inventory II) 
 
Statistics: t-test for continuous 
variables. Chi-squared for 
frequency among categorical 
variables. Cohen’s d for effect 
sizes differences in continuous 
variables. Cronbach’s alpha 
for internal consistency of 
each of the scales. Logistical 
regression was performed to 
assess associations between 
Tool uses a “truthfulness 
scale” to try and identify 
individuals who minimize 
their alcohol problem. Those 
who scored severe were 
omitted from the analysis 
(effect of this is unclear). 
 
Self-reporting method for risk 
behaviours places data at risk 
for recall bias. This sample 
was already involved with the 
legal system, potentially 
increasing bias.  
 
Study participants were 
primarily young-adult, 
Rural DUI offenders are 
slightly more likely to report 
problem alcohol use compared 
to their urban counterparts. 
 
Rural DUI offenders are 
slightly more likely to belong 
to the Medium, Problem, and 
Severe alcohol subscales than 
their urban counterparts. 
 
Utility: Rural populations are 
at greater risk for risky driving 
behaviours, thus may have a 
greater health/safety benefit 
from treatment. 
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risk categories and urban/rural 
status. 
 
No demographic differences 
other than blood alcohol 
content, which was actually 
quite small (likely driven by 
the large sample size).  
 
Caucasian, and male. Limiting 
generalizability. 
 
Data only from Nebraska, not 
representative of USA as a 
whole, and may not be 
consistent with my research 
population. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Marienfeld et al., 2014) 
 
Long-acting injectable depot 
naltrexone use in Veterans’ 
Health Administration: A 
national study. 
 
USA  
 
This is a cross-sectional study 
to examine prescription rates 
of depot naltrexone in 
qualifying veterans with AUD 
during the 2010 fiscal year. 
Depot naltrexone was FDA 
approved in 2006. 
 
Evidence level 3 
Large sample (n=101,026) 
 
T-test for bivariate continuous 
data. 
Chi-squared test for 
categorical significance (those 
prescribe depot naltrexone and 
those not). 
Multivariate logistical 
regression was used to identify 
factors linked to filling and 
being prescribed a depot 
naltrexone prescription.  
 
Examines prescription rates in 
normal clinical settings. 
 
 
Sample is predominately 
males (96%) and middle-aged.  
 
No data on compounding 
factors for lack of 
prescriptions (liver disease or 
other prescriptions). 
 
No data regarding reasoning 
behind the decision to use 
naltrexone or not. 
 
Sample population may not 
represent my research 
population. 
Patients with severe mental 
illness were more likely to 
receive a prescription for 
depot naltrexone. The 
reasoning for this is unclear. 
 
Efficacy and tolerability of 
depot naltrexone has been 
established. 
 
Only 7.5% of those receiving 
naltrexone received the depot 
formulation (0.24% of total 
sample).  
 
Reasons for lack of depot 
naltrexone prescriptions are 
unclear. More research is 
needed. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Mark et al., 2003) An experienced facilitator and Dated article (though there Generalised lack of 
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Barriers to the use of 
medication to treat alcoholism. 
 
Washington DC and Virginia, 
USA 
 
Qualitative design utilizing 
two focus groups.  
 
Aim was to understand both 
patient and physician attitudes 
towards medications used to 
treat alcoholism.  
 
Evidence level 3. 
co-facilitator chaired the focus 
groups.  
 
Diverse sample in the focus 
groups.  
 
Many barriers to prescribing 
medications for AUD were 
identified.  
 
The study did succeed in 
answering its research 
question. 
does not appear to be any 
contemporary articles 
addressing this question).  
 
Small sample size; n=11 
physicians, and n=11 patients. 
 
No statistical analysis of 
subject demographics. 
 
No electronic data analysis 
software was used.  
 
Only assessed naltrexone and 
disulfiram because that they 
were the only approved agents 
at the time. 
 
Questionable significance of 
each barrier identified because 
the study did not have a 
representative sample.  
 
Sample may not represent my 
research population. 
information for patients and 
prescribers about naltrexone 
limits its use.  
 
Perceived lack of efficacy and 
perceived insufficient research 
dissemination to prescribers. 
Effect size is perceived as 
small.  
 
Cost-benefit analysis is 
questionable with naltrexone 
($5 per pill) if patients have to 
pay. 
 
Programs focussed on 
abstinence were more likely to 
request disulfiram.  
 
Concerns regarding stigma 
may inhibit patients from 
seeking treatment. 
 
Primary care prescribers 
echoed the lack of familiarity, 
and reported difficulty with 
continuity of care. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Moos & Moos, 2006) 
 
Rates and predictors of relapse 
after natural and treated 
Large sample (n=461). 90% of 
the sample completed at least 
two of the four follow-up 
intervals.  
Dated article.  
 
Sample is mostly Caucasian. 
 
Self-efficacy, not avoidance 
coping showed greater chance 
of successful remission. 
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remission of alcohol use 
disorders.  
 
USA 
 
Prospective cohort study 
comparing relapse and 
remission rates between 
individuals who were treated 
for AUD and those who were 
not treated. Follow up was 
completed one year, three 
years, eight years, and 16 
years later.  
 
Evidence level 3 
 
Survey: questions to assess 
drinking based on the DSM-
III-R diagnostic criteria. Also 
included previously employed 
tools (Health and Daily Living 
form, and the Life stressors 
and Social Resource 
Inventory).  
 
Robust statistical analysis. 
Chi-squared test to compare 
helped, vs no help groups, as 
well as, AA treatment vs no 
AA treatment in two-three 
year and four-eight years 
groups.  
 
Two-way analysis of variance 
(ANOVA) was used to 
compare demographics and 
life history, and baseline 
drinking factors.  
 
Partial correlation and logistic 
regression analyses used to 
identify predictors of three-
year remit and 16 year relapse.  
 
Results from this study are 
compared with previously 
published study results. 
Sample self-selected 
themselves, thus may have 
been more motivated to 
change. Sample had already 
recognized the problem and 
sought help.   
 
Sample had never been in 
treatment before and were at 
relatively earlier stages of 
alcohol use disorder.  
 
Examining six-month 
windows of drinking 
behaviours at each follow up 
time may not have accounted 
for the sample’s entire 16 
years alcohol history.   
 
Sample may not represent my 
research population. 
Treatment and/or AA were 
positively associated with 
greater rates of remission at 
three years. 
 
Individuals who remitted 
without help were more likely 
to relapse (relapse rate of 
60%).  
 
Predictive factors for short-
term remission include: female 
sex, older age, and more 
socioeconomic resources.  
 
Predictive factors for relapse 
after remission: less education, 
lower likelihood of 
employment, more lifetime 
drinking problems, more 
frequent consumption when 
remitted, view drinking as less 
problematic, report less self-
efficacy, and relied more on 
drinking to reduce tension.  
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Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and important findings 
(Navarro et al., 2011) 
 
The potential cost-
effectiveness of general 
practitioner delivered brief 
intervention for alcohol 
misuse: Evidence from rural 
Australia. 
 
New South Wales, Australia 
 
A cross-sectional study using 
a survey mailed to randomly 
selected individuals within 10 
rural communities. Data used 
in combination with 
previously published census 
values to model the cost 
effectiveness of GP delivered 
screening and/or BI for AUD. 
 
Evidence Level 3 
Large sample size (n=1540).  
 
Use of AUDIT tool, which is 
validated and widely used. 
 
Addresses a difficult question 
to research. 
Randomization technique is 
not described. 
 
Questions used in the survey 
were of unknown validity. 
 
Combining survey data with 
community data may limit 
accuracy of estimates. 
 
Sample demographics are not 
clearly laid out for accurate 
analysis of population 
representation. 
 
Appears to over-estimate 
effect of BI and screening 
compared to other studies. 
 
Australian sample may not 
represent my research 
population. 
Projects that if all GPs in rural 
Australia employed screening 
and BI, reduction of risky 
drinking to low-risk levels 
would improve from 0.7% 
(current rates) to 36% per year 
= cost effective way to 
improve drinking rates. 
 
Difficult to implement 
universal screening and BI 
because of independent 
practice preferences, education 
challenges in BI techniques, 
policy for training, and 
difficulty accessing young 
male drinkers 
(disproportionately high rates 
of risky drinking who are less 
likely to access care). 
 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations  Utility and Important Findings 
(Navarro et al., 2012) 
 
The cost-effectiveness of 
tailored, postal feedback on 
general practitioners’ 
prescribing of 
pharmacotherapies for alcohol 
Large study (n=155,170) in 20 
communities.  
 
Use of AUDIT tool 
(validated).  
 
Demographics between each 
Randomization technique not 
described. 
 
More GPs in the control group 
(n=160) compared to the 
experimental group (n=115).  
 
When GPs were informed 
about the number of drinker’s 
in their communities that 
could benefit from 
pharmacotherapy, Rx rates for 
acamprosate increased and 
naltrexone decreased (overall 
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dependence. 
 
New South Wales, Australia 
 
This is a RCT to evaluate the 
cost-effectiveness of tailored 
postal feedback on GP 
prescription of acamprosate 
and naltrexone; and to see if a 
change is prescription rate 
would impact alcohol 
dependence hospitalizations. 
 
Evidence level 1 
 
community were matched in 
pairs, then each pair was 
randomized to experimental or 
control.  
 
Multiple imputation method 
was used to complete 
hospitalization and 
prescriptions rate that were 
retained by Medicare Australia 
to protect confidentiality  
(<8.2% of the longitudinal 
sample). 
 
Funding source is divulged. 
Number of drinkers in each 
community was estimated by a 
previously completed survey, 
which only had a 40% 
response rate.  
 
This study used the number of 
prescriptions filled to 
represent the number of 
prescriptions written by GPs. 
Bias may be introduced 
because one drug may be 
filled less than the other. 
 
Hospital admissions were 
recorded only if the admission 
ICD-10 code was alcohol-
related. This may bias data.  
 
Australian sample may not 
represent my research 
population. 
increased in pharmacotherapy 
use). 
 
In the quarter after the 
intervention was made, 
hospitalizations for alcohol 
dependence were significantly 
reduced.  
 
Cost-savings were found to be 
$3243 AUD per extra 
prescription (with the 
associated reduction in 
hospital costs). 
 
Utility: An increase in 
pharmacotherapy may reduce 
hospital admissions for 
alcohol dependence. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Shakeshaft, Petrie, Doran, 
Breen, & Sanson-Fisher, 
2012) 
 
An empirical approach to 
selecting community-based 
alcohol interventions: 
Combining research evidence, 
rural community views and 
Rural community survey 
response rate was 39% 
(n=2977), which is better than 
governmental surveys 
preceding this study. 
 
Tobit regression model did not 
show an association between 
professionals’ characteristics 
Professional response rate was 
20% (n=41). 
 
Over-representation of women 
and elderly people in rural 
respondents. 
 
Unclear if the professionals 
were rural or urban-based.  
Rural respondents selected in 
order of preference: school-
based interventions, promotion 
of safer drinking practices 
(training of premises staff and 
media advocacy), community-
wide activity (group 
integration, social work, 
counselling services, and 
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professional opinion. 
 
Australia 
 
This is a cross-sectional study 
to elicit the alcohol-related 
intervention preferences of 
rural communities and 
professional.  
 
Evidence level 3 
 
and their responses. 
 
 
Australian sample may not 
represent my research 
population. 
community development 
programs), and police activity 
(enforcement of liquor laws).  
 
Professional respondents 
selected in order: GP and 
hospital/ED training, school-
based interventions, 
community programs, and 
promoting safer drinking 
practices. 
 
Impact of these strategies is 
unclear.  
 
Utility: Rural communities 
support integration of alcohol 
reducing strategies in the 
school system and with the 
community. Harm-reduction 
may be the most viable in the 
school setting. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Slaunwhite & Macdonald, 
2015) 
 
Alcohol, isolation, and access 
to treatment: Family physician 
experiences of alcohol 
consumption and access to 
health care in rural British 
Columbia 
Respondents had an average 
of 15.8 years of experience in 
primary care.  
 
Inductive theoretical 
framework for data analysis is 
appropriate given the authors 
did not know the response 
themes prior to the research.  
Study response rate of 22% 
(n=67) limiting 
generalizability.  
 
Survey instrument was not 
previously validated. 
Limited alcohol related 
services in rural communities 
(lack of: detoxification and 
residential care). 
 
Barriers to accessing treatment 
include: long wait lists, travel 
costs, treatment costs, 
transportation issues, lost 
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BC, Canada 
 
Qualitative design using a 
cross-sectional survey. 
 
Evidence level 3 
 
Rural Coordination Centre of 
BC scoring system used to 
select physicians with rural 
primary care practices. 
 
Survey was piloted on 8 
administrator and substance 
use researchers.  
 
Minimal researchers influence 
over the responses because it 
was a survey.  
 
Study answered its original 
research question. 
 
 
work (opportunity costs), and 
family commitments  
 
Relapse on returning to home 
community is exceedingly 
common. 
 
Lack of First Nations specific 
and trauma informed care 
options. 
 
Lack of confidentiality when 
seeking treatment in 
small/rural communities.  
 
Utility: Population and 
geographical location are 
directly applicable to my 
integrative review. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Spithoff & Kahan, 2015a) 
 
Paradigm shift: Moving the 
management of alcohol use 
disorders from specialized 
care to primary care. 
 
Canada 
 
Non-systematic review article. 
Contrasts specialist vs primary 
care treatment of patients with 
Utilizes contemporary 
research to support 
conclusions.  
 
Canadian article that is 
applicable to my research 
population.  
 
This non-systematic review 
article.  
 
No details regarding the 
literature search, inclusion or 
exclusion criteria, or literature 
evaluation. 
Highlights the limitations of 
specialist care: frequently 
missed appointments (30-75% 
no show rates), lack of 
accessibility (costs, transport, 
logistics), and the lack of 
therapeutic alliance between 
specialist and patient. 
 
Highlights the benefits of 
primary care management: 
increased accessibility, 
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AUD.   
 
Evidence level 3 
increased follow-up on missed 
appointments (longitudinal 
care), less costs associated 
with access, and an established 
therapeutic relationship. 
 
Primary care management for 
moderate to severe AUD 
should include: frequent BI 
counselling sessions, 
prescription AUD 
medications, and connecting 
patients to other addictions 
and mental health services. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Spithoff & Kahan, 2015b) 
 
Primary care management of 
alcohol use disorder and at-
risk drinking. Part 1: 
Screening and assessment. 
 
Canada 
 
This is the first of a two-part 
non-systematic literature 
review series. Aim was to 
create evidence-based 
guidance for screening and 
assessment of primary care 
patients with at-risk drinking 
and AUD. 
Mostly contemporary 
literature included, except 
where more dated literature is 
still used as the gold-standard 
(validation of CAGE and 
AUDIT tools, and alcohol 
withdrawal treatment).  
 
Utilizes Canadian and 
international statistics and 
guidelines.  
 
Utilizes RTC’s, systematic 
reviews, and a meta-analysis. 
 
Canadian article that is 
applicable to my research 
Non-systematic review of 
literature.  
 
Not an exhaustive literature 
search.  
 
Does not detail search method, 
databases used, 
inclusion/exclusion criteria, or 
analysis techniques.   
All patients should be 
screened (using a validated 
screening tool) at least yearly 
for at-risk drinking and AUD. 
Screening also should include 
a PE and Labs. 
 
Strong association between 
mental health and substance 
use. 
 
Strong association between 
trauma and substance use. 
 
Suggests screening for at-risk 
dependant children. 
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Evidence level 3  
 
population. Suggests screening for 
drinking and driving habits. 
 
Suggests screening for 
children who may be at risk in 
the home. 
 
Advises against prescriptions 
for in-home withdrawal. 
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations Utility and Important Findings 
(Spithoff & Kahan, 2015c) 
 
Primary care management of 
alcohol use disorder and at-
risk drinking. Part 2: Counsel, 
prescribe, connect. 
 
Canada 
 
This is the second of a two-
part non-systematic literature 
review series. Aim was to 
create evidence-based 
guidance for management of 
primary care patients with at-
risk drinking and AUD. 
 
Evidence level 3 
Mostly contemporary 
literature included, except 
where more dated literature is 
still used as the gold-standard 
(validation of CAGE and 
AUDIT tools, and alcohol 
withdrawal treatment).  
 
Utilizes Canadian and 
international statistics and 
guidelines.  
 
Utilizes RTC’s, systematic 
reviews, and meta-analyses. 
 
Canadian article that is 
applicable to my research 
population.  
 
Non-systematic review of 
literature.  
 
Not an exhaustive literature 
search.  
 
Does not detail search method, 
databases used, 
inclusion/exclusion criteria, or 
analysis techniques.   
BI effective for mild AUD.  
 
Counselling and 
pharmacotherapy in the 
primary care setting is as 
effective in reducing heavy 
drinking as specialized 
addictions management.  
 
High-rates of engagement with 
primary care, trusting 
relationship already in place, 
little to no delay for treatment, 
frequent/long-term follow-up.  
 
Three arms of treatment in 
primary care: counsel, and if 
indicated (mod-severe AUD) 
prescribe and connect with 
addictions and mental health 
services.  
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If medications are prescribed 
early in treatment, it may 
improve outcomes. 
 
Council with frequent 
appointments. Strong 
relationship helps improve the 
success. 
 
Connect to support groups, 
counselling services, treatment 
programs, trauma services, 
and addictions medicine. 
 
Utility: Mostly applicable to 
the rural setting; however, 
connecting and having patients 
follow up with specialized 
care is a barrier.    
Article / Study Design and 
Overview / Evidence Level 
Strengths Limitations  Utility and Important Findings 
(Staton-Tindall et al., 2012) 
 
Telemedicine-based alcohol 
services for rural offenders. 
 
Kentucky, United States 
 
This is a preliminary report for 
a RCT of the telemedicine 
delivered motivational 
enhancement therapy to 
previously incarcerated 
Computerized randomization.  
 
Great lengths (federal 
confidentiality warrant, and 
private sessions) to maintain 
confidentiality for the study 
participants.  
 
Use of validated AUDIT tool 
to assess participants’ 
eligibility.  
 
Preliminary article. Full trial 
has not been published. 
 
Predominantly young, white 
males in the study. This is a 
good representation of the 
population in this area, 
however, it limits 
generalizability.  
 
Alcohol use was based on self-
reporting prior to 
This population reports very 
high alcohol use, an average 
of 15.3 drinks per day.  
 
Only 1/3 of the population had 
ever received treatment for 
alcohol use.  
 
2/3 of the population reported 
alcohol was a factor in the 
crime that lead to 
incarceration.  
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participants on parole. This 
report focuses on creating a 
profile of at-risk rural alcohol 
users, describing the 
intervention, and describing 
the telemedicine-based 
approach.  
 
Evidence level 1 
Use of the Addictions Severity 
Index to grade alcohol use. 
 
Computerized randomization. 
incarceration. Potential to 
introduce recall bias. 
 
Preliminary results indicate 
that telemedicine may be a 
feasible option for rural 
populations. 72.7% 
participating in some of the 
telemedicine session, and 50% 
completing all of the sessions. 
 
